type sequence filename description text html head title title head body bgcolor white style margin margin bottom font size font family time roman align right exhibit style margin margin bottom font size font family time roman align right execution version confidential style margin margin bottom font size font family time roman align center confidential material omitted filed separately with style margin margin bottom font size font family time roman align center security exchange commission double asterisk denote omission style margin margin bottom font size font family time roman align center license development agreement style margin margin bottom font size font family time roman align center dated august style margin margin bottom font size font family time roman align center between style margin margin bottom font size font family time roman align center emergent product development seattle style margin margin bottom font size font family time roman align center morphosys style page break before always size style color width align center style margin margin bottom font size font family time roman align center table content style font size margin margin bottom nbsp table cellspacing cellpadding width border style border collapse collapse font family time roman font size align center width valign bottom width width valign bottom width style font family time roman font size valign bottom style margin margin bottom margin left text indent font size font family time roman article nbsp valign bottom nbsp valign bottom nowrap definition valign bottom nbsp nbsp nowrap valign bottom nbsp nowrap valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign bottom style margin margin bottom margin left text indent font size font family time roman article nbsp valign bottom nbsp valign bottom nowrap license valign bottom nbsp nbsp nowrap valign bottom nbsp nowrap valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp valign bottom grant morphosys valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp valign bottom grant emergent valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp valign bottom additional licensing provision valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp valign bottom transfer emergent know valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp valign bottom performance affiliate subcontractor sublicensees valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp valign bottom exclusivity valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp valign bottom right first negotiation valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp valign bottom restrictive covenant valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign bottom style margin margin bottom margin left text indent font size font family time roman article nbsp valign bottom nbsp valign bottom nowrap governance valign bottom nbsp nbsp nowrap valign bottom nbsp nowrap valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp valign bottom joint steering committee valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp valign bottom joint steering committee membership valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp valign bottom joint steering committee meeting valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp valign bottom decision making valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp valign bottom dispute resolution procedure valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp valign bottom expert resolution dispute valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp valign bottom limit committee authority valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp valign bottom committee valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp valign bottom intellectual property committee valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp valign bottom minute committee meeting valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp valign bottom action valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp valign bottom exchange information valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp valign bottom alliance manager valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp valign bottom commercialization issue discussed party valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign bottom style margin margin bottom margin left text indent font size font family time roman article nbsp valign bottom nbsp valign bottom nowrap development valign bottom nbsp nbsp nowrap valign bottom nbsp nowrap valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp valign bottom overview valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp valign bottom objective under development plan valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp valign bottom development plan development budget valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp valign bottom development cost valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp valign bottom record report information valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp valign bottom development data valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp valign bottom sole funded activity valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp table style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center table cellspacing cellpadding width border style border collapse collapse font family time roman font size align center width valign bottom width width valign bottom width style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp valign bottom valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp valign bottom right audit valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign bottom style margin margin bottom margin left text indent font size font family time roman article nbsp valign bottom nbsp valign bottom nowrap regulatory valign bottom nbsp nbsp nowrap valign bottom nbsp nowrap valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp valign bottom regulatory data regulatory material valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp valign bottom regulatory filing regulatory approval valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp valign bottom communication valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp valign bottom adverse event reporting safety data exchange medical inquiry valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp valign bottom regulatory authority communication received party valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp valign bottom recall withdrawal market notification product valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign bottom style margin margin bottom margin left text indent font size font family time roman article nbsp valign bottom nbsp valign bottom nowrap commercialization valign bottom nbsp nbsp nowrap valign bottom nbsp nowrap valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp valign bottom commercialization territory valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp valign bottom both party performance valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp valign bottom compliance valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp valign bottom sale representative medical science liaison valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp valign bottom promotional material valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp valign bottom product mark valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign bottom style margin margin bottom margin left text indent font size font family time roman article nbsp valign bottom nbsp valign bottom nowrap supply valign bottom nbsp nbsp nowrap valign bottom nbsp nowrap valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp valign bottom general valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp valign bottom development supply valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp valign bottom commercial supply valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp valign bottom packaging labeling certain other manufacturing activity valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp valign bottom quality agreement valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp valign bottom product specification manufacturing change valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp valign bottom retention valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp valign bottom handling storing morphosys valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp valign bottom shortage risk mediation shortage valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp valign bottom failure supply serious supply risk valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp valign bottom third party manufacturing valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign bottom style margin margin bottom margin left text indent font size font family time roman article nbsp valign bottom nbsp valign bottom nowrap payment valign bottom nbsp nbsp nowrap valign bottom nbsp nowrap valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp valign bottom upfront license valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp valign bottom milestone payment valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp valign bottom royalty payment emergent valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp valign bottom royalty payment report valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp valign bottom third party royalty other payment valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp table style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center table cellspacing cellpadding width border style border collapse collapse font family time roman font size align center width valign bottom width width valign bottom width style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp valign bottom withholding valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp valign bottom currency conversion valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp valign bottom general payment procedure valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp valign bottom late payment valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp valign bottom development cost reimbursement procedure joint regulatory cost incurred valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp valign bottom record audit valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp valign bottom cost valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp valign bottom emergent royalty payment morphosys valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign bottom style margin margin bottom margin left text indent font size font family time roman article nbsp valign bottom nbsp valign bottom nowrap intellectual property matter valign bottom nbsp nbsp nowrap valign bottom nbsp nowrap valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp valign bottom invention related intellectual property right valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp valign bottom patent prosecution maintenance emergent patent valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp valign bottom patent prosecution maintenance emergent platform patent emergent manufacturing patent valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp valign bottom patent prosecution maintenance morphosys applied patent valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp valign bottom patent prosecution maintenance joint patent valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp valign bottom defense enforcement patent valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp valign bottom patent term extension valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp valign bottom patent marking valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp valign bottom patent challenge valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign bottom style margin margin bottom margin left text indent font size font family time roman article nbsp valign bottom nbsp valign bottom nowrap representation warranty covenant valign bottom nbsp nbsp nowrap valign bottom nbsp nowrap valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp valign bottom mutual representation warranty valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp valign bottom additional representation warranty emergent valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp valign bottom covenant emergent valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp valign bottom covenant morphosys valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp valign bottom disclaimer valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp valign bottom other representation warranty valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign bottom style margin margin bottom margin left text indent font size font family time roman article nbsp valign bottom nbsp valign bottom nowrap indemnification valign bottom nbsp nbsp nowrap valign bottom nbsp nowrap valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp valign bottom indemnification emergent valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp valign bottom indemnification morphosys valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp valign bottom indemnification procedure valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp valign bottom limitation liability valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp valign bottom insurance valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign bottom style margin margin bottom margin left text indent font size font family time roman article nbsp valign bottom nbsp valign bottom nowrap confidentiality valign bottom nbsp nbsp nowrap valign bottom nbsp nowrap valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp valign bottom confidential information valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp table style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center table cellspacing cellpadding width border style border collapse collapse font family time roman font size align center width valign bottom width width valign bottom width style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp valign bottom confidentiality obligation valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp valign bottom extended protection confidential information valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp valign bottom return confidential information valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp valign bottom permitted disclosure valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp valign bottom notification valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp valign bottom publicity filing this agreement valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp valign bottom publication valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp valign bottom name valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp valign bottom survival valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign bottom style margin margin bottom margin left text indent font size font family time roman article nbsp valign bottom nbsp valign bottom term termination valign bottom nbsp nbsp nowrap valign bottom nbsp nowrap valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp valign bottom term valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp valign bottom morphosys termination convenience valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp valign bottom termination breach bankruptcy patent challenge valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp valign bottom covenant amend development plan after notice termination delivered responsibility development cost until termination valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman article nbsp valign bottom nbsp valign bottom effect termination other remedy material breach default bankruptcy patent challenge termination convenience valign bottom nbsp nbsp nowrap valign bottom nbsp nowrap valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp valign bottom termination morphosys convenience termination emergent morphosys breach bankruptcy patent challenge prior latest emergent termination date valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp valign bottom remedy emergent morphosys breach bankruptcy patent challenge after latest emergent termination date valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp valign bottom termination morphosys emergent breach bankruptcy patent challenge prior completion phase clinical trial dose escalation phase valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp valign bottom remedy morphosys emergent breach bankruptcy patent challenge valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp valign bottom expiration this agreement valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp valign bottom accrued right valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp valign bottom survival valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp valign bottom joint patent valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp valign bottom right bankruptcy valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign bottom style margin margin bottom margin left text indent font size font family time roman article nbsp valign bottom nbsp valign bottom dispute resolution valign bottom nbsp nbsp nowrap valign bottom nbsp nowrap valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp valign bottom dispute valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp valign bottom arising between party valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp valign bottom dispute resolution valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp table style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center table cellspacing cellpadding width border style border collapse collapse font family time roman font size align center width valign bottom width width valign bottom width style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp valign bottom patent trademark dispute resolution valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp valign bottom arbitration valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp valign bottom injunctive relief valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign bottom style margin margin bottom margin left text indent font size font family time roman article nbsp valign bottom nbsp valign bottom nowrap miscellaneous valign bottom nbsp nbsp nowrap valign bottom nbsp nowrap valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp valign bottom entire agreement amendment valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp valign bottom force majeure valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp valign bottom notice valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp valign bottom strict construction interpretation valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp valign bottom assignment valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp valign bottom further action valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp valign bottom severability valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp valign bottom waiver valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp valign bottom independent contractor valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp valign bottom english language governing valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp valign bottom counterpart valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp table style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center table cellspacing cellpadding width border style border collapse collapse font family time roman font size align center width valign bottom width width valign bottom width style font family time roman font size valign colspan list schedule valign bottom nbsp nbsp valign style font family time roman font size valign schedule nbsp valign bottom nbsp valign emergent manufacturing patent valign bottom nbsp nbsp valign style font family time roman font size valign schedule valign bottom nbsp valign emergent patent valign bottom nbsp nbsp valign style font family time roman font size valign schedule valign bottom nbsp valign emergent platform patent valign bottom nbsp nbsp valign style font family time roman font size valign schedule valign bottom nbsp valign phase clinical trial valign bottom nbsp nbsp valign style font family time roman font size valign schedule nbsp valign bottom nbsp valign initial development plan valign bottom nbsp nbsp valign style font family time roman font size valign schedule valign bottom nbsp valign development supply price valign bottom nbsp nbsp valign style font family time roman font size valign schedule valign bottom nbsp valign disclosure valign bottom nbsp nbsp valign style font family time roman font size valign schedule nbsp valign bottom nbsp valign press release valign bottom nbsp nbsp valign table style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman align center license development agreement style margin margin bottom text indent font size font family time roman this license development agreement this agreement dated august nbsp effective date made between emergent product development seattle delaware limited liability corporation with office suite seattle washington emergent morphosys german stock corporation with office lena christ martinsried planegg germany morphosys emergent morphosys sometimes referred herein individually party collectively party style margin margin bottom font size font family time roman align center recital style margin margin bottom text indent font size font family time roman small hereas small small small emergent developed currently further developing novel compound defined below treatment control cancer style margin margin bottom text indent font size font family time roman small hereas small small small morphosys significant experience development pharmaceutical product style margin margin bottom text indent font size font family time roman small hereas small small small morphosys emergent desire establish global collaboration further joint development worldwide commercialization style margin margin bottom text indent font size font family time roman small hereas small small small emergent will have exclusive commercialization right united state canada morphosys will have exclusive commercialization right rest world style margin margin bottom text indent font size font family time roman small small small herefore small small small consideration foregoing premise mutual promise covenant condition contained this agreement party agree follows style margin margin bottom font size font family time roman align center article style margin margin bottom font size font family time roman align center definition style margin margin bottom text indent font size font family time roman used this agreement following initially capitalized term shall have meaning forth this article otherwise defined elsewhere this agreement style margin margin bottom text indent font size font family time roman affiliate mean person directly indirectly controlled controlling under common control with party only long such control shall continue purpose this definition control including with correlative meaning controlled controlling under common control with shall presumed exist with respect person event possession direct indirect nbsp power direct cause direction management policy such person whether through ownership security contract otherwise nbsp least fifty percent nbsp voting security other comparable equity interest party acknowledge that case certain entity organized under certain country outside united state maximum percentage ownership permitted foreign investor than fifty percent that such case such lower percentage shall substituted preceding sentence provided that such foreign investor power direct cause direction management policy such person avoidance doubt neither party shall deemed affiliate other style page break before always size style color width align center style margin margin bottom text indent font size font family time roman business mean other than saturday sunday which bank open business munich germany seattle washington united state style margin margin bottom text indent font size font family time roman binding domain mean portion pharmaceutical diagnostic product that bind antigen cell surface molecule including variable domain thereof style margin margin bottom text indent font size font family time roman calendar quarter mean respective period three nbsp consecutive calendar month ending march nbsp june nbsp september nbsp december style margin margin bottom text indent font size font family time roman calendar year shall mean period twelve consecutive calendar month beginning including january nbsp ending december style margin margin bottom text indent font size font family time roman antigen mean cell receptor complex more group cell surface molecule found cell including font style font family symbol font font style font family symbol font font style font family symbol font font style font family symbol font font style font family symbol font style margin margin bottom text indent font size font family time roman binding domain mean binding domain that bind antigen which greater binding selectivity antigen versus other antigen purpose this definition disregarding residual binding activity style margin margin bottom text indent font size font family time roman change control mean with respect party nbsp sale substantially such party asset business relating this agreement nbsp merger reorganization consolidation involving such party which holder voting security such party outstanding immediately prior thereto cease hold voting security that represent least fifty percent nbsp combined voting power surviving entity immediately after such merger reorganization consolidation nbsp person entity group person entity acting concert acquire more than fifty percent nbsp voting equity security management control such party style margin margin bottom text indent font size font family time roman clinical trial mean human clinical study which product administered otherwise evaluated human including phase clinical study sponsored either party sponsored both party investigator initiated human clinical study funded otherwise supported either party both party style margin margin bottom text indent font size font family time roman information mean information data related contained dmfs section equivalent thereof other regulatory approval product other similar data information style margin margin bottom text indent font size font family time roman commercialize commercializing commercialization mean activity covering marketing promotion selling offering sale product indication including planning market research marketing advertising educating marketing promoting importing exporting distributing post marketing safety surveillance reporting medical affair activity clarity commercialization shall include activity covering manufacturing development product style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom text indent font size font family time roman commercially reasonable effort mean with respect party obligation under this agreement including develop commercialize manufacture product those effort resource consistent with average usual practice similarly situated company pharmaceutical biopharmaceutical biotechnology industry each case pursuing development commercialization manufacture pharmaceutical product that similar market potential such product taking into account relevant factor including product labeling anticipated labeling present future market potential past performance such product financial return medical clinical consideration present future regulatory environment competitive market condition measured fact circumstance time such effort commercially reasonable effort shall determined market market basis particular product anticipated that level effort will different different market style margin margin bottom text indent font size font family time roman competitor mean third party that developing commercializing marketing alternative psma product that with respect most advanced clinical trial each such alternative psma product product phase development more than nbsp full phase earlier than product considering status completion category activity common both phase development term planning regulatory approval patient enrollment completion respective clinical trial product nbsp commenced phase clinical trial then such alternative psma product third party must have commenced phase clinical trial later development nbsp early middle stage enrollment phase clinical trial then such alternative psma product third party must middle late stage enrollment phase clinical trial such third party competitor style margin margin bottom text indent font size font family time roman compound mean bispecific polypeptide containing psma binding domain binding domain back follow compound comprised psma binding domain with without other binding domain including nbsp both psma binding domain binding domain nbsp both psma binding domain binding domain other than binding domain modification derivative foregoing including conjugated mono multi specific form thereof provided that such modification derivative comprises case psma binding domain style margin margin bottom text indent font size font family time roman control mean when used reference intellectual property including patent invention know confidential information other intangible property material that party owns license sublicense such intellectual property including patent invention know confidential information other intangible property material ability grant access license sublicense other right such intellectual property including patent invention know confidential information other intangible property material applicable provided herein provided however that case intellectual property currently envisioned necessary development product under initial development plan intellectual property other than nbsp emergent patent listed schedule emergent platform patent listed schedule emergent manufacturing patent listed schedule nbsp emergent know emergent platform know emergent manufacturing know existing effective date currently envisioned necessary development product under initial development plan such ability grant such access license sublicense other right included only extent nbsp requiring consent third party nbsp violating term agreement other arrangement with third party style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom text indent font size font family time roman cover mean with respect patent subject matter issue that license granted under valid claim such patent manufacture development sale offer sale importation subject matter issue would infringe such valid claim case patent that patent application would infringe valid claim such patent application were issue patent style margin margin bottom text indent font size font family time roman develop developing development mean activity covering research clinical preclinical clinical trial toxicology testing manufacturing development formulation development statistical analysis reporting preparation submission application including information regulatory approval including pricing approval product territory necessary reasonably useful requested required regulatory authority condition support obtaining maintaining regulatory approval including pricing approval product territory clarity development shall include clinical trial well other post product approval study including interventional study conducted aforementioned purpose shall include activity covering commercialization manufacture style margin margin bottom text indent font size font family time roman development activity mean nbsp general development activity nbsp manufacturing development activity nbsp those morphosys territory required development activity morphosys territory discretionary development activity emergent territory required development activity emergent territory discretionary development activity jointly funded party accordance with section each case undertaken behalf party affiliate with respect product consistent with applicable development plan style margin margin bottom text indent font size font family time roman development cost mean cost expense incurred party affiliate directly attributable reasonably allocable development product including cost incurred morphosys credited emergent accordance with section product supplied development activity development supply price performance manufacturing development activity packaging labeling product development activity included development supply price release product development activity subject section included development supply price joint regulatory cost that consistent with applicable development plan development cost shall include nbsp pocket cost nbsp internal cost staff administrative that directly attributable reasonably allocable development product performance manufacturing development activity each case accordance with development plan clarity nbsp pocket cost included development cost shall include cost liability insurance conduct clinical trial under development plan obtained maintained accordance with section nbsp development cost shall exclude regulatory cost avoidance doubt extent cost partly directly attributable development activity partly attributable other activity emergent morphosys such cost shall constitute development cost rata basis style margin margin bottom text indent font size font family time roman development data mean clinical clinical technical chemical safety scientific data information other result including relevant laboratory notebook information screening data regulatory data synthesis scheme including description form data other information generated resulting from connection with conduct development activity jointly funded development data connection with conduct sole funded activity sole funded development data style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom text indent font size font family time roman discretionary development activity mean emergent territory discretionary development activity morphosys territory discretionary activity style margin margin bottom text indent font size font family time roman dollar mean dollar shall interpreted accordingly style margin margin bottom text indent font size font family time roman drug substance mean purified bulk compound final formulation stored bulk container suitable filled finished into vialed product style margin margin bottom text indent font size font family time roman mean european medicine agency successor style margin margin bottom text indent font size font family time roman emergent know mean know that controlled emergent affiliate effective date time during term including emergent sole funded invention which necessary reasonably useful development commercialization product morphosys territory provided however that emergent know shall include emergent platform know emergent manufacturing know style margin margin bottom text indent font size font family time roman emergent manufacturing invention mean invention made behalf either party jointly party that relates general manufacturing product that severable from product provided however that emergent manufacturing invention shall include product invention style margin margin bottom text indent font size font family time roman emergent manufacturing know mean know controlled emergent affiliate effective date time during term including emergent sole funded invention that relates general manufacturing product that severable from product which necessary reasonably useful manufacture product territory commercialization territory including information provided however that emergent manufacturing know shall include product know style margin margin bottom text indent font size font family time roman emergent manufacturing patent mean patent controlled emergent affiliate nbsp effective date including patent listed schedule nbsp time during term covering emergent manufacturing invention including emergent sole funded patent that relates general manufacturing product that severable from product each case nbsp nbsp which necessary reasonably useful manufacture product provided however that emergent manufacturing patent shall include product patent style margin margin bottom text indent font size font family time roman emergent manufacturing technology mean emergent manufacturing patent emergent manufacturing know style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom text indent font size font family time roman emergent patent mean patent territory that nbsp controlled emergent affiliate effective date including patent listed schedule nbsp that come under control emergent affiliate during term including emergent sole funded patent each case nbsp nbsp which necessary reasonably useful development commercialization product territory provided however that emergent patent shall include emergent platform patent emergent manufacturing patent style margin margin bottom text indent font size font family time roman emergent platform mean technology relating nbsp single chain polypeptide capable dimerizing wherein dimerized molecule contains more antibody derived binding domain separated immunoglobulin constant domain nbsp single chain polypeptide comprising from amino terminus carboxy terminus first antibody derived variable chain region immunoglobulin hinge region immunoglobulin constant region linker second anti body derived variable domain region nbsp polypeptide containing nbsp least antibody derived binding domain capable binding tumor antigen other than psma pathogen nbsp least antibody derived binding domain nbsp bispecific multispecific fusion protein polypeptide containing binding domain provided however that emergent platform shall include compound product other individual molecule technology within clause nbsp above also referred herein emergent rtcc platform style margin margin bottom text indent font size font family time roman emergent platform invention mean invention made behalf either party jointly party that relates emergent platform that severable from product including invention relating improvement binding domain provided however that emergent platform invention shall include product invention style margin margin bottom text indent font size font family time roman emergent platform know mean know that related emergent platform that severable from product that nbsp controlled emergent affiliate effective date nbsp come under control emergent affiliate time during term including emergent sole funded invention each case nbsp nbsp which necessary reasonably useful development commercialization product territory provided however that emergent platform know includes emergent platform invention shall include product know style margin margin bottom text indent font size font family time roman emergent platform patent mean patent that cover emergent platform invention that nbsp controlled emergent affiliate effective date including patent listed schedule nbsp come under control emergent affiliate during term including emergent sole funded patent each case nbsp nbsp which necessary reasonably useful development commercialization product territory excluding patent listed schedule provided however that emergent platform patent shall include product patent style margin margin bottom text indent font size font family time roman emergent platform technology mean emergent platform patent emergent platform know style margin margin bottom text indent font size font family time roman emergent sole funded patent mean patent that claim emergent sole funded invention style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom text indent font size font family time roman emergent sole funded invention mean invention arising solely from sole funded activity emergent invented either party affiliate person under obligation assignment emergent affiliate style margin margin bottom text indent font size font family time roman emergent technology mean emergent patent emergent know style margin margin bottom text indent font size font family time roman emergent territory mean united state canada their respective territory district commonwealth possession style margin margin bottom text indent font size font family time roman emergent territory discretionary development activity mean development activity product emergent territory other than emergent territory required development activity general development activity manufacturing development activity that jointly funded party accordance with section style margin margin bottom text indent font size font family time roman emergent territory required development activity mean development activity product that necessary solely obtaining maintaining regulatory approval product canada that jointly funded party accordance with section style margin margin bottom text indent font size font family time roman european union mean country european union constituted effective date which consists austria belgium bulgaria croatia cyprus czech republic denmark estonia finland france germany greece hungary ireland italy latvia lithuania luxembourg malta netherlands poland portugal romania slovakia slovenia spain sweden united kingdom such other country included morphosys territory effective date that after effective date become member style margin margin bottom text indent font size font family time roman expert mean disinterested conflict interest free individual affiliated with either party affiliate with respect dispute concerning financial scientific medical technical commercial regulatory matter referred such expert accordance with section expert particular area issue shall expert arbitrator style margin margin bottom text indent font size font family time roman facility mean applicable party manufacturing facility such other facility used such party those affiliate third party contractor manufacture packaging labeling storage nbsp product nbsp material utilized manufacture packaging labeling product each case with respect product development commercialization territory style margin margin bottom text indent font size font family time roman mean food drug administration successor style margin margin bottom text indent font size font family time roman mean federal food drug cosmetic amended regulation promulgated thereunder style margin margin bottom text indent font size font family time roman field mean field including therapeutic palliative prophylactic diagnostic research human animal style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom text indent font size font family time roman finished product mean product full packaging final presentation form ready release user style margin margin bottom text indent font size font family time roman first commercial sale mean with respect product country country basis first sale such product given country other regulatory jurisdiction territory after receipt regulatory approval including pricing approval extent required sale product given country regulatory jurisdiction such product such country regulatory jurisdiction style margin margin bottom text indent font size font family time roman mean equivalent scientific medical technical avoidance doubt including managerial financial legal marketing business development unless otherwise decided work nbsp person directly specifically related development product full time nbsp year which equates total forty nbsp hour week forty seven nbsp week year style margin margin bottom text indent font size font family time roman general development activity mean development activity that either have applicability development product country morphosys territory country emergent territory necessary development product major market general development activity include morphosys territory required development activity morphosys territory discretionary development activity emergent territory required development activity emergent territory discretionary development activity activity under development proposal sole funded activity unless they become jointly funded party accordance with section which case they shall considered general development activity development activity product unless party have decided develop such product under development plan product under this agreement pursuant section style margin margin bottom text indent font size font family time roman good clinical practice mean applicable good clinical practice standard design conduct performance monitoring auditing recording analysis reporting clinical trial including applicable nbsp forth european commission directive relating implementation good clinical practice conduct clinical trial medicinal product human brought into european commission directive laying down principle detailed guideline good clinical practice investigational medicinal product nbsp regulation european parliament council nbsp april clinical trial medicinal product human nbsp international conference harmonisation technical requirement registration pharmaceutical human harmonised tripartite guideline good clinical practice cpmp other guideline good clinical practice trial medicinal product nbsp declaration helsinki nbsp last amended style font size vertical align world medical association october further amendment clarification thereto nbsp code federal regulation title part protection human subject institutional review board investigational drug application amended from time time nbsp equivalent relevant country each amended applicable from time time each case that provide among other thing assurance that clinical data reported result credible accurate protect right integrity confidentiality trial subject style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom text indent font size font family time roman good laboratory practice mean applicable good laboratory practice standard including applicable nbsp forth european commission directive relating application principle good laboratory practice amended from time time well oecd series principle good laboratory practice nbsp then current good laboratory practice standard promulgated endorsed defined part nbsp equivalent relevant country each amended applicable from time time style margin margin bottom text indent font size font family time roman good manufacturing practice mean applicable good manufacturing practice including nbsp applicable part quality assurance ensure that product consistently produced controlled accordance with quality standard appropriate their intended defined european commission directive laying down principle guideline good manufacturing practice nbsp principle detailed current good manufacturing practice section nbsp rule governing medicinal product european community volume good manufacturing practice medicinal product nbsp principle detailed guideline nbsp equivalent relevant country each amended applicable from time time style margin margin bottom text indent font size font family time roman governmental authority mean multinational federal state local municipal other governmental authority nature including governmental association division prefecture subdivision department agency bureau branch office commission committee council court other tribunal such statutory health insurance fund their association each case having jurisdiction over applicable subject matter style margin margin bottom text indent font size font family time roman indication mean product treatment prevention cure delay progression human disease condition clarity broadening product particular disease such extension product from treating particular disease condition adjuvant treatment such disease condition product front line therapy after receiving regulatory approval second line therapy treatment same disease condition shall deemed separate indication example prostate cancer indication different treatment line different patient population prostate cancer considered different indication whereas lung cancer considered different indication style margin margin bottom text indent font size font family time roman mean equivalent application investigational drug application equivalent agency territory such clinical trial application clinical trial exemption filing which necessary commence conduct clinical testing pharmaceutical product human such jurisdiction style margin margin bottom text indent font size font family time roman invented mean inventor determined accordance with applicable patent relating inventorship forth patent title united state code discovering conceiving completing invention style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom text indent font size font family time roman invention mean writing invention discovery improvement technology other know each case whether patentable that existing effective date invented generated under this agreement whether performance development activity performance morphosys territory required development activity morphosys territory discretionary development activity emergent territory required development activity emergent territory discretionary development activity during term style margin margin bottom text indent font size font family time roman jmaa mean application that filed with mhlw obtain product approval product japan style margin margin bottom text indent font size font family time roman joint invention mean invention that emergent sole funded invention morphosys sole funded invention emergent platform invention emergent manufacturing invention style margin margin bottom text indent font size font family time roman joint know mean nbsp know other than emergent platform know emergent manufacturing know resulting from development activity whether generated behalf either party their respective affiliate course development activity including joint invention nbsp invention other than emergent platform invention emergent manufacturing invention that generated jointly employee emergent affiliate person under obligation assignment emergent affiliate employee morphosys affiliate person under obligation assignment emergent affiliate style margin margin bottom text indent font size font family time roman joint patent mean patent claiming joint invention style margin margin bottom text indent font size font family time roman joint regulatory cost mean cost expense incurred party affiliate attributable reasonably allocable preparation obtaining regulatory material product major market that consistent with development activity performed under applicable development plan shall exclude cost filing associated with submission regulatory approval style margin margin bottom text indent font size font family time roman joint steering committee mean joint steering committee formed party described section style margin margin bottom text indent font size font family time roman joint technology mean joint know joint patent style margin margin bottom text indent font size font family time roman know mean proprietary data result material technology nonpublic information type whatsoever tangible intangible form including know trade secret practice technique method process invention development specification formulation formula material composition matter type kind patentable otherwise software algorithm marketing report plan market research expertise technology test data including pharmacological biological chemical biochemical toxicological preclinical clinical test data analytical quality control data stability data other study data procedure including development data style margin margin bottom text indent font size font family time roman mean statute rule regulation directive decision ordinance guideline other pronouncement governmental authority style margin margin bottom text indent font size font family time roman major market mean united state japan china style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom text indent font size font family time roman manufacture manufacturing mean activity related manufacturing drug substance vialed product finished product placebo thereof ingredient thereof including manufacturing clinical commercial sale process release testing release drug substance vialed product finished product placebo quality assurance activity related manufacturing drug substance vialed product finished product placebo thereof handling storage drug substance vialed product finished product placebo thereof provided however that purpose clarity manufacture shall include fill compounding lyophilization required drug substance placebo into vialed product finished product placebo thereof shall unless otherwise agreed party include packaging labeling whether commercial clinical packaging presentation style margin margin bottom text indent font size font family time roman manufacturing development activity mean development test method stability testing formulation development process development quality assurance activity quality control activity qualification validation activity analytic process development manufacturing process validation scale other activity including related activity necessary related development manufacture product placebo style margin margin bottom text indent font size font family time roman manufacturing license occurrence mean occurrence circumstance forth section which shall included also supply agreement whereby morphosys receives license manufacture product accordance with section style margin margin bottom text indent font size font family time roman marketing authorization application mean application appropriate regulatory authority approval market product excluding pricing approval particular country regulatory jurisdiction including such application filed with with pursuant centralized procedure with mhlw with applicable regulatory authority country territory style margin margin bottom text indent font size font family time roman medical affair activity mean activity compliant with applicable designed ensure improve appropriate medical conduct medical education further research regarding product sold territory including example nbsp activity medical science liaison nbsp provision grant support continuing medical education symposium third party research related product nbsp development publication dissemination publication relating product related disease therapeutic indication nbsp medical information service provided response inquiry communicated medical representative received letter phone call email other mean communication nbsp conduct advisory board meeting meeting with prescribing doctor other professional other program each case purpose which obtain advice feedback related commercialization medical activity concerning product style margin margin bottom text indent font size font family time roman medical representative mean individual sale representative responsible promoting detailing product territory style margin margin bottom text indent font size font family time roman medical science liaison mean individual employed behalf either party affiliate provides educational service other educational effort directed towards medical scientific community style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom text indent font size font family time roman mhlw mean japan ministry health labor welfare subsidiary agency local government responsible pharmaceutical matter successor agency having substantially same function style margin margin bottom text indent font size font family time roman morphosys applied know mean know that controlled morphosys affiliate effective date come under control morphosys affiliate during term other than result license granted emergent morphosys under this agreement nbsp incorporated decision morphosys product prior termination this agreement provided however that such know necessary reasonably useful development manufacture commercialization product nbsp morphosys sole funded invention style margin margin bottom text indent font size font family time roman morphosys applied patent mean patent that controlled morphosys affiliate effective date come under control morphosys affiliate during term other than result license granted emergent morphosys under this agreement nbsp that claim morphosys applied know nbsp morphosys sole funded patent style margin margin bottom text indent font size font family time roman morphosys applied technology mean morphosys applied know morphosys applied patent style margin margin bottom text indent font size font family time roman morphosys sole funded patent mean patent that claim morphosys sole funded invention style margin margin bottom text indent font size font family time roman morphosys sole funded invention mean invention arising solely from sole funded activity morphosys invented either party affiliate person under obligation assignment morphosys affiliate style margin margin bottom text indent font size font family time roman morphosys territory mean entire world except country emergent territory style margin margin bottom text indent font size font family time roman morphosys territory discretionary development activity mean development activity product morphosys territory other than morphosys territory required development activity general development activity manufacturing development activity that jointly funded party accordance with section style margin margin bottom text indent font size font family time roman morphosys territory required development activity mean development activity that necessary solely obtaining maintaining regulatory approval product those part morphosys territory that major market that jointly funded party accordance with section style margin margin bottom text indent font size font family time roman sale mean gross amount invoiced behalf either party selling party accordance with this agreement selling party respective affiliate sublicensees permitted distributor independent third party account sale product following deduction specifically solely related product actually allowed style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom text indent font size font family time roman customary trade cash quantity discount actually paid granted accrued extent already reflected amount invoiced style margin margin bottom text indent font size font family time roman value added excise sale custom duty extent included price separately itemized invoice price specifically excluding clarity income assessed against income arising from such sale style margin margin bottom text indent font size font family time roman outbound freight shipment insurance cost extent included price separately itemized style margin margin bottom text indent font size font family time roman amount actually paid granted accrued return accordance with selling party returned good policy provided other party style margin margin bottom text indent font size font family time roman compulsory payment rebate directly related sale product paid governmental authority pursuant governmental regulation reason national local health insurance program similar program style margin margin bottom text indent font size font family time roman clarity amount discount rebate allowance granted taken with respect total sale customer multiple product selling party affiliate sublicensee permitted distributor agent distributee designee thereof shall deducted calculating sale item forth above that would otherwise deducted from invoice price calculation sale which separately charged paid third party shall deducted from invoice price calculation sale case sale product value other than length transaction exclusively cash such barter counter trade sale shall determined referencing sale which substantially similar quantity product sold length transaction cash style margin margin bottom text indent font size font family time roman notwithstanding foregoing amount billed selling party affiliate sublicensees permitted distributor sale product among selling party affiliate sublicensees permitted distributor resale shall included computation sale hereunder sale shall accounted accordance with generally accepted accounting principle gaap consistently applied selling party affiliate sublicensees permitted distributor sell product part bundle with other product offer package deal customer that include product product shall offered loss leader discount shall applied proportionally among product other product bundled together with product style margin margin bottom text indent font size font family time roman product sold part product containing additional clinically active component sale product purpose determining royalty payment shall determined multiplying sale defined above combination product fraction where average sale price product containing compound alone when sold separately finished form average sale price additional clinically active component sold separately finished form provided that individual component sold separately party will agree good faith reasonable apportionment sale price between component product question style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom text indent font size font family time roman pocket cost mean cost expense excluding value added paid third party payable third party accrued accordance with gaap other than affiliate employee either party style margin margin bottom text indent font size font family time roman patent mean patent patent application substitution division continuation continuation part patent issued with respect such patent application reissue reexamination utility model design renewal extension including supplementary protection certificate such patent confirmation patent registration patent patent addition based such patent counterpart thereof country style margin margin bottom text indent font size font family time roman patent term extension mean term extension supplementary protection certificate equivalent thereof offering patent protection beyond initial term with respect issued patent style margin margin bottom text indent font size font family time roman person mean corporation limited general partnership limited liability company joint venture trust unincorporated association governmental body authority bureau agency other entity body individual style margin margin bottom text indent font size font family time roman phase clinical trial mean human clinical trial country that would satisfy requirement foreign equivalent thereof style margin margin bottom text indent font size font family time roman phase clinical trial shall mean clinical trial product conducted under protocol number synopsis which forth schedule further protocol amendment style margin margin bottom text indent font size font family time roman phase clinical trial mean human clinical trial country that would satisfy requirement foreign equivalent thereof style margin margin bottom text indent font size font family time roman phase clinical trial mean human clinical trial country that would satisfy requirement foreign equivalent thereof style margin margin bottom text indent font size font family time roman phase clinical trial mean certain post marketing study delineate additional information about pharmaceutical product risk benefit optimal commenced after receipt regulatory approval product indication which such trial being conducted style margin margin bottom text indent font size font family time roman placebo mean substance mixture substance lacking presence compound manufactured purpose control treatment blinded clinical trial purpose herein placebo refers finished packaged form such substance style margin margin bottom text indent font size font family time roman marketing mean sale marketing activity undertaken prior preparation launch product given country other regulatory jurisdiction territory marketing shall include market research opinion leader development advisory board medical education disease related public relation sale force training other launch activity prior first commercial sale product given country other regulatory jurisdiction territory style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom text indent font size font family time roman pricing approval mean approval agreement determination decision from governmental authority establishing price reimbursement product sale given country regulatory jurisdiction required applicable such country other regulatory jurisdiction prior subsequent marketing sale product such country regulatory jurisdiction style margin margin bottom text indent font size font family time roman product mean pharmaceutical product containing compound alone with other active ingredient form presentation formulation administration dosage dosage form package clarity product shall include product unless party have decided develop such product under development plan pursuant section style margin margin bottom text indent font size font family time roman product approval mean approval governmental authority necessary marketing sale product given country regulatory jurisdiction which include approval shall include pricing approval style margin margin bottom text indent font size font family time roman product complaint mean written verbal electronic expression dissatisfaction regarding product sold behalf either party affiliate sublicensees territory including report actual suspected product tampering contamination mislabeling inclusion improper ingredient style margin margin bottom text indent font size font family time roman product invention mean invention relating psma binding domain including invention relating composition matter method method manufacture product style margin margin bottom text indent font size font family time roman product know mean know relating psma binding domain including know relating composition matter method method manufacture product clarity product know shall either emergent know joint know morphosys applied know style margin margin bottom text indent font size font family time roman product patent mean patent that cover product invention clarity product patent shall either emergent patent joint patent morphosys applied patent style margin margin bottom text indent font size font family time roman product mark mean trademark connection with commercialization product including trade dress style packaging internet domain name used connection with commercialization product style margin margin bottom text indent font size font family time roman product specification mean those manufacturing performance quality control release packaging labeling specification product territory which agreed party initially forth applicable product approval product such specification amended from time time pursuant term this agreement style margin margin bottom text indent font size font family time roman promotional material mean written printed video graphic advertising promotional educational communication material other than product label package insert marketing advertising promoting product territory nbsp sale representative medical science liaison nbsp advertisement site direct mail piece style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom text indent font size font family time roman psma antigen mean prostate specific membrane antigen psma also known enzyme glutamate carboxypeptidase gcpii acetyl aspartyl glutamate peptidase naaladase naag peptidase style margin margin bottom text indent font size font family time roman psma binding domain mean binding domain that bind psma antigen which greater binding selectivity psma antigen versus other antigen purpose this definition disregarding residual binding activity style margin margin bottom text indent font size font family time roman regulatory approval mean necessary approval including inds product approval pricing approval each case supplement amendment thereto license registration authorization governmental authority necessary manufacture distribution promotion sale product given country regulatory jurisdiction style margin margin bottom text indent font size font family time roman regulatory authority mean particular country regulatory jurisdiction applicable governmental authority involved granting regulatory approval such country regulatory jurisdiction including nbsp nbsp european union european commission relevant national medicine regulatory authority style margin margin bottom text indent font size font family time roman regulatory cost mean cost expense incurred party affiliate attributable reasonably allocable nbsp with respect major market filing associated with submission regulatory approval product including product approval pricing approval manufacturing related regulatory approval preparation obtaining maintaining regulatory material subsequent receipt respective regulatory approval which such regulatory material necessary cost maintaining such respective regulatory approval after received including expense meeting with regulatory authority after filing respective regulatory approval nbsp with respect territory outside major market preparation obtaining maintaining those part regulatory material required regulatory approval product including product approval pricing approval manufacturing related regulatory approval including filing expense meeting with regulatory authority each nbsp nbsp that consistent applicable with development plan regulatory cost shall exclude joint regulatory cost style margin margin bottom text indent font size font family time roman regulatory data mean research data pharmacology data chemistry manufacturing control data preclinical data clinical data other documentation submitted required submitted regulatory authority association with obtaining maintaining regulatory approval including pricing approval product territory including applicable drug master file dmfs chemistry manufacturing control data similar documentation style margin margin bottom text indent font size font family time roman regulatory exclusivity mean exclusive marketing right data exclusivity right conferred governmental authority with respect product given country regulatory jurisdiction other than patent right style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom text indent font size font family time roman regulatory material mean regulatory application submission notification communication correspondence registration regulatory approval other filing made received from otherwise conducted with regulatory authority that necessary order develop manufacture obtain maintain regulatory approval market sell otherwise commercialize product particular country regulatory jurisdiction regulatory material include material relating meeting inds meeting including biologics license application filed with maas presentation response application other regulatory approval style margin margin bottom text indent font size font family time roman release mean required local applicable designated country finished product placebo including applicable defined european directive amended from time time release quality control unit qualified person clinical trial commercially placing market other equivalent release style margin margin bottom text indent font size font family time roman royalty term mean country country product product basis emergent territory morphosys territory case period time beginning date which cumulative sale emergent territory morphosys territory respectively have reached million dollar after first commercial sale such product emergent territory morphosys territory respectively royalty start date ending upon latest date which such product including sale offer sale importation development manufacturing thereof longer covered valid claim such country extended time period from first commercial sale such product such country until royalty start date twelfth style font size vertical align anniversary royalty start date such product style margin margin bottom text indent font size font family time roman mean serious adverse event style margin margin bottom text indent font size font family time roman sale representative mean individual employed behalf either party affiliate sublicensees authorized distributor subcontractor performs detail other promotional effort with respect product style margin margin bottom text indent font size font family time roman susar mean suspected unexpected serious adverse reaction style margin margin bottom text indent font size font family time roman territory mean collectively emergent territory morphosys territory territory mean emergent territory with respect emergent morphosys territory with respect morphosys applicable style margin margin bottom text indent font size font family time roman third party mean person other than emergent morphosys their respective affiliate style margin margin bottom text indent font size font family time roman third party manufacturing license agreement mean that certain license agreement dated december nbsp between existing manufacturing licensor emergent amended style margin margin bottom text indent font size font family time roman third party manufacturing payment mean royalty milestone payment other existing manufacturing licensor under third party manufacturing license agreement account license intellectual property manufacture subsequent sale product behalf party affiliate sublicensees subcontractor applicable style margin margin bottom text indent font size font family time roman united state mean united state america possession territory which includes commonwealth puerto rico district columbia style margin margin bottom text indent font size font family time roman license mean that exclusive license agreement dated december nbsp between emergent style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom text indent font size font family time roman valid claim mean nbsp claim issued unexpired emergent patent emergent platform patent emergent manufacturing patent joint patent morphosys applied patent other than morphosys sole funded patent emergent sole funded patent only long there into respective sole funded activity accordance with section that nbsp been rejected revoked held invalid unenforceable court other authority competent jurisdiction from which decision appeal further taken nbsp been finally abandoned disclaimed admitted invalid unenforceable through reissue disclaimer nbsp claim included pending patent application emergent patent emergent platform patent emergent manufacturing patent joint patent morphosys applied patent other than morphosys sole funded patent emergent sole funded patent only long there into respective sole funded activity accordance with section whether filed before after effective date that nbsp been pending more than year from earliest claimed priority date such patent application provided however that purpose clarity event such pending claim subsequently issue issued patent then such claim shall again valid claim date issuance such patent nbsp been finally determined unallowable applicable governmental authority from which appeal taken style margin margin bottom text indent font size font family time roman vialed product mean finished form product packaged unlabeled vial style margin margin bottom text indent font size font family time roman interpretation except where expressly stated otherwise this agreement following rule interpretation apply this agreement nbsp include includes including limiting nbsp hereof hereto herein hereunder word similar import when used this agreement refer this agreement whole particular provision this agreement nbsp word gender include other gender nbsp reference contract other agreement mean such contract other agreement from time time amended modified supplemented nbsp reference person also permitted successor assigns nbsp reference article section exhibit schedule refer article section exhibit schedule this agreement unless expressly stated otherwise nbsp reference include amendment modification such rule regulation issued thereunder whether such amendment modification made issuance such rule regulation occurs before after date this agreement style margin margin bottom text indent font size font family time roman additional definition following term have meaning forth corresponding section this agreement style font size margin margin bottom nbsp table cellspacing cellpadding width border style border collapse collapse font family time roman font size align center width valign bottom width style font family time roman font size valign bottom term valign bottom nbsp nbsp valign bottom colspan align center section valign bottom nbsp style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman agreement valign bottom nbsp nbsp valign bottom nbsp valign bottom align right preamble nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman alliance manager valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman alternative product mark valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman assumed development activity valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman assumed development activity option valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman audit valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman audited party valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman auditing party valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp table style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center table cellspacing cellpadding width border style border collapse collapse font family time roman font size align center width valign bottom width style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman bankrupt party valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman chmp valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman chief executive officer valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman commercial supply price valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman committee valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman confidential information valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman controlling party valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman credit agreement valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman minimis overage amount valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman developing party valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman development budget valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman development cost valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman development plan valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman development proposal valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman development supply price valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman disclosing party valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman dmfs valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman effective date valign bottom nbsp nbsp valign bottom nbsp valign bottom align right preamble nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman emergent valign bottom nbsp nbsp valign bottom nbsp valign bottom align right preamble nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman emergent remedy notice valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman emergent royalty payment valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman emergent diagnostic royalty rate valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman emergent rtcc platform valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman emergent therapeutic royalty rate valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman excess development cost increment valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman excess development cost increment enhanced product valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman excess development cost increment label expansion product valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman excess development cost increment product valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman excess development cost increment product valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman excess overage amount valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman excess overage amount product valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman existing manufacturing licensor valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman extended protection confidential information valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman failure supply valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman gaap valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman global product mark valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman indemnification claim notice valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman indemnified party indemnifying party valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman indemnitee indemnitees valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman infringement claim valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp table style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center table cellspacing cellpadding width border style border collapse collapse font family time roman font size align center width valign bottom width width style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman initial development plan valign bottom nbsp nbsp valign bottom align right style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman intellectual property committee valign bottom nbsp nbsp valign bottom align right style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman invalidation proceeding valign bottom nbsp nbsp valign bottom align right style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman invalidation examination patent valign bottom nbsp nbsp valign bottom align right style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman joint steering committee valign bottom nbsp nbsp valign bottom align right style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman jointly funded development data valign bottom nbsp nbsp valign bottom align right style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman latest emergent termination date valign bottom nbsp nbsp valign bottom align right style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman loss valign bottom nbsp nbsp valign bottom align right style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman manufacturing license occurrence valign bottom nbsp nbsp valign bottom align right style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman milestone notification notice valign bottom nbsp nbsp valign bottom align right style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman morphosys valign bottom nbsp nbsp valign bottom align right preamble style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman morphosys diagnostic royalty rate valign bottom nbsp nbsp valign bottom align right style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman morphosys remedy notice valign bottom nbsp nbsp valign bottom align right style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman morphosys royalty payment valign bottom nbsp nbsp valign bottom align right style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman morphosys therapeutic royalty rate valign bottom nbsp nbsp valign bottom align right style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman opposition patent valign bottom nbsp nbsp valign bottom align right style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman opposition proceeding valign bottom nbsp nbsp valign bottom align right style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman packaging labeling valign bottom nbsp nbsp valign bottom align right style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman party party valign bottom nbsp nbsp valign bottom align right preamble style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman patent challenge valign bottom nbsp nbsp valign bottom align right style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman phase clinical trial dose escalation phase valign bottom nbsp nbsp valign bottom align right style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp nbsp valign bottom align right style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman quality agreement valign bottom nbsp nbsp valign bottom align right style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman receiving party valign bottom nbsp nbsp valign bottom align right style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman reconciliation development payment valign bottom nbsp nbsp valign bottom align right style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman recoupment amount valign bottom nbsp nbsp valign bottom align right style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman recovery valign bottom nbsp nbsp valign bottom align right style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman redacted agreement valign bottom nbsp nbsp valign bottom align right style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman examination proceeding valign bottom nbsp nbsp valign bottom align right style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman product valign bottom nbsp nbsp valign bottom align right style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman royalty recoupment adjustment valign bottom nbsp nbsp valign bottom align right style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman royalty recoupment adjustment date valign bottom nbsp nbsp valign bottom align right style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman second third party manufacturing amendment valign bottom nbsp nbsp valign bottom align right style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman senior officer valign bottom nbsp nbsp valign bottom align right style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman serious supply risk valign bottom nbsp nbsp valign bottom align right style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman sole funded development data valign bottom nbsp nbsp valign bottom align right style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman sole funded activity valign bottom nbsp nbsp valign bottom align right style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman supply agreement valign bottom nbsp nbsp valign bottom align right style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman term valign bottom nbsp nbsp valign bottom align right style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman third party claim valign bottom nbsp nbsp valign bottom align right style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman third party valign bottom nbsp nbsp valign bottom align right style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman third party agreement valign bottom nbsp nbsp valign bottom align right style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman upfront valign bottom nbsp nbsp valign bottom align right style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp nbsp valign bottom align right table style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman align center article style margin margin bottom font size font family time roman align center license style margin margin bottom text indent font size font family time roman grant morphosys style margin margin bottom text indent font size font family time roman general grant morphosys subject term condition this agreement emergent hereby grant morphosys morphosys hereby accepts style margin margin bottom text indent font size font family time roman during term exclusive even emergent affiliate subject emergent retained right section license including right sublicense through multiple tier subject restriction forth section under emergent technology emergent platform technology emergent manufacturing technology emergent interest joint technology develop product morphosys territory field style margin margin bottom text indent font size font family time roman during term exclusive license even emergent affiliate including right sublicense through multiple tier subject restriction forth section under emergent technology emergent platform technology emergent manufacturing technology emergent interest joint technology commercialize product field morphosys territory style margin margin bottom text indent font size font family time roman during term exclusive cost free perpetual worldwide license under emergent technology emergent platform technology emergent manufacturing technology emergent interest joint technology perform development activity emergent territory solely accordance with development plan sole funded activity morphosys style margin margin bottom text indent font size font family time roman manufacturing grant morphosys subject term condition this agreement supply agreement quality agreement event manufacturing license occurrence emergent hereby grant morphosys exclusive with emergent affiliate license during term including right sublicense through multiple tier subject restriction forth section under emergent manufacturing technology emergent interest joint technology emergent patent emergent platform technology manufacture product development worldwide field commercialization field morphosys territory morphosys hereby accepts such license emergent shall best effort together with morphosys which will best effort obtain second third party manufacturing amendment within period nbsp month after effective date hereinafter second third party manufacturing amendmen mean amendment third party manufacturing license agreement under which existing manufacturing licensor allows emergent grant under such third party manufacturing license agreement sublicense manufacture product addition morphosys least third party contract manufacturer behalf morphosys least them being capable manufacturing product required applicable china japan acceptable existing manufacturing licensor hand both emergent morphosys other hand being understood that contract manufacturer term capacity manufacturing other similar manufacturing volume worldwide regional basis applicable would acceptable morphosys emergent style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman transfer manufacturing process such contract manufacturer event that party able obtain second third party manufacturing amendment within period nbsp month after effective date morphosys seek obtain direct license from existing manufacturing licensor permitting morphosys sublicense manufacture product least third party contract manufacturer behalf morphosys transfer manufacturing process such contract manufacturer event morphosys enters into such direct license with existing manufacturing licensor emergent shall reimburse morphosys percent incremental amount including upfront payment milestone payment license royalty other payment payable morphosys existing manufacturing licensor under such direct license beyond amount payable existing manufacturing licensor under third party manufacturing license agreement style margin margin bottom text indent font size font family time roman grant emergent style margin margin bottom text indent font size font family time roman general grant emergent subject term condition this agreement morphosys hereby grant emergent emergent hereby accepts style margin margin bottom text indent font size font family time roman during term exclusive license including right sublicense through multiple tier subject restriction forth section under morphosys applied technology morphosys interest joint technology nbsp develop product emergent territory field nbsp commercialize product field emergent territory nbsp manufacture product worldwide nbsp development field nbsp commercialization field emergent territory nbsp commercialization field morphosys territory behalf morphosys style margin margin bottom text indent font size font family time roman during term exclusive cost free perpetual worldwide license sublicense applicable under emergent technology emergent platform technology emergent manufacturing technology emergent interest joint technology morphosys applied technology morphosys interest joint technology perform development activity morphosys territory solely accordance with development plan sole funded activity emergent style margin margin bottom text indent font size font family time roman additional grant emergent subject term condition this agreement extent that legally possible morphosys assign emergent right title interest emergent platform invention emergent manufacturing invention pursuant section morphosys hereby grant emergent exclusive with morphosys affiliate sublicensees perpetual license including right sublicense through multiple tier subject with respect only product restriction forth section under emergent platform invention emergent manufacturing invention contained morphosys applied technology morphosys sole funded invention make have made have used sell have sold product accordance with license granted under section other product emergent hereby accepts such license style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom text indent font size font family time roman additional licensing provision style margin margin bottom text indent font size font family time roman negative covenant each party covenant that will practice other party patent know other intellectual property right licensed sublicensed applicable under this article except purpose nbsp permitted under this agreement nbsp allowed under applicable where such patent know other intellectual property right public domain without violation such party confidentiality obligation other party under this agreement style margin margin bottom text indent font size font family time roman implied license retained right except explicitly forth this agreement neither party grant license express implied under intellectual property right other party whether implication estoppel otherwise style margin margin bottom text indent font size font family time roman emergent manufacturing subject term condition this agreement supply agreement quality agreement emergent retains right manufacture product worldwide nbsp development field nbsp commercialization field emergent territory nbsp commercialization field morphosys territory behalf morphosys style margin margin bottom text indent font size font family time roman certain research emergent within year after effective date emergent control molecule vitro experiment study mechanistic function structural analysis other emergent rtcc platform molecule development upon prior approval from morphosys considered morphosys good faith emergent conduct other experiment publish result those experiment style margin margin bottom text indent font size font family time roman document declaration each party shall execute document give declaration regarding license granted hereunder reasonably cooperate with other party upon reasonable request cost requesting party extent such document declaration cooperation required recordal registration license granted hereunder patent office requesting party territory style margin margin bottom text indent font size font family time roman transfer emergent know within ninety nbsp calendar after effective date emergent shall furnish morphosys data package that shall include tangible physical embodiment electronic file emergent know emergent platform know existing effective date morphosys shall emergent platform know furnished emergent under this agreement purpose whatsoever except specifically authorized this agreement event morphosys reasonably belief time during term that tangible physical embodiment electronic file emergent know emergent platform know event manufacturing license occurrence tangible physical embodiment electronic file emergent manufacturing know furnished emergent incomplete morphosys shall provide written notice thereof emergent emergent shall furnish such missing know promptly practicable after receipt morphosys written notice hereunder emergent shall reasonable endeavor answer question received from morphosys regarding emergent know emergent platform know event manufacturing license occurrence emergent manufacturing know soon reasonably possible after receipt morphosys request style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom text indent font size font family time roman performance affiliate subcontractor sublicensees style margin margin bottom text indent font size font family time roman performance affiliate party recognize that each party perform some obligation under this agreement through affiliate provided however that each party shall remain responsible guarantor performance affiliate shall cause affiliate comply with provision this agreement connection with such performance each party hereby expressly waif requirement that other party exhaust right power remedy proceed against affiliate obligation performance hereunder prior proceeding directly against such party wherever this agreement party delegate responsibility affiliate party agree that such entity make decision inconsistent with this agreement amend term this agreement contrary term style margin margin bottom text indent font size font family time roman subcontractor each party shall ensure that each subcontractor accepts complies with term condition this agreement such party shall guarantee subcontractor performance under this agreement avoidance doubt each party will remain directly responsible development commercialization obligation amount owed other party under this agreement each party hereby expressly waif requirement that other party exhaust right power remedy proceed against subcontractor obligation performance hereunder prior proceeding directly against such party style margin margin bottom text indent font size font family time roman sublicensees style margin margin bottom text indent font size font family time roman prior filing product approval morphosys shall required obtain prior written consent emergent sublicensing transferring assigning conveying nbsp development right alone combination with commercialization right under right granted morphosys under section nbsp manufacturing right granted under section provided that after filing product approval subject section morphosys shall required obtain prior written consent existing manufacturing licensor under third party manufacturing license agreement sublicensing transferring assigning conveying manufacturing right granted under section morphosys intends sublicense right referenced previous sentence prior filing product approval morphosys shall disclose emergent identity potential sublicensee emergent shall within twenty five nbsp calendar notify morphosys whether consent such sublicense provided however that emergent shall unreasonably withhold consent shall unreasonable emergent withhold such consent potential sublicensee pharmaceutical biotechnology company based annual sale with good standing with relevant capability expertise perform obligation under such sublicense unless such potential sublicensee competitor event that emergent fails deny consent such proposed sublicense within such twenty five nbsp calendar period emergent shall deemed have given consent with respect such sublicense morphosys shall required obtain prior written consent emergent sublicensing transferring assigning conveying commercialization right combination with development right under right granted morphosys under section country region morphosys territory morphosys good faith determines that such sublicensee relevant capability expertise perform obligation under sublicense style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom text indent font size font family time roman prior filing product approval united state emergent shall required obtain prior written consent morphosys sublicensing transferring assigning conveying development right alone combination with commercialization right under right granted emergent under section development right alone combination with commercialization right under emergent technology emergent platform technology emergent manufacturing technology emergent interest joint technology each case product field emergent territory emergent intends sublicense right activity referenced foregoing sentence this section emergent shall disclose morphosys identity potential sublicensee morphosys shall within twenty five nbsp calendar notify emergent whether consent such sublicense provided however that morphosys shall unreasonably withhold consent shall unreasonable morphosys withhold such consent potential sublicensee pharmaceutical biotechnology company based annual sale with good standing with relevant capability expertise perform obligation under sublicense unless such potential sublicensee competitor event that morphosys fails deny consent such proposed sublicense within such twenty five nbsp calendar period morphosys shall deemed have given consent with respect such sublicense emergent shall required obtain prior written consent morphosys sublicensing transferring assigning conveying commercialization right combination with development right under right granted emergent under section country region emergent territory emergent good faith determines that such sublicensee relevant capability expertise perform obligation under sublicense style margin margin bottom text indent font size font family time roman condition sublicenses subcontract with respect each such sublicense pursuant section subcontract pursuant section applicable each party shall ensure that each sublicensees subcontractor accepts complies with applicable term condition this agreement such party shall remain responsible performance sublicensees subcontractor hereunder such sublicense subcontract shall nbsp subject subordinate term condition this agreement nbsp contain term condition which inconsistent with term condition this agreement nbsp diminish reduce eliminate such party right obligation under this agreement nbsp impose sublicensee subcontractor applicable obligation under term this agreement including extent applicable reporting audit inspection confidentiality provision hereunder well provision prohibiting such sublicensee subcontractor from sublicensing subcontracting violation term this agreement avoidance doubt each party will remain directly responsible development commercialization obligation amount owed other party under this agreement each party hereby expressly waif requirement that other party exhaust right power remedy proceed against sublicensee subcontractor obligation performance hereunder prior proceeding directly against such party each party shall provide other party with copy each such sublicense agreement granted pursuant section within thirty nbsp calendar after execution thereof redacted such party reasonably determines protect confidential commercially sensitive information style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom text indent font size font family time roman exclusivity style margin margin bottom text indent font size font family time roman forbearance emergent hereby covenant that period year after first commercial sale product emergent territory shall shall cause affiliate directly indirectly commercialize pharmaceutical product morphosys hereby covenant that period year after first commercial sale product morphosys territory shall shall cause affiliate directly indirectly commercialize style margin margin bottom text indent font size font family time roman alternative psma product event that prior first product approval product morphosys territory with respect morphosys emergent territory with respect emergent such party respective affiliate clinically develops alternative psma product such party developing party shall notify other party writing within thirty nbsp calendar after commencing such development with confidential information relating such alternative psma product other party written request additional information relating such alternative psma product from receipt such notice until such time developing party informs other party writing that abandoned development such alternative psma product other party shall have right exercisable upon written notice developing party assumed development activity option assume performance development activity under this agreement assumed development activity provided that remainder this agreement shall continue apply with respect such assumed development activity mutatis mutandis giving effect assumption such activity other party including continuation bearing such development cost thirty percent nbsp emergent sixty four percent nbsp morphosys upon other party exercise assumed development activity option developing party shall transition transfer applicable assumed development activity previously performed developing party other party commercially reasonable effort provide reasonable assistance other party enable other party assume such assumed development activity style margin margin bottom text indent font size font family time roman exception notwithstanding restriction forth section both party shall allowed nbsp perform contract research activity service discovery third party using platform technology nbsp pursue outward bound technology platform transfer agreement each case clause nbsp nbsp without target restriction without violating this agreement style margin margin bottom text indent font size font family time roman jurisdictional compliance desire intent party that exclusivity covenant contained this section enforced fullest extent permissible under public policy applied each jurisdiction which enforcement sought emergent morphosys believe that restrictive covenant this section valid enforceable however restrictive covenant should reason become declared competent court competition authority invalid unenforceable jurisdiction such restrictive covenant shall deemed have been amended extent necessary order that such provision valid enforceable such amendment shall apply only with respect operation such provision this section particular jurisdiction which such declaration made style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom text indent font size font family time roman right first negotiation party mutually decide jointly develop alternative psma product comprised psma binding domain other binding domain more than other binding domain product which case such product will then developed under development plan accordance with this agreement after first product approval product morphosys territory with respect morphosys emergent territory with respect emergent either party intends develop intends grant third party right develop product then such party shall notify other party writing submit development proposal other party jointly develop such product under development plan which case section shall apply mutatis mutandis this section provided that other party shall have right elect include such product development plan joint development which case such intending party shall free develop such product subject restriction section such product shall longer deemed product shall longer subject license grant under section style margin margin bottom text indent font size font family time roman restrictive covenant style margin margin bottom text indent font size font family time roman activity each party hereby covenant agrees that shall shall cause respective affiliate sublicensees subcontractor either directly indirectly market distribute sell product into country outside respective territory without limiting generality foregoing neither party shall nbsp engage advertising activity relating product directed solely customer located country within territory other party nbsp solicit order from prospective purchaser located country within territory other party style margin margin bottom text indent font size font family time roman contract event that either party affiliate enters into agreement with subcontractor including distributor wholesaler sublicensee product shall include such agreement provision substantially similar those forth section such that such subcontractor sublicensee applicable shall only authorized market distribute sell product within applicable country respective territory such party shall prohibited from marketing distributing selling product outside such territory style margin margin bottom text indent font size font family time roman jurisdictional compliance desire intent party that restrictive covenant contained this section enforced fullest extent permissible under public policy applied each jurisdiction which enforcement sought emergent morphosys believe that restrictive covenant this section valid enforceable however restrictive covenant should reason become declared competent court competition authority invalid unenforceable jurisdiction such restrictive covenant shall deemed have been amended extent necessary order that such provision valid enforceable such amendment shall apply only with respect operation such provision this section particular jurisdiction which such declaration made style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman align center article style margin margin bottom font size font family time roman align center governance style margin margin bottom text indent font size font family time roman joint steering committee party shall establish within thirty nbsp calendar after effective date shall perform following function style margin margin bottom text indent font size font family time roman review coordinate discus overall strategy developing product territory including overall strategy seeking regulatory approval product territory approve overall strategy developing product seeking regulatory approval product each case under development plan style margin margin bottom text indent font size font family time roman manage oversee preparation implementation development plan style margin margin bottom text indent font size font family time roman review discus update material amendment development plan style margin margin bottom text indent font size font family time roman approve development plan including development budget material amendment thereto decide upon which party will responsible performance various activity forth development plan basis each party respective experience capability capacity style margin margin bottom text indent font size font family time roman review discus inclusion excess overage amount style margin margin bottom text indent font size font family time roman review discus approve clinical trial other development activity proposed either party included development plan style margin margin bottom text indent font size font family time roman review discus development proposal progress sole funded activity style margin margin bottom text indent font size font family time roman facilitate exchange information between party under this agreement regarding strategy implementing development activity including sharing development data created pursuant this agreement establishing procedure efficient sharing information material know reasonably necessary useful development product territory style margin margin bottom text indent font size font family time roman coordinate facilitate exchange both party information regulatory data regulatory material support filing facility inspection product launch morphosys territory emergent territory style margin margin bottom text indent font size font family time roman review discus approve design clinical trial protocol endpoint oversee conduct clinical trial required forth development plan general development activity well review discus morphosys territory required development activity morphosys territory discretionary development activity emergent territory required development activity emergent territory discretionary development activity conducted with respect product territory style margin margin bottom text indent font size font family time roman review discus content submission regulatory authority governmental authority territory regulatory approval including pricing approval regulatory material necessary filing registration activity related thereto style margin margin bottom text indent font size font family time roman review regulatory approval product territory style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom text indent font size font family time roman discus during development approve which party will responsible maintenance global safety database style margin margin bottom text indent font size font family time roman review discus oversee issue regarding pharmacovigilance safety territory including maintenance global safety database style margin margin bottom text indent font size font family time roman oversee discus approve manufacturing development activity discus progress issue concerning manufacturing development activity style margin margin bottom text indent font size font family time roman review discus amount timeline product supply sole funded activity review discus approve amount timeline product supply development activity provided that supply available product limited then prioritization such available product shall first development activity then equitably each party sole funded activity style margin margin bottom text indent font size font family time roman review progress other committee style margin margin bottom text indent font size font family time roman discus approve draft report resulting from activity conducted under development plan comment draft report resulting from activity conducted under sole funded activity style margin margin bottom text indent font size font family time roman discus approve upon potential development possible modification product combination product containing compound follow backup product product style margin margin bottom text indent font size font family time roman discus approve potential development possible diagnostic product including whether seek amendment license include diagnostic right style margin margin bottom text indent font size font family time roman review discus approve subcontractor development activity style margin margin bottom text indent font size font family time roman resolve dispute other matter referred other committee other than style margin margin bottom text indent font size font family time roman resolve dispute arising under section which clarity shall subject section style margin margin bottom text indent font size font family time roman discus approve engaging third party contract manufacturing organization supply finished product development under section style margin margin bottom text indent font size font family time roman have such other responsibility assigned pursuant this agreement mutually agreed upon party writing from time time style margin margin bottom text indent font size font family time roman joint steering committee membership emergent morphosys shall each designate nbsp representative appropriate seniority experience serve written notice other party either party designate substitute representative nbsp more such party designated representative unable present meeting from time time each party replace representative written notice other party specifying prior representative their replacement shall chaired style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman representative each morphosys emergent member shall serve secretary each committee meeting secretary shall alternate from meeting meeting between morphosys committee member emergent committee member chairperson shall responsible nbsp calling meeting nbsp preparing issuing minute each such meeting within twenty nbsp calendar thereafter nbsp preparing circulating agenda upcoming meeting provided that chairperson shall consider including agenda item proposed either party than seven nbsp calendar prior next scheduled meeting style margin margin bottom text indent font size font family time roman joint steering committee meeting shall hold least nbsp meeting calendar quarter such time during such calendar quarter elect provided that shall meet more frequently morphosys emergent mutually agree upon appropriate meeting shall effective only least nbsp representative each party present participating case representative party being present participating such party chairperson refuse calling meeting such party representative refuse accept invitation meeting participate meeting each over period more than calendar quarter meet either nbsp person either party facility such location party otherwise agree nbsp audio video teleconference provided that than nbsp meeting during each calendar year shall conducted person alternate location each party respective designated office other representative each party involved with product attend meeting voting participant subject confidentiality provision forth article additional meeting also held with consent each party required resolve dispute disagreement deadlock other committee otherwise required under this agreement neither party shall unreasonably withhold consent hold such additional meeting each party shall responsible expense incurred connection with participating meeting other committee meeting style margin margin bottom text indent font size font family time roman decision making expressly forth section make decision with respect subject matter that subject decision making authority function decision shall made unanimous vote unanimous written consent with morphosys emergent each having collectively among respective member nbsp vote decision shall commercially reasonable effort resolve matter within role function otherwise referred reach consensus matter within fifteen nbsp calendar after such matter been brought attention then such matter shall first referred alliance manager alliance manager shall their commercially reasonable effort reach mutually acceptable resolution such disputed matter alliance manager unable resolve such dispute within seven nbsp calendar after dispute first referred alliance manager matter shall resolved provided section style margin margin bottom text indent font size font family time roman dispute resolution procedure event that matter remains unresolved pursuant section then following shall apply style margin margin bottom text indent font size font family time roman with respect dispute arising between party under party unable resolve such dispute pursuant section either party refer such dispute writing chief development officer executive vice president each party designee from senior management with decision making authority chief development officer executive vice president such designee senior officer attempted resolution good faith negotiation within fifteen nbsp calendar after such notice received style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom text indent font size font family time roman senior officer unable resolve such dispute within fifteen nbsp calendar after such dispute first referred them pursuant section senior officer shall refer such dispute chief executive officer each party designee from senior management with decision making authority chief executive officer such designee chief executive officer attempted resolution good faith negotiation within nbsp calendar after such notice received chief executive officer unable resolve such dispute within nbsp calendar after such dispute first referred them pursuant this section then style margin margin bottom text indent font size font family time roman such dispute relates development activity then morphosys shall have final decision making authority provided that extent emergent legitimate concern that design registrational clinical trial clinical trial support filing meet regulatory authority requirement product approval neither party shall have final decision making authority either party refer matter determination expert accordance with section style margin margin bottom text indent font size font family time roman such dispute relates whether sole funded activity performed party accordance with section because other party reasonably belief that such suggested sole funded activity would materially adversely affect product development commercialization product such other party respective territory neither party shall have final decision making authority either party refer matter determination expert accordance with section style margin margin bottom text indent font size font family time roman subject section matter forth section properly brought approval specifically forth section shall decided casting vote morphosys accordance with section style margin margin bottom text indent font size font family time roman notwithstanding foregoing provision this section neither party shall exercise right finally resolve dispute hereunder manner that excuse such party from obligation specifically enumerated under this agreement manner that negates consent right other right specifically allocated other party under this agreement addition resolving dispute hereunder each party shall good faith commercially reasonable manner while disputed matter remains unresolved last previously agreed upon right obligation each party with respect such disputed matter development plan shall continue remain effect style margin margin bottom text indent font size font family time roman nothing this section shall affect right party exercise right remedy breach this agreement other party style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom text indent font size font family time roman event that prior filing product approval morphosys undergoes change control with third party that competitor company that pharmaceutical biopharmaceutical biotechnology operation then morphosys shall longer have casting vote including pursuant section section party will need decide upon matter decision chief executive officer subject section chief executive officer unable resolve dispute either party refer matter determination expert accordance with section style margin margin bottom text indent font size font family time roman expert resolution dispute dispute controversy claim remaining unresolved pursuant section section section which neither party deciding vote where this agreement provides upon written request either party other party party shall promptly negotiate good faith appoint appropriate expert party unable agree expert mutual written agreement within seven nbsp calendar after receipt party written request immediately preceding sentence expert shall appointed international centre expertise international chamber commerce under rule expertise provided that initially party shall equally share charged upon appointment expert party will then promptly make available same document supporting their proposal mutually agreed expert appointed expert case such expert shall have right meet with party either alone together necessary make determination each party shall submit such expert exchange with each other advance such expert review their last best offer such expert shall limited awarding only other offer submitted later than thirty nbsp calendar after agreement designation such expert case such expert shall make determination such expert shall provide party with written statement setting forth basis determination connection therewith decision such expert shall final conclusive binding party their affiliate absent manifest error cost such expert shall borne party whose position approved such party shall reimburse such other party initial payment borne other party that were charged upon appointment expert party shall their good faith effort expedite process forth this section style margin margin bottom text indent font size font family time roman limit committee authority other committee shall have only power assigned expressly this agreement shall have power amend modify waive compliance with this agreement furtherance thereof each party shall retain right power discretion granted under this agreement such right power discretion shall delegated vested other committee unless such delegation vesting right expressly provided this agreement party expressly agree writing without limiting generality foregoing neither other committee shall have decision making authority with respect review discus nbsp commercialization activity product territory nbsp sole funded activity except dispute arising under section nbsp emergent territory required development activity except dispute arising under section nbsp emergent territory discretionary development activity except dispute arising under section nbsp morphosys territory required development activity except dispute arising under section nbsp morphosys territory discretionary development activity except dispute arising under section nbsp quantity timeline manufacturing supply product sole funded activity commercialization viii nbsp approving publication conduct outcome clinical trial pursuant section nbsp obtaining maintaining enforcing patent protection market data exclusivity product territory nbsp shortage risk mitigation action including whether establish second manufacturing site under section style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom text indent font size font family time roman committee from time time establish delegate duty other committee directed team each committee oversee particular project activity each such committee shall constituted shall operate determines provided that each committee shall have equal representation from each party committee established basis purpose specific project such other basis determine each committee activity shall subject oversight review approval shall report event shall authority committee exceed that effective date party have agreed that will form finance committee discus development cost development budget manufacturing committee discus manufacturing development activity joint project team discus development operational level style margin margin bottom text indent font size font family time roman intellectual property committee without limiting generality subject section party shall within thirty nbsp calendar after formation establish intellectual property committee intellectual property committee committee shall provide collaborative forum party address intellectual property matter under this agreement shall nbsp primary point contact party regarding exchange information emergent sole funded invention morphosys sole funded invention filing prosecution maintenance enforcement defense matter forth article nbsp review discus overall strategy obtaining maintaining enforcing patent protection aligning patenting strategy with other exclusivities available product nbsp discus selection product trademark filing prosecution maintenance enforcement defense matter forth section shall also responsible discussing prosecution strategy with goal achieving strong robust patent taking into consideration emergent patent joint patent morphosys applied patent additionally event either party determines that requires license third party commercialize product such matter shall discussed accordance with section style margin margin bottom text indent font size font family time roman minute committee meeting definitive minute committee meeting shall finalized after meeting which minute pertain follows style margin margin bottom text indent font size font family time roman within seven nbsp calendar after committee meeting secretary such committee shall prepare distribute member such committee draft minute meeting such minute shall provide list issue resolved either within such committee through relevant resolution process style margin margin bottom text indent font size font family time roman member each committee shall then have seven nbsp calendar after receiving such draft minute collect comment thereon provide them secretary such committee style margin margin bottom text indent font size font family time roman upon expiration such second seven nbsp calendar period party shall have additional seven nbsp calendar discus each other comment finalize minute secretary chairperson such committee shall each sign date final minute signature such chairperson secretary upon final minute shall indicate each party assent minute style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom text indent font size font family time roman action developing strategy making decision exercising right under this agreement including acting through representative committee alliance manager each party shall good faith commercially reasonable effort achieve goal then current development plan style margin margin bottom text indent font size font family time roman exchange information each party shall keep other party fully promptly informed progress activity relating manufacture development commercialization product territory including with respect regulatory matter meeting with regulatory authority update appropriate committee other party event that committee disbanded otherwise specified this agreement reasonably requested from time time other party case least once calendar quarter extent reasonably requested either party other party shall promptly provide such party copy regulatory material connection therewith nbsp emergent morphosys shall provide each other with such information regarding such progress activity under development plan otherwise relating product other party reasonably request from time time during term nbsp emergent shall disclose morphosys emergent know emergent platform know once becomes available emergent nbsp morphosys shall disclose emergent morphosys applied know once becomes available morphosys style margin margin bottom text indent font size font family time roman alliance manager promptly following effective date each party shall designate individual serve main point contact each party exchange information facilitate communication coordinate party activity under this agreement relating product provide support committee each alliance manager each alliance manager shall experienced project management shall have appropriate experience pharmaceutical industry alliance manager shall attend meeting between party including committee meeting commercialization related meeting accordance with section shall also work together resolve deadlock between party accordance with procedure forth section each party change designated alliance manager from time time upon written notice other party provided that party recognize agree importance continuity their relationship activity hereunder style margin margin bottom text indent font size font family time roman commercialization issue discussed party beginning least year prior anticipated first commercial sale product territory least once calendar quarter such time during such calendar quarter they elect party shall meet discus matter forth this section provided that party shall meet more frequently morphosys emergent mutually agree upon appropriate more representative party with relevant commercial pharmaceutical expertise shall meet discus matter forth this section party meet either nbsp person either party facility such location party otherwise agree nbsp audio video teleconference provided that than nbsp meeting party during each calendar year pursuant this section shall conducted person meeting pursuant this section shall cover following activity style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom text indent font size font family time roman review discus overall strategy launching product territory after receipt product approval style margin margin bottom text indent font size font family time roman provide forum party discus commercialization product territory broader context global branding strategy style margin margin bottom text indent font size font family time roman discus global branding strategy style margin margin bottom text indent font size font family time roman subject applicable discus align range suggested price which product will sold third party territory discount strategy product territory well pricing reimbursement strategy provided that nothing contained herein shall limit restrict either party from having final decision setting price which product will sold respective territory style margin margin bottom font size font family time roman align center article style margin margin bottom font size font family time roman align center development style margin margin bottom text indent font size font family time roman overview style margin margin bottom text indent font size font family time roman overview development subject term condition this agreement party shall collaborate with respect development product forth development plan party shall conduct development activity compliance with applicable based their respective experience capability capacity agreed development plan provided that emergent shall party primarily conduct phase clinical trial indication prostate cancer product forth development plan each party shall utilize adequately skilled personnel perform oversee applicable development manufacturing product accordance with term this agreement style margin margin bottom text indent font size font family time roman manufacturing development activity subject section party hereby agree acknowledge that emergent shall commercially reasonable effort perform manufacturing development activity however morphosys will commercially reasonable effort support emergent performance manufacturing development activity manufacturing development activity shall planned discussed manufacturing committee until such committee formed implemented development plan shall approved reported discussed meeting forth section style margin margin bottom text indent font size font family time roman certain additional restriction except forth section each party agrees acknowledges that affiliate sublicensees shall conduct development product except accordance with development plan established pursuant this agreement style margin margin bottom text indent font size font family time roman objective under development plan style margin margin bottom text indent font size font family time roman development activity each party shall commercially reasonable effort carry development activity well manufacture supply product development assigned under development plan accordance with time frame forth development plan style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom text indent font size font family time roman compliance each party shall conduct development activity well manufacture supply product development assigned under development plan consistent with sound ethical business scientific practice compliance with applicable gcps glps gmps style margin margin bottom text indent font size font family time roman development plan development budget style margin margin bottom text indent font size font family time roman general connection with development product territory party shall conduct development activity including manufacturing development activity pursuant comprehensive development plan development plan development plan shall forth among other thing following development activity style margin margin bottom text indent font size font family time roman preclinical study toxicology study pharmaco economic study process development study other clinical study each case together with protocol endpoint investigator conducting such study style margin margin bottom text indent font size font family time roman post product approval clinical trial study including phase clinical trial style margin margin bottom text indent font size font family time roman regulatory plan other element obtaining maintaining regulatory approval style margin margin bottom text indent font size font family time roman detailed annual budget development cost development activity applicable development plan development budget style margin margin bottom text indent font size font family time roman subject provision section allocation development activity conducted each party timeline completing such development activity style margin margin bottom text indent font size font family time roman plan timeline preparing necessary regulatory material obtaining regulatory approval territory style margin margin bottom text indent font size font family time roman manufacturing development activity well plan amount timeline manufacture supply product necessary development taking into account product supply chain timeline inventory product stock style margin margin bottom text indent font size font family time roman potential development subcutaneous formulation product indication prostate cancer style margin margin bottom text indent font size font family time roman number ftes necessary performance development plan style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom text indent font size font family time roman initial development plan initial development plan development indication prostate cancer attached this agreement schedule initial development plan style margin margin bottom text indent font size font family time roman updating amending development plan development budget additional development activity style margin margin bottom text indent font size font family time roman before september nbsp each year during term shall review update approve development plan including development budget contained therein which shall cover development activity conducted during upcoming calendar year shall least annual basis review update appropriate then current development plan including development budget reflect change reprioritizations addition development plan provided however that dispute with respect thereto shall resolved pursuant section style margin margin bottom text indent font size font family time roman from time time during term either party submit proposed expansion other amendment development plan cover additional development activity otherwise amend development activity with respect product territory review approval provided however that dispute with respect thereto shall resolved pursuant section once approved otherwise resolved pursuant section each amended development plan including development budget contained therein shall become effective supersede previous development plan development budget date such approval such other time decided otherwise resolved pursuant section style margin margin bottom text indent font size font family time roman development cost style margin margin bottom text indent font size font family time roman general style margin margin bottom text indent font size font family time roman emergent shall bear thirty percent nbsp development cost morphosys shall bear sixty four percent nbsp development cost whether incurred emergent morphosys their respective affiliate sublicensees subcontractor forth applicable development budget with respect development activity including manufacturing development activity provided however that emergent obligation bear development cost subject development cost style margin margin bottom text indent font size font family time roman development cost morphosys territory required development activity morphosys territory discretionary development activity shall borne morphosys except forth section style margin margin bottom text indent font size font family time roman development cost emergent territory required development activity emergent territory discretionary development activity shall borne emergent except forth section style margin margin bottom text indent font size font family time roman budget overrun each party shall promptly inform other party upon determining that likely exceed budget amount forth annual development budget development activity forth development plan accordance with section under annual amendment accordance with section extent that style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman party affiliate sublicensees subcontractor incurs development cost development activity particular calendar year which exceed development budget such development activity percent minimis overage amount then such minimis overage amount shall automatically included development budget such calendar year however extent that party affiliate sublicensees subcontractor incurs development cost development activity particular calendar year which exceed development budget such development activity more than percent such excess over percent excess overage amount party that exceeded budget shall provide full explanation exceeding budget such excess overage amount shall only included development budget such calendar year shall review discus foregoing subject mutual agreement party some excess overage amount shall included such development budget they consider equitable under circumstance extent that party agree treat excess overage amount development cost party that exceeded development budget development activity shall solely responsible excess overage amount style margin margin bottom text indent font size font family time roman payment reimbursement development cost party shall adhere procedure section reimburse each other sharing development cost forth this section style margin margin bottom text indent font size font family time roman development cost style margin margin bottom text indent font size font family time roman notwithstanding anything contained this agreement contrary emergent shall have obligation bear development cost excess emergent thirty percent nbsp share five hundred eighteen million dollar accordance with section development cost however emergent right unilaterally increase development cost written notice morphosys which expressly refers section section within thirty nbsp after decision increase development budget increase development budget pursuant section excess development cost amount such increase certain development activity such event such increased amount development cost development budget shall deemed apply development cost which emergent shall bear thirty percent share style margin margin bottom text indent font size font family time roman extent that morphosys solely incurs development cost development activity excess development cost which would have otherwise been incurred emergent where morphosys borne thirty percent nbsp share that would otherwise have been borne emergent addition sixty four percent nbsp share such thirty percent nbsp share excess development cost being referred herein excess development cost increment then nbsp least month prior expected first commercial sale product that incorporates invention generated from performance development activity funded such excess development cost increment excess development cost increment product nbsp least month prior expected first commercial sale product with label expansion either indication expansion existing indication such label expansion covered regulatory approval based supported fully part regulatory data generated from performance style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman development activity funded such excess development cost increment excess development cost increment label expansion product nbsp nbsp within month after completion development activity related product that covered regulatory approval nbsp least month prior expected first commercial sale product that covered regulatory approval which development activity have been completed each case such development activity clinical trial such product which meet their primary endpoint have detrimental safety outcome according draft study report such clinical trial expected benefit sale such product unless otherwise reasonably demonstrated emergent including clinical trial requested regulatory authority maintain product approval excess development cost increment enhanced product together with excess development cost increment product excess development cost increment label expansion product collectively excess development cost increment product party shall jointly generate agree nbsp sale forecast such excess development cost increment product territory over year period commencing with first commercial sale such excess development cost increment product nbsp based such sale forecast amount which nbsp morphosys therapeutic royalty rate payable morphosys sale such excess development cost increment product morphosys territory would need reduced provided that morphosys therapeutic royalty rate shall reduced more than percent nbsp extent that such reduction morphosys therapeutic royalty rate sufficient expected first commercial sale excess development cost increment product will occur emergent territory prior morphosys territory amount which emergent therapeutic royalty rate payable emergent sale such excess development cost increment product emergent territory would need increased each clause nbsp with provide morphosys with recoupment amount within year after royalty recoupment adjustment date such sale forecast will reviewed annually required percentage amount decrease morphosys therapeutic royalty rate increase emergent therapeutic royalty rate will adjusted latest month before anniversary royalty recoupment adjustment date party agree sale forecast percentage amount decrease morphosys therapeutic royalty rate increase emergent therapeutic royalty rate annual adjustment thereof either party refer matter determination final decision expert pursuant section pursuant this section morphosys shall provided with following amount nbsp development cost nbsp development activity funded excess development cost increment phase clinical trial nbsp development activity which clinical trial which initially phase clinical trial continuation thereof phase clinical trial emergent shall royalty recoupment adjustment morphosys until such royalty recoupment adjustment equal percent applicable excess development cost increment nbsp development cost development activity funded excess development cost increment phase clinical trial emergent shall royalty recoupment adjustment morphosys until such royalty recoupment adjustment equal percent applicable excess development cost increment nbsp development cost development activity funded excess development cost increment after product approval united state phase clinical trial emergent shall royalty recoupment adjustment morphosys until such royalty recoupment adjustment equal percent applicable excess development cost increment nbsp nbsp style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman aggregate recoupment amount clarity nbsp event phase clinical trial clause nbsp above shall applicable portion such clinical trial relating phase clause nbsp above shall applicable portion such clinical trial relating phase royalty recoupment adjustment relates only excess development cost increment excess development cost increment product recoupment amount shall provided emergent morphosys within year decreasing amount morphosys therapeutic royalty rate sale such excess development cost increment product morphosys territory increasing amount emergent therapeutic royalty rate sale such excess development cost increment product emergent territory collectively royalty recoupment adjustment with effect date royalty recoupment adjustment date follows style margin margin bottom text indent font size font family time roman excess development cost increment product morphosys therapeutic royalty rate such excess development cost increment product will reduced extent necessary emergent therapeutic royalty rate such excess development cost increment product will increased applicable effective date first commercial sale such excess development cost increment product style margin margin bottom text indent font size font family time roman excess development cost increment label expansion product morphosys therapeutic royalty rate such excess development cost increment label expansion product will reduced extent necessary emergent therapeutic royalty rate such excess development cost increment label expansion product will increased applicable effective first commercial sale excess development cost increment label expansion product style margin margin bottom text indent font size font family time roman excess development cost increment enhanced product morphosys therapeutic royalty rate such excess development cost increment enhanced product will reduced extent necessary emergent therapeutic royalty rate such excess development cost increment enhanced product will increased clause nbsp definition excess development cost increment enhanced product effective month after completion development activity clause nbsp definition excess development cost increment enhanced product effective date first commercial sale such excess development cost increment enhanced product style margin margin bottom text indent font size font family time roman clarity development activity funded morphosys under development plan excess development cost increment shall considered development activity morphosys sole funded activity additional clarity development data generated morphosys result performance development activity funded excess development cost increment shall considered jointly funded development data invention know generated morphosys result performance development activity funded excess development cost increment shall considered joint invention joint know style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom text indent font size font family time roman record report information style margin margin bottom text indent font size font family time roman general each party shall maintain current accurate record work conducted under development plan well manufacturing supply product under development plan connection with sole funded activity data other information resulting from such work which record shall include applicable book record report research note chart graph comment computation analysis recording photograph computer program documentation thereof sample material other graphic written data generated connection with such development activity manufacturing sole funded activity such record shall properly reflect work done result achieved performance such development activity manufacturing sole funded activity sufficient detail good scientific manner appropriate regulatory patent purpose each party shall document such development activity including clinical trial conducted pursuant development plan such manufacturing such sole funded activity formal written study report according applicable national international guideline clinical trial activity should documented setting maintaining controlling trial master file according each party shall given adequate opportunity event than fifteen nbsp calendar comment draft report resulting from such manufacturing such sole funded activity style margin margin bottom text indent font size font family time roman status update territory each party shall provide with report detailing respective development activity under development plan result thereof least seven nbsp calendar prior meeting event least calendar quarter basis without limiting foregoing each party shall promptly event within seven nbsp calendar after receipt thereof provide other party with copy material document correspondence received from regulatory authority related development activity style margin margin bottom text indent font size font family time roman development data development data shall owned shared party forth this section style margin margin bottom text indent font size font family time roman ownership development data subject this section jointly funded development data shall jointly owned both party shall considered emergent know morphosys applied know purpose under this agreement shall considered confidential information both party that both party shall keep confidential jointly funded development data accordance with article notwithstanding forgoing morphosys shall assign hereby assigns emergent right title interest jointly funded development data extent such jointly funded development data emergent platform invention emergent manufacturing invention morphosys shall execute deliver such document provide such assistance emergent reasonably request order vest emergent right title interest therein thereto foregoing shall considered confidential information emergent with respect sole funded development data generated either party such sole funded development data shall owned party funded sole funded activity style margin margin bottom text indent font size font family time roman sharing jointly funded development data style margin margin bottom text indent font size font family time roman with respect jointly funded development data generated party such party shall promptly provide other party with copy report summary thereof each case such report summary become available such party sole funded development data shall owned solely exclusively party generating such data which style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman shall confidential information such party emergent will share jointly funded development data generated behalf emergent affiliate sublicensees with morphosys free charge morphosys entitled disclose such jointly funded development data affiliate sublicensees only inside morphosys territory accordance with term this agreement morphosys will share jointly funded development data generated behalf morphosys affiliate sublicensees with emergent free charge subject this section emergent entitled disclose such jointly funded development data affiliate sublicensees only emergent territory accordance with term this agreement subject this section emergent shall ensure that affiliate sublicensees agree disclosure jointly funded development data morphosys affiliate sublicensees morphosys shall ensure that affiliate sublicensees agree disclosure jointly funded development data emergent affiliate sublicensees style margin margin bottom text indent font size font family time roman each party shall promptly provide other party with copy relevant safety data medical data from sole funded activity such safety data medical data becomes available such party provided that such medical data shall responding medical inquiry support efficacy claim apart from both party obligation share safety medical data under foregoing sentence this section neither party shall have obligation disclose sole funded development data other party affiliate sublicensees style margin margin bottom text indent font size font family time roman sole funded activity style margin margin bottom text indent font size font family time roman should morphosys wish perform have performed morphosys territory required development activity morphosys territory discretionary development activity morphosys shall submit proposal party jointly develop fund such activity through development plan style margin margin bottom text indent font size font family time roman should emergent wish perform have performed emergent territory required development activity emergent territory discretionary development activity emergent shall submit proposal party jointly develop fund such activity through development plan style margin margin bottom text indent font size font family time roman proposal made morphosys pursuant section emergent pursuant section shall contain minimum information supporting rationale such development from scientific regulatory commercial standpoint well estimated developmental critical path estimate timeframe cost such development each development proposal style margin margin bottom text indent font size font family time roman shall meet review discus development proposal within sixty nbsp calendar after such development proposal submitted proposing party proposing party agrees such morphosys territory required development activity morphosys territory discretionary development activity emergent territory required development activity emergent territory discretionary development activity development plan party agree which party will responsible performing such development activity then notwithstanding section emergent shall responsible thirty percent nbsp development cost morphosys shall responsible sixty four percent nbsp development cost connection with such development proposal style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom text indent font size font family time roman proposing party wish such development activity development plan such development proposal approved proposing party within such sixty nbsp calendar period after such development proposal then such development proposal carried proposing party proposing party sole cost expense sole funded activity subject term condition this section party performing such sole funded activity shall consider comment good faith clarity sole funded activity shall include development commercialization product style margin margin bottom text indent font size font family time roman notwithstanding section nbsp emergent shall shall cause affiliate sublicensees undertake sole funded activity morphosys notifies emergent writing prior commencement such sole funded activity that reasonably belief that such development would materially adversely affect product development commercialization morphosys territory nbsp morphosys shall shall cause affiliate sublicensees undertake sole funded activity emergent notifies morphosys writing prior commencement such sole funded activity that reasonably belief that such development would materially adversely affect product development commercialization emergent territory provided however that nbsp morphosys shall have right conduct sole funded activity morphosys territory required development activity shall manner that most effectively avoids such material adverse effect nbsp emergent shall have right conduct sole funded activity emergent territory required development activity shall manner that most effectively avoids such material adverse effect will decide upon dispute party arising from this section subject section style margin margin bottom text indent font size font family time roman neither party right incorporate reference sole funded development data resulting from other party sole funded activity marketing authorization application regulatory approval except connection with this section funding party wish obtain share sole funded development data resulting from sole funded activity performed other party funding party wish receive copy sole funded development data generated sole funded activity performed other party addition safety data funding party shall have right requesting itemized invoice development cost incurred such sole funded activity paying party that funded such sole funded activity amount equal percent development cost that would have otherwise been incurred such party such sole funded activity accordance with allocation forth section such development proposal been added development plan upon payment aforementioned amount such sole funded activity shall deemed general development activity with corresponding consequence including that nbsp sole funded development data resulting from such sole funded activity shall considered jointly funded development data that owned shared pursuant section nbsp emergent sole funded invention morphosys sole funded invention case resulting from such sole funded activity other than emergent platform invention emergent manufacturing style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman invention shall considered clarity also purpose determining royalty term joint invention that jointly owned subject term this agreement party that originally funded such sole funded activity shall make necessary assignment transfer that joint invention applicable joint patent jointly owned accordance with section party receiving itemized invoice development cost incurred such sole funded activity shall have right audit record other party order check full accuracy itemized invoice provided that notwithstanding right each party annual audit section shall apply conduct such audit style margin margin bottom text indent font size font family time roman right audit extent required applicable whether party conducted development product territory accordance with applicable development plan each party shall ensure that other party authorized representative regulatory authority extent permitted applicable during regular business hour upon reasonable advance written notice more than once annually except cause example requested regulatory authority nbsp examine inspect facility subject third party confidentiality restriction other obligation facility subcontractor investigator site used performance development manufacture product territory hereunder nbsp subject applicable third party confidentiality restriction other obligation inspect data documentation work product record maintained party under development plan relating activity performed subcontractor investigator site including extent permitted applicable privacy medical record patient participating clinical study each case generated pursuant such development such right inspect such data documentation work product relating product territory exercised time during term upon reasonable notice subject each party record retention policy then effect such longer period shall required applicable style margin margin bottom font size font family time roman align center article style margin margin bottom font size font family time roman align center regulatory style margin margin bottom text indent font size font family time roman regulatory data regulatory material style margin margin bottom text indent font size font family time roman regulatory material during term responsibility overseeing monitoring coordinating regulatory action communication filing with submission applicable regulatory authority with respect product territory shall allocated between party forth this article style margin margin bottom text indent font size font family time roman regulatory data generated emergent morphosys within twenty nbsp calendar after effective date emergent shall provide morphosys with copy regulatory material regulatory data necessary reasonably useful morphosys execute right under this agreement perform obligation under development plan during term emergent morphosys shall promptly provide each other copy further regulatory material regulatory data accordance with section style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom text indent font size font family time roman information upon reasonable request morphosys emergent shall provide morphosys with information necessary reasonably useful otherwise requested required regulatory authority governmental authority condition support obtaining maintaining regulatory approval including pricing approval product morphosys territory support morphosys accordance with section style margin margin bottom text indent font size font family time roman regulatory filing regulatory approval style margin margin bottom text indent font size font family time roman general responsibility ownership regulatory approval style margin margin bottom text indent font size font family time roman general responsibility morphosys morphosys shall responsible preparation regulatory material necessary desirable obtaining maintaining regulatory approval morphosys territory including connection with patient information leaflet labeling packaging product morphosys territory emergent shall have right review essential material provide advice morphosys proposed strategy documentation submission morphosys territory morphosys shall reasonably consider such comment good faith preparing such material morphosys shall submit such regulatory material maas applicable applicable governmental authority morphosys territory style margin margin bottom text indent font size font family time roman general responsibility emergent emergent shall responsible preparation regulatory material necessary desirable obtaining maintaining regulatory approval emergent territory including connection with patient information leaflet labeling packaging product emergent territory morphosys shall have right review essential material provide advice emergent proposed strategy documentation submission emergent territory emergent shall reasonably consider such comment good faith preparing such material emergent shall submit such regulatory material maas applicable applicable governmental authority emergent territory style margin margin bottom text indent font size font family time roman meeting with authority extent prohibited applicable morphosys emergent shall each entitled attend meeting with relevant regulatory authority territory with respect obtaining maintaining product approval product territory including oral explanation before committee human medicinal product chmp before foreign equivalent thereof participate fully such meeting provision this section shall subject provision section style margin margin bottom text indent font size font family time roman ownership regulatory approval regulatory approval product territory shall name party responsible preparing submitting such regulatory approval respective territory portion thereof such party shall right title interest such regulatory approval related regulatory material style margin margin bottom text indent font size font family time roman submission strategy subject section party agree that regulatory strategy filing maintaining product approval will involve meeting with relevant regulatory authority seek advice acceptability proposed submission package filing with respect under style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman centralized procedure provided under regulation feasible requesting accelerated assessment procedure under article regulation with respect under equivalent prior filing each party will have however final with respect regulatory strategy respective territory style margin margin bottom text indent font size font family time roman cooperation each party shall cooperate with provide reasonable assistance other party connection with activity undertaken such party relating obtaining maintaining regulatory approval style margin margin bottom text indent font size font family time roman certain regulatory approval style margin margin bottom text indent font size font family time roman pricing approval notwithstanding provision section extent that given country regulatory jurisdiction territory requires pricing approval sale product such country regulatory jurisdiction morphosys shall extent permitted applicable solely responsible shall commercially reasonable effort toward obtaining maintaining pricing approval country regulatory jurisdiction morphosys territory name emergent shall extent permitted applicable solely responsible shall commercially reasonable effort toward obtaining maintaining pricing approval country regulatory jurisdiction emergent territory name without limiting foregoing each party shall commercially reasonable effort apply pricing approval country regulatory jurisdiction respective territory where pricing approval required sale product within reasonable time following receipt product approval such country regulatory jurisdiction each party shall keep other party informed ongoing basis each party strategy seeking result obtains seeking such pricing approval respective territory including result material discussion other communication with relevant governmental authority regarding such pricing approval extent prohibited applicable morphosys emergent shall entitled attend meeting with relevant regulatory authority with respect obtaining maintaining pricing approval product each other respective territory style margin margin bottom text indent font size font family time roman manufacturing approval manufacturing related section morphosys territory emergent shall responsible preparing those portion regulatory material related manufacture product commercialization morphosys territory including dmfs equivalent section regulatory material shall provide such section morphosys shall cooperate with provide reasonable assistance morphosys connection with submitting those portion regulatory material related manufacture product commercialization morphosys territory style margin margin bottom text indent font size font family time roman cost regulatory activity joint regulatory cost incurred connection with preparation regulatory material obtaining product approval pricing approval product under development plan shall included development budget shall shared accordance with section between party each party shall responsible solely bear regulatory cost product respective territory style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom text indent font size font family time roman reporting review each party shall keep other party reasonably regularly informed connection with preparation material regulatory material regulatory authority review regulatory material regulatory approval each case with respect product within respective territory upon reasonable request each party shall provide other party timely manner with copy material notice question request information tangible form which receives from regulatory authority with respect product respective territory provided however that such party shall have right redact information extent related product style margin margin bottom text indent font size font family time roman consultation prior regulatory filing party shall consult with each other package strategy filing with respect regulatory approval territory product prior filing style margin margin bottom text indent font size font family time roman communication party shall cooperate communicating with regulatory authority having jurisdiction regarding product territory each party shall keep other party informed planned regulatory submission material communication either initiative accordance with this agreement result such regulatory authority initiating contact with such party connection therewith each party shall promptly provide cause affiliate sublicensees permitted distributor provide other party with copy regulatory submission material communication with regulatory authority territory notwithstanding foregoing except required applicable neither party shall with respect product communicate with regulatory authority having jurisdiction other party territory regarding product unless explicitly provided development plan requested permitted writing other party unless ordered such regulatory authority which case such party shall immediately notify other party such order shall extent permitted applicable take further action communicate with such regulatory authority further until other party provided instruction proceed communication with regulatory authority regarding product territory shall undertaken provided this agreement style margin margin bottom text indent font size font family time roman adverse event reporting safety data exchange medical inquiry style margin margin bottom text indent font size font family time roman pharmacovigilance morphosys shall responsible collection review assessment tracking filing information related adverse event associated with product morphosys territory whether product approval been achieved each case accordance with applicable this agreement morphosys shall ensure that development commercialization product will record investigate summarize notify report review adverse event accordance with applicable emergent shall responsible collection review assessment tracking filing information related adverse event associated with product emergent territory whether product approval been achieved each case accordance with applicable this agreement emergent shall ensure that development commercialization product will record investigate summarize notify report review adverse event accordance with applicable each party shall keep other party informed nbsp within reasonable period time after such identified reported nbsp susar soon reasonably possible after such susar identified reported event same time style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman reporting such susar regulatory authority independent whether such susar occurred under development activity sole funded activity safety representative from each party shall meet agree upon written pharmacovigilance agreement exchanging adverse event other safety information relating product first dosing first patient first clinical trial performed under this agreement provided that during development shall discus approve during commercialization party shall discus jointly approve which party shall responsible maintaining global safety database product cost establishing maintaining global safety database product shall borne thirty percent nbsp emergent sixty four percent nbsp morphosys such written pharmacovigilance agreement shall ensure that adverse event other safety information exchanged according schedule that will permit each party affiliate sublicensees subcontractor comply with applicable regulatory requirement their respective territory emergent shall also keep morphosys informed susar arising respect other emergent rtcc platform molecule within reasonable period time after such susar identified reported emergent emergent shall also keep morphosys informed other information event relating emergent rtcc platform molecule technology which might represent safety risk product each case extent aware such information event style margin margin bottom text indent font size font family time roman medical inquiry product morphosys shall responsible handling medical question inquiry including product complaint morphosys territory with regard product sold behalf morphosys affiliate sublicensees including setting call center connection therewith each case accordance with applicable this agreement emergent shall responsible handling medical question inquiry including product complaint emergent territory with regard product sold behalf emergent affiliate sublicensees permitted distributor including setting call center connection therewith each case accordance with applicable this agreement party shall exchange copy standardized response medical inquiry information morphosys shall promptly forward medical question inquiry which receives with respect product sold behalf emergent affiliate sublicensees permitted distributor emergent territory emergent accordance with applicable emergent shall promptly forward medical question inquiry which receives with respect product sold behalf morphosys affiliate sublicensees morphosys territory morphosys accordance with applicable notwithstanding foregoing morphosys shall responsible handling product complaint received from inside morphosys territory related manufacture product emergent shall support morphosys provide reasonably requested assistance information handle such product complaint style margin margin bottom text indent font size font family time roman regulatory authority communication received party style margin margin bottom text indent font size font family time roman general each party shall promptly inform other party notification action notification other information which receives directly indirectly from regulatory authority whether morphosys territory emergent territory which nbsp raise material concern regarding safety efficacy product nbsp indicates suggests potential material liability either party third party connection with style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman product nbsp reasonably likely lead recall market withdrawal market notification with respect product whether morphosys territory emergent territory nbsp relates expedited exchange individual case safety report periodic safety report with respect product whether morphosys territory emergent territory product complaint which have adverse impact regulatory approval continued commercialization product whether morphosys territory emergent territory morphosys shall solely responsible responding such communication relating product morphosys territory emergent shall solely responsible responding such communication relating product emergent territory each party shall reasonably cooperate with assist other party complying with regulatory obligation including providing other party within nbsp business after request such information documentation which such party possession necessary reasonably helpful other party prepare response inquiry from regulatory authority whether morphosys territory emergent territory with respect product each party shall promptly provide cause affiliate sublicensees provide other party with copy material correspondence received from regulatory authority whether morphosys territory emergent territory specifically regarding matter referred above style margin margin bottom text indent font size font family time roman disclosure addition obligation under this agreement each party shall disclose other party following regulatory information style margin margin bottom text indent font size font family time roman regulatory action information pertaining material action taken regulatory authority whether morphosys territory emergent territory connection with product including notice audit notice inspection notice notice initiation regulatory authority investigation inspection detention seizure injunction concerning product whether morphosys territory emergent territory notice violation letter untitled letter warning letter service process other substantial inquiry which nbsp raise material concern regarding safety efficacy product nbsp alleges potential material liability either party third party connection with product nbsp reasonably likely lead recall market withdrawal market notification with respect product whether morphosys territory emergent territory nbsp relates expedited exchange individual case safety report periodic safety report with respect product whether morphosys territory emergent territory product complaint which reasonably likely have adverse impact regulatory approval continued commercialization product whether morphosys territory emergent territory provided however that party shall entitled redact those portion thereof extent related product without limiting generality foregoing each party shall promptly event within three nbsp business inform other party such material action regulatory authority with respect product whether morphosys territory emergent territory style margin margin bottom text indent font size font family time roman regulatory compliance with respect information pertaining notice from regulatory authority whether morphosys territory emergent territory compliance with applicable connection with product including receipt warning letter other notice alleged compliance from regulatory authority directly indirectly relating product whether morphosys territory emergent territory such party shall entitled redact those portion thereof extent related product style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom text indent font size font family time roman recall withdrawal market notification product style margin margin bottom text indent font size font family time roman notification determination event that governmental authority threatens initiate action remove product from market whether morphosys territory emergent territory whole part party receiving notice thereof shall notify other party such communication promptly event later than nbsp business after receipt thereof notwithstanding foregoing case morphosys shall determine whether initiate recall withdrawal market notification product morphosys territory emergent shall determine whether initiate such recall withdrawal market notification product emergent territory including scope such recall withdrawal full partial recall temporary permanent recall market notification provided however that before morphosys emergent case initiate recall withdrawal market notification party shall promptly meet discus good faith reason therefor provided further that such discussion shall delay action that morphosys emergent case reasonably belief taken relation recall withdrawal market notification event such recall withdrawal market notification morphosys emergent case shall determine necessary action taken shall implement such action with other party providing reasonable input which first party shall good faith consider incorporate into recall withdrawal market notification strategy reasonable assistance conduct such recall withdrawal market notification without limiting foregoing each party shall have right propose that product recall withdrawal market notification should initiated other party such other party shall make final decision whether recall withdrawal market notification will initiated territory each party shall time utilize batch tracing system which will enable each identify prompt basis customer within territory have been supplied with product particular batch recall such product from such customer forth this section style margin margin bottom text indent font size font family time roman cost allocation direct cost expense associated with implementing recall withdrawal market notification with respect product territory shall allocated between emergent morphosys follows style margin margin bottom text indent font size font family time roman event extent that recall withdrawal market notification arises result breach this agreement supply agreement quality agreement emergent then emergent shall bear cost expense including internal pocket cost morphosys implementing such recall withdrawal market notification style margin margin bottom text indent font size font family time roman event extent that recall withdrawal market notification arises result breach this agreement supply agreement quality agreement morphosys then morphosys shall bear cost expense including internal pocket cost emergent implementing such recall withdrawal market notification style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom text indent font size font family time roman other case other than provided section above major market cost expense incurred either party implementing recall withdrawal market notification shall borne follows emergent responsible thirty percent nbsp such cost expense morphosys shall responsible sixty four percent nbsp such cost expense style margin margin bottom text indent font size font family time roman other case other than provided section above outside major market cost expense incurred either party implementing recall withdrawal market notification morphosys territory shall borne hundred percent nbsp morphosys cost expense incurred either party implementing recall withdrawal market notification emergent territory shall borne hundred percent nbsp emergent style margin margin bottom font size font family time roman align center article style margin margin bottom font size font family time roman align center commercialization style margin margin bottom text indent font size font family time roman commercialization territory during term morphosys shall solely responsible commercializing product morphosys territory accordance with this agreement emergent shall solely responsible commercializing product emergent territory accordance with this agreement subject term condition this agreement each party shall responsible hundred percent nbsp expense including marketing other commercialization expense incurred connection with commercialization product respective territory without limiting foregoing each party shall commercially reasonable effort commercialize product respective territory style margin margin bottom text indent font size font family time roman both party performance without limiting generality provision section each party shall solely responsible nbsp receiving accepting filling order product such party territory nbsp handling return product such party territory nbsp controlling invoicing order processing collection account receivable sale product such party territory nbsp distributing managing inventory product such party territory style margin margin bottom text indent font size font family time roman general each party shall provide written update other party regional country country basis than once calendar year regarding significant activity product respective territory style margin margin bottom text indent font size font family time roman other report each party shall submit writing other party such other summary report such other party reasonably request from time time during term with respect material activity undertaken morphosys product morphosys territory emergent product emergent territory case including general market condition general sale information style margin margin bottom text indent font size font family time roman compliance each party shall commercializing product comply with applicable including foreign corrupt practice bribery bribery provision german criminal code well applicable regulatory approval product respective territory addition neither party shall capacity style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman connection with commercialization development product hereunder person been debarred pursuant section nbsp similar outside subject conviction described such section each party shall inform other party writing immediately person performing service each party hereunder debarred subject conviction described section nbsp similar outside action suit claim investigation legal administrative proceeding pending such party knowledge threatened relating debarment such party person used capacity such party connection with commercialization development product hereunder style margin margin bottom text indent font size font family time roman sale representative medical science liaison each party shall shall cause sale representative conduct detail with respect product perform other commercialization activity under this agreement such party territory adherence with applicable regulatory approval product package insert labeling packaging professional requirement including those relating promotion pharmaceutical product consumer protection fraud abuse false claim each party shall solely responsible omission sale representative medical science liaison while performing commercialization activity each party shall solely responsible compensation including that payable sale representative medical science liaison further each party shall solely responsible training cost associated with such training sale representative medical science liaison using commercially reasonable effort case accordance with applicable including timely reporting adverse event with respect product party will cooperate preparing updating training material program will exchange training material update thereof once they become available style margin margin bottom text indent font size font family time roman promotional material style margin margin bottom text indent font size font family time roman creation promotional material party will coordinate create develop promotional material territory accordance with regulatory approval applicable provided however that each party shall responsible finalization promotional material respective territory such coordination party intended ensure that such promotional material consistent with global strategy product party shall exchange sample promotional material information comment each party shall consider such comment good faith prior distributing such promotional material clarity such sample need only submitted each different type promotional material opposed each item promotional material needing submitted extent either party want include trademark controlled other party other than product mark promotional material product packaging labeling such party include upon other party prior written approval only include such trademark shall comply with other party then current guideline trademark usage copy which shall provided such other party within thirty nbsp calendar effective date style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom text indent font size font family time roman inclusion logo packaging promotional material extent permitted required applicable subject obtaining necessary regulatory authority approval with respect product sold behalf morphosys affiliate sublicensees territory emergent housemark shall appear package insert utilized morphosys however equal prominence except that morphosys sublicensed product given country morphosys territory only logo permitted relevant regulatory authority such country then morphosys display logo logo sublicensee emergent hereby grant morphosys exclusive royalty free right license during term utilize emergent housemark including trademark name logo order perform commercialization activity required performed morphosys hereunder accordance with term this agreement morphosys hereby grant emergent exclusive royalty free right license during term utilize morphosys housemark including trademark name logo order perform manufacturing other activity performed behalf emergent under term this agreement supply agreement each party shall only housemark other party with necessary trademark designation each party shall other party housemarks manner that derogate from such party right trademark name logo each party shall submit representative sample other party housemark review style margin margin bottom text indent font size font family time roman ownership promotional material each party shall right title interest promotional material created behalf hereunder relating product territory including copyright trademark including product mark forth under section below name logo other mark owned behalf either party affiliate style margin margin bottom text indent font size font family time roman promotional material exclusively product promotional material aspect thereof uniquely tied product shall used party exclusively connection with commercialization product territory accordance with term this agreement each party shall allow other person such promotional material except accordance with this agreement style margin margin bottom text indent font size font family time roman product mark style margin margin bottom text indent font size font family time roman product mark style margin margin bottom text indent font size font family time roman party shall through jointly responsible establishing global branding strategy product identifying where agreed party selecting global product mark global branding aspect product including where agreed party global look feel product product packaging emergent morphosys affiliate sublicensees respectively shall only product mark pursuant term this agreement identify connection with commercialization product emergent morphosys shall shall cause each their affiliate sublicensees such product mark identify connection with marketing other product extent agreed emergent morphosys shall same product mark emergent territory morphosys territory respectively global product mark global product mark shall owned emergent morphosys country region which such global product mark applied registered used where joint ownership possible impracticable under applicable party shall discus good faith possible solution through whether global product mark style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman adopted party morphosys shall have right select alternative product mark exclusively morphosys territory emergent shall have right select alternative product mark exclusively emergent territory alternative product mark provided that such alternative product mark selected either party shall consistent with global branding strategy extent practicable clarity product mark shall include corporate name logo emergent morphosys style margin margin bottom text indent font size font family time roman event that either party intends prepare file prosecute maintain global product mark respective territory such party shall provide reasonable prior written notice such intention which notice shall event given later than four nbsp week prior next deadline action that taken with respect such global product mark respective territory other party shall thereupon have option sole discretion assume control direction preparation filing prosecution maintenance such global product mark upon continuing party written exercise such option continuing party continuing party shall assume responsibility full control preparation filing prosecution maintenance such global product mark continuing party shall bear cost that accrue connection therewith continuing party shall assign continuing party interest such global product mark shall execute such document perform such continuing party expense reasonably necessary permit continuing party file such global product mark application prosecute maintain such global product mark style margin margin bottom text indent font size font family time roman alternative product mark used exclusively within emergent territory shall owned emergent emergent shall have right obligation prepare file prosecute maintain such alternative product mark worldwide sole cost expense alternative product mark shall limited emergent territory emergent sole cost expense shall control filing prosecution enforcement maintenance such alternative product mark style margin margin bottom text indent font size font family time roman alternative product mark used exclusively within morphosys territory shall owned morphosys morphosys shall have right obligation prepare file prosecute maintain such alternative product mark morphosys territory sole cost expense alternative product mark shall limited morphosys territory morphosys sole cost expense shall control filing prosecution enforcement maintenance such alternative product mark style margin margin bottom text indent font size font family time roman infringement product mark event that either party becomes aware infringement product mark third party territory such party shall promptly notify other party party shall consult with each other good faith with respect thereto each party shall sole discretion have right determine proceed with respect such infringement respective territory including institution legal proceeding against such third party which case cost award relating such legal proceeding will borne exclusively party concerned requested other party shall reasonably cooperate with action initiated initiating party reasonable expense style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom text indent font size font family time roman acknowledgment each party acknowledges sole ownership other party validity trademark trade dress logo slogan related element global branding strategy other than jointly owned global product trademark owned other party used intended used connection with commercialization product other party territory accordance with this agreement each party agrees that will time during after term assert claim interest anything which adversely affect validity enforceability copyright trademark trade dress logo slogan owned other party used intended used connection with marketing sale product accordance with this agreement neither party will register seek register cause registered copyright trademark trade dress logo slogan owned other party used intended used connection with marketing sale product variation thereof under applicable providing registration copyright trademark service mark trade name fictitious name including internet domain name similar such other party territory without other party prior written consent sole discretion each party agrees that other party trademark name logo will inure benefit such other party including goodwill connection therewith extent global product mark used morphosys territory emergent territory party shall jointly right internet domain name incorporating product trademark variation part such trademark address part such address under country code level domain corresponding country respective territory with respect other generic level domain party shall jointly determine respective domain shall registered which party shall entitled register respective domain each party shall responsible cost incurred with respect internet domain name registered such party style margin margin bottom font size font family time roman align center article style margin margin bottom font size font family time roman align center supply style margin margin bottom text indent font size font family time roman general emergent will commercially reasonable effort develop have developed process manufacture product scale have scaled such process level sufficient manufacture have manufactured perform packaging labeling supply required quantity compliant finished product accordance with applicable those country where development activity take place including placebo clinical territory accordance with applicable this agreement product specification unless expressly agreed between party supply emergent shall form finished product where party agreed drug substance vialed product supplied instead finished product depending agreed circumstance such event reference this article finished product shall substituted drug substance vialed product applicable style margin margin bottom text indent font size font family time roman development supply style margin margin bottom text indent font size font family time roman general emergent will commercially reasonable effort manufacture arrange third party manufacture which arrangement nbsp case third party performing manufacture drug substance shall subject morphosys prior approval such approval unreasonably withheld conditioned delayed nbsp case third party performing other manufacturing activity than forth nbsp above shall style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman notified emergent morphosys with respect which morphosys shall have burden demonstrate writing that withholding consent reasonable within reasonable time longer than thirty nbsp calendar such notice which case emergent shall such third party perform such manufacture supply morphosys requirement compliant finished product placebo including packaging labeling including required documentation release including applicable certificate compliance with requirement accordance with applicable product specification agreed time delivery development activity performed party accordance with development plan morphosys requirement connection with sole funded activity such finished product placebo shall supplied accordance with procedure forth this article style margin margin bottom text indent font size font family time roman supply price development finished product placebo supplied planned accordance with development plan relevant sole funded activity case supplied particular clinical trial development activity sole funded activity respectively shall invoiced cost vial forth schedule development supply price which reflects emergent cost development supply price shall subject adjustment reflect increase decrease nbsp pocket cost incurred emergent material external testing specifically outlined schedule nbsp change morphosys shall purchase clinical requirement product development activity sole funded activity exclusively from emergent pursuant term this article during term emergent shall shall cause affiliate supply third party with compound drug substance vialed product finished product placebo sale other supply morphosys territory decides reason engage third party contract manufacturer supply finished product placebo development then party shall bear cost expense such engagement related technology transfer including third party manufacturing payment sixty four percent nbsp morphosys thirty percent nbsp emergent style margin margin bottom text indent font size font family time roman ordering procedure finished product development morphosys shall submit purchase order finished product placebo expressly agreed party drug substance vialed product under development plan morphosys sole funded activity emergent shall supply product placebo itself needed perform development activity under development plan emergent sole funded activity emergent shall deliver product placebo accordance with purchase order placed morphosys finished product placebo expressly agreed party drug substance vialed product development activity morphosys sole funded activity itself needed perform development activity under development plan morphosys sole funded study provided that delivery date amount accordance with development plan emergent accepted purchase order case sole funded activity each case delivery date amount complied with commercially reasonable effort supply available product placebo limited then prioritization available product placebo shall first development activity then equitably each party sole funded activity style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom text indent font size font family time roman release with respect finished product placebo supplied development activity release shall performed party that sponsor clinical trial which such finished product placebo will used morphosys shall responsible release finished product placebo used morphosys sole funded activity emergent shall responsible release finished product placebo used emergent sole funded activity each party shall perform release accordance with product specification quality agreement applicable gmps style margin margin bottom text indent font size font family time roman title shipping risk loss finished product placebo morphosys sole funded activity shall supplied morphosys free carrier defined incoterms emergent designee site delivery shall occur title risk loss will morphosys when each order finished product placebo cleared export placed disposal morphosys designated carrier emergent designee site pursuant loading instruction provided morphosys otherwise agreed party cost complying with such instruction shall borne morphosys finished product placebo shall shipped morphosys expense carrier identified morphosys applicable purchase order provided that event that morphosys fails identify carrier emergent choose carrier reasonable discretion cost transporting insuring finished product placebo transit used development activity under development plan shall considered development cost style margin margin bottom text indent font size font family time roman invoice emergent shall invoice finished product placebo development supply price finished product placebo expected administered given clinical trial upon dosing first patient such clinical trial with respect sole funded activity upon shipment finished product placebo additional finished product placebo needed development activity such finished product placebo shall invoiced upon shipment such finished product placebo development supply price finished product placebo used development activity under development plan accordance with product specification agreed time delivery nbsp delivered undisputedly invoiced morphosys shall considered development cost morphosys nbsp used emergent credited emergent shall considered development cost emergent party shall adhere procedure section reimburse each other sharing development cost with respect finished product placebo ordered morphosys connection with sole funded activity morphosys will issue payment against undisputed invoice development supply price within forty five nbsp calendar style margin margin bottom text indent font size font family time roman development supply price audit morphosys shall have right audit calculation development supply price order accuracy thereof information purpose only morphosys shall have right audit emergent prevailing manufacturing cost manufacture finished product placebo provided section order confirm increase decrease development supply price pocket cost incurred emergent material external testing change well rata adjustment change concentration vial schedule such audit shall carried same manner audit provision section which shall apply mutatis mutandis both party facilitate such right audit style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom text indent font size font family time roman commercial supply party shall good faith effort enter commercial supply agreement least month prior expected first commercial sale product morphosys territory supply agreement style margin margin bottom text indent font size font family time roman supply agreement supply agreement shall provide manufacture supply finished product behalf emergent morphosys including affiliate sublicensees during term commercial morphosys territory accordance with this article provided however that morphosys decide before conclusion supply agreement during term have product manufactured supplied third party contract manufacturer which case emergent shall conduct technology transfer such third party contract manufacturer morphosys sole cost expense supply agreement shall include forecast ordering mechanism shall specify which party responsible release finished product commercial morphosys territory supply agreement will regulate that morphosys shall have option cause emergent initiate subject section least year prior expected expiration term expeditiously conclude technology transfer morphosys designee which shall third party reasonably acceptable emergent provided that shall reasonable deny acceptance such third party reputable contract manufacturing organization morphosys sole cost expense additionally supply agreement shall provide that least year prior expected expiration term upon morphosys written request party will negotiate good faith supply emergent morphosys with finished product after expiration term style margin margin bottom text indent font size font family time roman exclusivity except situation manufacturing license occurrence where morphosys decides have product manufactured supplied third party contract manufacturer accordance with section during term morphosys shall purchase from emergent morphosys affiliate sublicensees requirement finished product commercial territory during term emergent shall shall cause affiliate sublicensees supply third party with compound drug substance vialed product finished product placebo sale morphosys territory style margin margin bottom text indent font size font family time roman commercial supply price commercial supply price forth supply agreement shall subject adjustment reflect increase decrease nbsp cost material unless already reflected change producer price index nbsp change producer price index pharmaceutical sector reported bureau labor statistic previous twelve nbsp month commercial supply price such quantity morphosys shall order pursuant accordance with supply agreement supply agreement shall provide that during term morphosys demonstrate writing that third party contract manufacturer offered writing manufacture supply product term condition substantially similar those forth supply agreement supply price which equal lower than level commercial supply price then morphosys notify emergent thereof party will discus good faith reduction commercial supply price provided however that emergent willing able reduce commercial supply price equal lower than price offered third party contract manufacturer then morphosys elect written notice emergent invoke provision section provided further that morphosys shall bear percent cost expense effectuating provision section emergent shall reimbursed morphosys direct internal cost expense with respect which section shall apply direct approved pocket cost style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom text indent font size font family time roman supply agreement party good faith negotiation agree supply agreement date that month prior expected first commercial sale product stipulated then applicable development plan morphosys shall have right elect written notice emergent that section shall apply provided however that emergent shall reimbursed direct internal cost expense direct approved pocket cost section shall apply emergent internal cost style margin margin bottom text indent font size font family time roman packaging labeling certain other manufacturing activity emergent designated third party shall responsible final product labeling packaging whether commercial clinical packaging presentation including insertion material such patient insert patient medication guide professional insert other written printed graphic material accompanying product territory considered part finished product handling storage quality control quality assurance testing related activity product connection with foregoing collectively packaging labeling cost packaging labeling accounted development supply price will accounted commercial supply price style margin margin bottom text indent font size font family time roman quality agreement party shall execute nbsp quality agreement development supply product within ninety nbsp calendar effective date nbsp quality agreement commercial supply product within ninety nbsp calendar execution supply agreement which shall forth party quality compliance obligation with respect manufacture finished product both quality agreement quality agreement morphosys emergent agree comply with requirement provision forth quality agreement style margin margin bottom text indent font size font family time roman product specification manufacturing change product specification manufacturing change including those resulting from request received party from governmental authority change that emergent make shall dealt with pursuant quality agreement provided that applicable regulatory material shall prepared filed party accordance with provision article style margin margin bottom text indent font size font family time roman retention unless party agree otherwise emergent will maintain analytical sample each finished product storage time period based upon provision forth quality agreement applicable requirement regulatory authority territory style margin margin bottom text indent font size font family time roman handling storing morphosys from after time finished product delivered emergent hereunder such finished product shall handled stored shipped morphosys compliance with applicable including gmps contain material that would cause product adulterated misbranded within meaning applicable style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom text indent font size font family time roman shortage risk mediation shortage least prior expected first commercial sale product territory thereafter during term party will discus validation second manufacturing site manufacture product premise other than primary manufacturing site operation which site will comply with have adequate capacity meet expected requirement product party agree establish second manufacturing site cost establishing such second manufacturing site shall borne within nbsp month effective date emergent will prepare thereafter from time time necessary update including upon first commercial sale product territory risk mitigation plan ensure continuous uninterrupted supply product such risk mitigation plan shall reasonably satisfactory morphosys emergent shall commercially reasonable effort carry comply with such plan event that material manufacturing capacity required manufacture deliver finished product morphosys timely manner short supply emergent shall promptly notify morphosys such shortage writing party shall promptly meet discus shortage emergent shall treat morphosys demand equally emergent demand demand emergent other commercial partner allocate portion available amount finished product manufacturing capacity respective demand rata basis provided that foregoing supply rata basis limit other remedy morphosys have partial failure supply under this agreement supply agreement emergent shall promptly provide written plan action stating reasonable detail root cause shortage proposed measure remedy shortage date such shortage expected emergent shall commercially reasonable effort minimize duration shortage provided that foregoing effort emergent limit remedy morphosys have partial failure supply under this agreement supply agreement style margin margin bottom text indent font size font family time roman failure supply serious supply risk supply agreement shall provide that event failure supply event serious supply risk morphosys shall have right elect written notice emergent that section shall apply style margin margin bottom text indent font size font family time roman failure supply used herein failure supply shall mean that emergent unable supply full compliance with applicable product specification term supply agreement emergent notified morphosys that emergent anticipates that will unable supply such full compliance least percent quantity product ordered period consecutive calendar other than extent caused force majeure event omission morphosys affiliate sublicensees subcontractor style margin margin bottom text indent font size font family time roman serious supply risk used herein serious supply risk shall mean that other than extent caused force majeure event omission morphosys affiliate sublicensees subcontractor nbsp emergent within period consecutive month fails supply under more purchase order morphosys full compliance with applicable product specification term supply agreement delivery date least percent quantity product ordered under such purchase order emergent notifies morphosys that emergent anticipates that such failure occur nbsp either nbsp emergent able demonstrate morphosys that used commercially reasonable effort promptly after first failure under this section style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman follow risk mitigation section provide written plan action stating reasonable detail root cause shortage propose measure remedy shortage nbsp aforementioned risk mitigation measure sufficiently successful such that emergent within period consecutive month starting with first failure under this section respective notification time unable supply under purchase order full compliance with applicable product specification term supply agreement least percent quantity product under such purchase order emergent notifies morphosys again that emergent anticipates that such failure occur style margin margin bottom text indent font size font family time roman third party manufacturing event that elected under section morphosys elected written notice emergent under section that this section shall apply manufacturing license occurrence then case section party shall engage third party contract manufacturer assume case section morphosys shall have right assume engage third party assume each such case manufacturing compound drug substance vialed product finished product placebo case morphosys election under section emergent hereby grant morphosys morphosys hereby accepts with respect product exclusive with emergent affiliate royalty free license except forth below with respect through applicable third party manufacturing payment sublicensable such third party contract manufacturer accordance with section emergent manufacturing technology emergent platform technology morphosys such third party contract manufacturer behalf morphosys manufacture compound drug substance vialed product finished product anywhere world commercialization field morphosys territory nbsp morphosys shall responsible paying font style font family symbol font nbsp percent third party manufacturing payment other than form royalty szlig percent third party manufacturing payment form royalty sale morphosys territory each party shall bear third party manufacturing payment form royalty sale respective territory each case emergent forwarding emergent nbsp cost expense emergent morphosys third party transferee contract manufacturer other charge activity contemplated clause nbsp nbsp below achievement manufacturing technology transfer forth clause nbsp below shall borne nbsp percent morphosys morphosys elect that this section shall apply pursuant section nbsp percent emergent percent morphosys morphosys elect that this section shall apply pursuant section nbsp emergent shall nbsp provide copy such emergent manufacturing know extent controlled emergent necessary manufacture compound drug substance vialed product finished product placebo nbsp provide reasonable assistance personnel including answering question transfer manufacturing process each case order allow morphosys third party contract manufacturer designated morphosys replicate implement manufacturing process take over manufacturing compound drug substance vialed product finished product placebo validate obtain approval manufacturing facility morphosys such third party contract manufacturer designated morphosys alternate source supply compound drug substance vialed product finished product placebo event emergent wish resume manufacturing under supply agreement after failure supply serious supply risk emergent will notify morphosys thereof style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman party shall discus emergent future supply provided that emergent demonstrate reasonable satisfaction morphosys that will able meet forecasted demand finished product then current forecast established under supply agreement morphosys shall have right claim future manufacture supply emergent exclusive supply exclusive purchase basis further nbsp event morphosys shall have entered into manufacturing agreement with third party manufacturer supply emergent shall fully indemnify morphosys cost expense loss arising transfer manufacturing finished product back emergent result resumption emergent manufacturing hereunder event morphosys shall have manufacturing without entering manufacturing agreement with third party supply emergent shall reimburse morphosys direct cost expense directly related pocket cost nbsp event emergent failure supply serious supply risk deemed result inability meet requirement relevant quality agreement manufacture drug substance fill finish finished product then emergent shall demonstrate morphosys reasonable satisfaction that condition giving rise failure have been corrected event manufacturing license occurrence nbsp where third party contract manufacturer assumes manufacturing product emergent shall precluded from entering into separate manufacturing agreement with such third party contract manufacturer nbsp where morphosys assumes manufacture product party will emergent request negotiate good faith term condition under which morphosys shall manufacture supply product emergent such case license section shall expanded accordingly event morphosys borne percent cost accordance with clause above emergent enters into such manufacturing agreement with such third party contract manufacturer with morphosys according foregoing sentence nbsp within month after date that nbsp morphosys entered into such supply agreement with such third party contract manufacturer morphosys commenced manufacture product then emergent shall reimburse morphosys percent such cost nbsp after month prior anniversary date that nbsp morphosys entered into such supply agreement with such third party contract manufacturer morphosys commenced manufacture product then emergent shall reimburse morphosys percent such cost provided that clarity emergent enters into such manufacturing agreement with such third party contract manufacturer with morphosys after anniversary such applicable date then emergent shall have obligation reimburse morphosys portion such cost case morphosys take over manufacturing product under this section methodology calculation development supply price supply product development activity development cost section first sentence shall apply mutatis mutandis style margin margin bottom font size font family time roman align center article style margin margin bottom font size font family time roman align center payment style margin margin bottom text indent font size font family time roman upfront license upfront payment amount equal twenty million dollar upfront shall from morphosys emergent payable within fifteen nbsp calendar effective date upon receipt respective invoice from emergent payable wire transfer immediately available fund into account designated writing emergent such upfront shall nonrefundable noncreditable against other payment hereunder style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom text indent font size font family time roman milestone payment morphosys shall emergent milestone payment described this section upon achievement first occurrence corresponding milestone event provided however that morphosys shall promptly notify emergent writing event later than calendar after achievement case morphosys sublicensee achieving such milestone later than calendar after receipt notice such sublicensee each such milestone event each milestone notification notice achieved emergent shall provide respective invoice morphosys morphosys shall applicable milestone payment wire transfer immediately available fund into account designated emergent within sixty nbsp calendar after receipt such written undisputed invoice pursuant section provided however that event shall failure deliver milestone notification notice relieve morphosys obligation emergent milestone payment described this section each such payment nonrefundable noncreditable against other payment hereunder only payable first product achieve such milestone event each milestone payment shall only first product achieve applicable milestone indication indication basis irrespective number product that subsequently achieve applicable milestone event clarity milestone payment will made once only style font size margin margin bottom nbsp table cellspacing cellpadding width border style border collapse collapse font family time roman font size align center width valign bottom width style font family time roman font size valign bottom nowrap align center style margin margin bottom border bottom solid width font size font family time roman align center development milestone event first product achieving such development milestone event valign bottom nbsp nbsp valign bottom align center style border bottom solid milestone nbsp payment bgcolor cceeff style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman dosing first patient first phase clinical trial first indication product valign bottom nbsp nbsp valign bottom align center five nbsp million nbsp dollar style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp nbsp valign bottom align center bgcolor cceeff style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp nbsp valign bottom align center style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp nbsp valign bottom align center bgcolor cceeff style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp nbsp valign bottom align center style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp nbsp valign bottom align center bgcolor cceeff style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp nbsp valign bottom align center style font family time roman font size valign bottom nowrap align center style margin margin bottom border bottom solid width font size font family time roman align center regulatory milestone event first product achieving such regulatory milestone event valign bottom nbsp nbsp valign bottom align center style border bottom solid milestone payment bgcolor cceeff style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp nbsp valign bottom align center style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp nbsp valign bottom align center bgcolor cceeff style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp nbsp valign bottom align center style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp nbsp valign bottom align center bgcolor cceeff style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp nbsp valign bottom align center style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp nbsp valign bottom align center table style margin margin bottom text indent font size font family time roman clarity fourth subsequent indication further development milestone payment shall under this agreement milestone event described preceding table under heading development milestone event achieved before achievement milestone event listed under such heading then milestone event shall deemed automatically achieved corresponding milestone payment shall payable together with payment milestone payment subsequent milestone event milestone event described preceding table under heading development milestone event achieved before achievement milestone event listed under such heading then milestone event shall deemed automatically achieved corresponding milestone payment shall payable together with payment milestone payment subsequent milestone event style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom text indent font size font family time roman royalty payment emergent further consideration right granted morphosys under this agreement morphosys shall emergent payment morphosys royalty payment nbsp rate percent sale product morphosys territory other than diagnostic morphosys therapeutic royalty rate portion calendar year falling within royalty term nbsp rate negotiated good faith party sale product morphosys territory diagnostic morphosys diagnostic royalty rate portion calendar year falling within royalty term morphosys royalty payment shall become until morphosys first time generates aggregate sale product morphosys territory excess million dollar morphosys royalty payment payable first million dollar sale product morphosys territory example there sale product morphosys territory first calendar year after first commercial sale morphosys royalty payment shall first million dollar sale morphosys royalty payment shall next sale morphosys territory during royalty term clarity including extension period under section nbsp morphosys royalty payment payable under this section shall reduced percent amount forth this section after date which such product including sale offer sale importation development manufacturing thereof longer covered valid claim such country morphosys therapeutic royalty rate morphosys diagnostic royalty rate apply only sale morphosys territory style margin margin bottom text indent font size font family time roman royalty payment report morphosys shall calculate morphosys royalty payment payable emergent pursuant section report sale morphosys territory with respect sale morphosys territory each calendar quarter which amount shall converted dollar such time accordance with section morphosys shall emergent morphosys royalty payment sale morphosys territory during given calendar quarter within sixty nbsp calendar after such calendar quarter each morphosys royalty payment emergent shall accompanied nbsp statement gross amount invoiced account sale product nbsp morphosys territory whole nbsp country country basis during applicable calendar quarter including such amount expressed local currency converted dollar nbsp itemized calculation sale nbsp morphosys territory whole nbsp country country basis showing both nbsp nbsp deduction provided definition sale during such calendar quarter nbsp calculation country country basis amount morphosys royalty payment such sale such calendar quarter without limiting generality foregoing morphosys shall require affiliate sublicensees permitted distributor account sale provide such report with respect thereto such sale were made morphosys style margin margin bottom text indent font size font family time roman third party royalty other payment style margin margin bottom text indent font size font family time roman certain existing obligation except otherwise forth this agreement payment royalty sublicense revenue milestone other payment third party under agreement between emergent affiliate third party existing effective date covering development manufacturing commercialization product hereunder style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom text indent font size font family time roman license third party patent style margin margin bottom text indent font size font family time roman morphosys determines that necessary reasonably useful obtain license under patent third party relevant development manufacture commercialization product morphosys territory third party shall inform such determination along with documentation supporting such determination shall discus desirability obtaining license acquiring such third party determined party obtain license acquire such third party discus recommend appropriate financial term condition including scope license negotiated such license acquisition agreement such agreement third party agreement also designate party that party jointly responsible handling negotiation third party agreement absent such determination party obtain license acquire such third party absent designation which party shall responsible handling negotiation third party agreement morphosys shall have right sole discretion negotiate such third party agreement morphosys territory accordance with section negotiating party shall have responsibility authority negotiating executing such third party agreement provided that through their representative negotiating party shall keep other party reasonably informed with respect negotiation deal term relating such third party agreement including scope license financial term such negotiating party shall consider good faith comment recommendation analysis provided other party provided further that negotiating party shall agree term condition relating other party territory without prior written consent other party notwithstanding anything contrary this agreement contemplated section connection with emergent regard alternative mitigation strategy morphosys after discussion elect seek third party agreement emergent negotiate execute party such third party agreement third party agreement morphosys territory with respect opposition patent invalidation examination patent provided that emergent shall third party amount morphosys territory including upfront payment milestone payment license royalty other payment payable under such third party agreement morphosys shall reimburse emergent percent such paid amount upon emergent sending invoice morphosys which reimbursement amount other than with respect length good faith negotiated upfront payment milestone payment license payable under such third party agreement morphosys shall entitled deduct from morphosys royalty payment style margin margin bottom text indent font size font family time roman amount including upfront payment milestone payment license royalty other payment payable under third party agreement attributable morphosys territory shall borne morphosys provided however that nbsp case where third party agreement relates opposition patent party through agree that would prudent enter into third party agreement development manufacture commercialization product morphosys territory morphosys shall entitled deduct percent nbsp other case percent each case amount including upfront payment milestone payment license royalty other payment payable such third party account sale relation development manufacture commercialization product morphosys territory from morphosys royalty payment thereafter made morphosys emergent hereunder provided further that morphosys royalty payment payable under style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman section nbsp shall reduced such event below percent amount forth section nbsp extent that calendar quarter morphosys able aforementioned sentence allowed deduct entire amount above percentage amount payable such third party such calendar quarter morphosys shall entitled carry forward such remaining amount deduct them from morphosys royalty payment subsequent calendar quarter style margin margin bottom text indent font size font family time roman avoidance doubt provision section section apply mutatis mutandis third party emergent territory provided however that emergent shall only entitled deduct percent with respect payment made license covered section style margin margin bottom text indent font size font family time roman should same third party necessary reasonably useful develop manufacture commercialize product both territory both party shall jointly negotiate third party agreement payment amount under such third party agreement shall morphosys territory forth section emergent territory forth section party agree desirability securing license such third party unable agree term negotiation conclusion such third party agreement after good faith discussion each party shall have right execute third party agreement with such third party respective territory take deduction accordance with section respectively style margin margin bottom text indent font size font family time roman withholding each party shall comply with applicable regulation regarding filing reporting income purpose amount payable under this agreement value added event that amount under this agreement subject invoice respective party payment shall state applicable separately applicable require withholding income other imposed upon payment paying party shall assist payee party obtain withholding exemption certificate issued competent authority payee party shall provide paying party with such withholding exemption certificate least fifteen nbsp calendar prior payable date such payment payee party fails paying party shall permitted withhold withholding amount rate forth from such payment provided that paying party such amount competent authority paying party shall submit appropriate proof payment withholding payee party within reasonable period time shall make reasonable effort assist payee party recoup such from respective authority style margin margin bottom text indent font size font family time roman currency conversion payment hereunder shall made dollar purpose calculating under otherwise reimbursable pursuant this agreement including cost defined this agreement development cost calculation sale expressed currency other than dollar amount expressed foreign currency shall converted into dollar using average exchange rate european central bank published applicable reporting period payment style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom text indent font size font family time roman general payment procedure payment under this article other than royalty pursuant section subject prior written undisputed invoice served party owing payment complying with reasonable accounting requirement party owing payment receiving party shall invoice paying party amount such receiving party under this agreement such payment shall made within sixty nbsp calendar following receipt paying party undisputed invoice from receiving party specifying amount accordance with this agreement event either party dispute invoice delivered under this agreement receiving party shall deliver written notice delivery party dispute such invoice within fifteen nbsp calendar after receipt such invoice party shall good faith effort resolve such dispute soon practicable including providing supporting documentation reasonably requested receiving party connection therewith style margin margin bottom text indent font size font family time roman late payment amount required paid party hereunder which paid date shall bear interest rate equal thirty nbsp calendar dollar libor rate effective date that payment first reported wall street journal plus percent such interest shall computed basis year calendar actual number calendar payment delinquent style margin margin bottom text indent font size font family time roman development cost reimbursement procedure joint regulatory cost incurred style margin margin bottom text indent font size font family time roman report development cost within fifteen nbsp calendar following each calendar quarter beginning with effective date each party shall prepare deliver other party estimated quarterly report detailing development cost incurred during such period within forty five nbsp calendar following each calendar quarter beginning with effective date each party shall prepare deliver other party quarterly report detailing development cost incurred during such period including accurate record book account containing data reasonably required calculation verification ftes actually used each party accordance with development plan specifying whether such development cost were attributable morphosys territory required development activity morphosys territory discretionary activity emergent territory required development activity emergent territory discretionary activity manufacturing development activity manufacturing general development activity each party shall submit additional information with level detail reasonably requested other party related development cost included report within forty five nbsp calendar receipt such request style margin margin bottom text indent font size font family time roman reconciliation report payment within forty five nbsp calendar after receipt report delivered each party each calendar quarter portion such calendar quarter first last calendar quarter term emergent shall prepare deliver morphosys composite report that nbsp summarizes development cost incurred each party such calendar quarter broken down stipulated section nbsp applies percentage such cost which each party responsible with respect such development cost nbsp computes amount dollar emergent morphosys applicable such calendar quarter order party share total development cost such calendar quarter based principle forth section each reconciliation development payment party whom reconciliation development payment shall issue invoice other party reconciliation development payment such style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman other party shall reconciliation development payment within forty five nbsp calendar after receipt undisputed invoice party will cooperate order address issue regarding disputed invoice each party shall have right audit record other party with respect purported development cost demarcation these cost from other related cost included such report accordance with section provided that each party have additional audit case disputed invoice justified doubt that such report fully accurate style margin margin bottom text indent font size font family time roman report joint regulatory cost incurred extent either party incurs joint regulatory cost connection with preparation regulatory material obtaining product approval other than those cost related matter described section which shall borne emergent accordance with development plan then within forty five nbsp calendar following such calendar quarter which such regulatory cost were incurred such party shall prepare deliver report other party detailing regulatory cost other than those cost related matter described section which shall borne emergent other party shall have right audit record such party incurring such joint regulatory cost included such report accordance with section style margin margin bottom text indent font size font family time roman record audit each party affiliate sublicensees permitted distributor subcontractor shall keep full true accurate record book account containing particular that necessary purpose confirming accuracy calculating applicable royalty payment particular morphosys royalty payment emergent royalty payment respectively other amount payable other party hereunder including record sale other record reasonably required maintained with respect each party obligation under this agreement each party shall maintain complete accurate record sufficient detail permit other party confirm accuracy development cost regulatory cost invoiced party other party pursuant section including their demarcation cost related sole funded activity manufacture supply product development activity sole funded activity other amount payable otherwise reimbursable hereunder each case minimum period four nbsp year such longer period required applicable each party shall have right request audit other party order confirm accuracy foregoing audit provided however that each party shall only have right request such audit other party time during given calendar year upon written request party auditing party audit other party audited party auditing party shall have right engage independent internationally recognized accounting firm perform review reasonably necessary enable such accounting firm calculate otherwise confirm accuracy foregoing calendar year requested auditing party provided that nbsp such accountant shall given access shall permitted examine copy such book record audited party upon fifteen nbsp calendar prior written notice audited party reasonable time such calendar nbsp prior such examination taking place such accountant shall enter into confidentiality agreement with audited party reasonably acceptable audited party order keep information data contained such book record strictly confidential shall disclose such information copy such book record third person including auditing party shall only same purpose review calculation which they need perform order determine amount being reviewed nbsp such accountant shall reasonable style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman effort minimize disruption audited party business audited party shall make personnel reasonably available during regular business hour answer query such book record required purpose audit accountant shall deliver copy their finding each party within fifteen nbsp calendar completion review absence fraud manifest error finding such accountant shall final binding each party underpayment party well interest underpayment according section shall paid other party within fifteen nbsp calendar notification result such inspection overpayment made party shall refunded other party together with interest overpayment according section within fifteen nbsp calendar notification result such inspection cost accountant shall responsibility auditing party unless accountant calculation show that actual royalty payable sale development cost regulatory cost such other amount audited hereunder different more than percent than amount previously calculated audited party style margin margin bottom text indent font size font family time roman cost with respect those cost under article article with respect cost which this agreement expressly refers this section which party obligated bear internally then submit other party sharing reimbursement case each party shall calculate internal cost using rate dollar year rate cover employee salary employee specific benefit travel cost material after anniversary effective date rate shall subject adjustment reflect change producer price index pharmaceutical sector reported bureau labor statistic previous twelve month style margin margin bottom text indent font size font family time roman emergent royalty payment morphosys further consideration contribution development made morphosys emergent license from morphosys emergent pursuant section emergent shall morphosys payment emergent royalty payment nbsp tiered rate below sale product emergent territory medical other than diagnostic emergent therapeutic royalty rate portion calendar year falling within royalty term nbsp rate negotiated good faith party sale product emergent territory medical diagnostic emergent diagnostic royalty rate portion calendar year falling within royalty term emergent royalty payment shall become until emergent first time generates aggregate sale product emergent territory excess million dollar emergent royalty payment payable first million dollar sale product emergent territory example there sale product emergent territory first calendar year after first commercial sale emergent royalty payment shall first million dollar sale emergent royalty payment shall next sale product emergent territory emergent royalty payment shall final sale product emergent territory during royalty term clarity including extension period under section emergent royalty payment payable under this section shall reduced percent above amount forth this section after date which such product including sale offer sale importation development manufacturing thereof longer covered valid claim such country style font size margin margin bottom nbsp table cellspacing cellpadding width border style border collapse collapse font family time roman font size align center width valign bottom width style font family time roman font size valign bottom nowrap style margin margin bottom font size font family time roman annual sale emergent style margin margin bottom border bottom solid width font size font family time roman territory valign bottom nbsp nbsp valign bottom align center style border bottom solid emergent therapeutic royalty nbsp rate bgcolor cceeff style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman that portion aggregate annual sale than dollar valign bottom nbsp nbsp valign bottom align center nbsp percent style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman that portion aggregate annual sale greater than dollar than dollar valign bottom nbsp nbsp valign bottom align center nbsp percent table style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center table cellspacing cellpadding width border style border collapse collapse font family time roman font size align center width valign bottom width bgcolor cceeff style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman that portion aggregate annual sale equal greater than dollar than dollar valign bottom nbsp nbsp valign bottom align center nbsp percent style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman that portion aggregate annual sale equal greater than dollar valign bottom nbsp nbsp valign bottom align center twenty nbsp percent table style margin margin bottom text indent font size font family time roman emergent therapeutic royalty rate emergent diagnostic royalty rate apply only sale emergent territory section shall apply emergent with respect emergent royalty payment mutatis mutandis except that reference morphosys royalty payment shall deemed refer emergent royalty payment reference morphosys territory shall deemed refer emergent territory reference definition sale morphosys shall deemed refer emergent style margin margin bottom font size font family time roman align center article style margin margin bottom font size font family time roman align center intellectual property matter style margin margin bottom text indent font size font family time roman invention related intellectual property right style margin margin bottom text indent font size font family time roman emergent emergent platform invention emergent manufacturing invention emergent sole funded invention shall owned emergent deemed emergent platform know emergent manufacturing know emergent know respectively shall subject license right granted morphosys under this agreement style margin margin bottom text indent font size font family time roman morphosys except extent comprising including emergent platform invention emergent manufacturing invention morphosys sole funded invention shall owned morphosys deemed morphosys applied know shall subject license right granted emergent under this agreement style margin margin bottom text indent font size font family time roman joint technology joint invention joint know shall jointly owned party with each party entitled free enjoyment such joint invention respective territory subject term condition this agreement including territorial limitation license grant under section section including limitation provided section each party shall fifty percent nbsp undivided interest such joint invention joint know without accounting obtaining consent from other party entitled grant license joint invention joint know within respective territory only subject restriction forth this agreement including section which shall apply mutatis mutandis notwithstanding anything contrary contained herein emergent platform invention emergent manufacturing invention regardless which party generated such invention shall deemed owned exclusively emergent shall joint invention joint know shall deemed emergent platform technology emergent manufacturing technology applicable shall subject license right granted morphosys under this agreement style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom text indent font size font family time roman assignment extent legally possible morphosys hereby assigns emergent right title interest emergent platform invention emergent manufacturing invention morphosys shall execute deliver such document provide such assistance emergent reasonably request order vest emergent right title interest therein thereto extent such assignment legally possible such invention shall subject license grant section style margin margin bottom text indent font size font family time roman disclosure each party shall promptly disclose other writing shall cause affiliate licensee sublicenses their employee agent contractor disclose development making conception reduction practice joint invention product invention emergent sole funded invention morphosys sole funded invention style margin margin bottom text indent font size font family time roman employee each party will require will cause affiliate require their employee assign invention that developed made conceived such employee such affiliate respectively further assignment according ownership principle described this section free clear lien encumbrance charge security interest mortgage other similar restriction shall ensure that such assignment complies with applicable local including making required payment inventor such invention each party will also commercially reasonable effort require agent independent contractor sublicensees other third party performing activity pursuant this agreement assign invention that developed made conceived such agent independent contractor sublicensees further assignment according ownership principle described section free clear lien encumbrance charge security interest mortgage other similar restriction shall commercially reasonable effort ensure that that such assignment complies with applicable local including making required payment inventor such invention each party shall responsible performing action executing document necessary under applicable including limited german employee invention arbnerfg ensure that such party becomes owner applicable invention accordance with this agreement each party shall bear cost relating payment that inventor under arbnerfg other applicable employee invention style margin margin bottom text indent font size font family time roman amendment patent schedule without limiting emergent warranty provided under section time after effective date either party identifies emergent patent emergent platform patent emergent manufacturing patent that existed effective date which previously included schedule schedule schedule applicable then such patent shall added applicable schedule style margin margin bottom text indent font size font family time roman patent prosecution maintenance emergent patent style margin margin bottom text indent font size font family time roman emergent patent morphosys territory between party morphosys territory morphosys shall have obligation prepare file prosecute including reissue examination post grant proceeding request patent term extension supplementary protection certificate interference derivation proceeding supplemental examination defense opposition maintain emergent patent style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom text indent font size font family time roman emergent patent emergent territory between party emergent territory emergent shall have obligation prepare file prosecute including reissue examination post grant proceeding request patent term extension supplementary protection certificate interference derivation proceeding supplemental examination defense opposition maintain emergent patent style margin margin bottom text indent font size font family time roman general provision party will keep each other informed with regard filing prosecution maintenance emergent patent morphosys territory emergent territory party will share discus material aspect patent prosecution including nbsp material communication from patent authority nbsp draft material filing response made such patent authority each case regarding emergent patent such exchange information shall made sufficiently advance order allow other party review comment thereon prosecuting party shall consider good faith comment other party with respect strategy filing prosecuting emergent patent prosecuting party fails provide comment reasonably advance deadline filing otherwise responding patent authority prosecuting party shall free without consideration prosecuting party comment party shall also strive coordinate align their activity under this agreement professional proactive manner intellectual property related activity shall reviewed discussed intellectual property committee morphosys shall provide emergent data information material necessary emergent meet disclosure obligation uspto under style margin margin bottom text indent font size font family time roman cost cost prosecution maintenance emergent patent territory shall before entry national regional phase thereafter cost prosecution maintenance emergent patent morphosys territory shall borne morphosys cost prosecution maintenance emergent patent emergent territory shall borne emergent style margin margin bottom text indent font size font family time roman patent prosecution maintenance emergent platform patent emergent manufacturing patent style margin margin bottom text indent font size font family time roman emergent right between party morphosys territory emergent territory emergent shall have sole right prepare file prosecute including reissue examination post grant proceeding request patent term extension supplementary protection certificate interference derivation proceeding supplemental examination defense opposition maintain emergent platform patent emergent manufacturing patent through emergent shall keep morphosys informed with regard filing prosecution maintenance emergent platform patent emergent manufacturing patent territory providing with least once every nbsp month summary report regarding status emergent platform patent emergent manufacturing patent material action taken with respect thereto emergent shall bound shall consider good faith comment with respect such emergent summary report with respect strategy filing prosecuting emergent platform patent emergent manufacturing patent territory style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom text indent font size font family time roman continuing application party through shall determine appropriate action separately prosecute emergent patent from emergent platform patent morphosys territory emergent territory morphosys shall bear hundred percent nbsp cost filing prosecution maintenance more continuation divisional application morphosys territory that claim priority emergent platform patent provided that such continuation divisional claim subject matter beyond scope emergent patent emergent shall bear hundred percent nbsp cost filing prosecution maintenance more continuation divisional application emergent territory that claim priority emergent platform patent event that either party inadvertently miss final deadline file such continuation divisional application then respective other party take respective action avoid remedy such omission cost party which missed respective deadline furtherance thereof patent family where possible morphosys shall allowed file least nbsp patent application with patent office further country morphosys territory desired morphosys effort obtain issued patent that specifically cover compound morphosys shall responsible discretion perform prosecution maintenance such patent application shall responsible prosecution maintenance cost morphosys shall unless approved emergent prosecute claim which broader scope than compound itself style margin margin bottom text indent font size font family time roman abandonment event that emergent intends file longer prosecute maintain emergent platform patent emergent manufacturing patent country belonging morphosys territory emergent shall provide reasonable prior written notice such intention which notice shall event given later than four nbsp week prior next deadline action that taken with respect such emergent platform patent emergent manufacturing patent morphosys territory morphosys shall thereupon have option sole discretion cost file continuation divisional application that complies with provision section style margin margin bottom text indent font size font family time roman cost except cost prosecution maintenance patent mentioned section which shall borne morphosys cost prosecution maintenance emergent platform patent emergent manufacturing patent territory shall borne emergent style margin margin bottom text indent font size font family time roman patent prosecution maintenance morphosys applied patent style margin margin bottom text indent font size font family time roman morphosys right morphosys shall have first right obligation prepare file prosecute including reissue examination post grant proceeding request patent term extension supplementary protection certificate interference derivation proceeding supplemental examination defense opposition maintain morphosys applied patent worldwide morphosys cost through morphosys shall keep emergent informed with regard filing prosecution maintenance morphosys applied patent territory style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom text indent font size font family time roman emergent right event that morphosys intends prosecute maintain morphosys applied patent country world morphosys shall provide reasonable prior written notice such intention which notice shall event given later than twenty nbsp calendar prior next deadline action that taken with respect such morphosys applied patent emergent shall thereupon have option sole discretion sole cost assume control direction prosecution maintenance such morphosys applied patent such country morphosys behalf style margin margin bottom text indent font size font family time roman cost cost prosecution maintenance morphosys applied patent territory shall borne morphosys style margin margin bottom text indent font size font family time roman patent prosecution maintenance joint patent style margin margin bottom text indent font size font family time roman initial phase patent filing party shall jointly decide through optimal strategy prosecution maintenance joint patent such decision shall include content timing respective patent application selection jurisdiction filing provisional initial patent application stage entry into national regional phase party will jointly discus agree action taken style margin margin bottom text indent font size font family time roman national regional phase upon entry into national regional phase emergent shall have obligation prepare file prosecute including reissue examination post grant proceeding request patent term extension supplementary protection certificate interference derivation proceeding supplemental examination defense opposition maintain joint patent emergent territory morphosys shall have obligation prepare file prosecute including reissue examination post grant proceeding request patent term extension supplementary protection certificate interference derivation proceeding supplemental examination defense opposition maintain joint patent morphosys territory party shall closely cooperate prosecutional matter section shall apply mutatis mutandis style margin margin bottom text indent font size font family time roman right take over event that either party intends prepare file prosecute maintain joint patent country jurisdiction within respective territory such party shall provide reasonable prior written notice such intention which notice shall event given later than four nbsp week prior next deadline action that taken with respect such joint patent respective territory other party shall thereupon have option sole discretion assume control direction preparation filing prosecution maintenance such joint patent provided there other patent same patent family respective jurisdiction which cover product upon continuing party written exercise such option continuing party continuing party shall assume responsibility full control preparation filing prosecution maintenance such joint patent continuing party shall bear cost that accrue connection therewith continuing party shall assign continuing party interest such joint patent shall execute such document perform such continuing party expense reasonably necessary permit continuing party file such patent application prosecute maintain such joint patent clarity event that continuing party continues prosecution maintenance such joint patent pursuant this section then such patent shall longer considered joint patent shall deemed licensed other party under section case style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom text indent font size font family time roman cost cost prosecution maintenance joint patent territory shall before entry national regional phase thereafter cost prosecution maintenance joint patent morphosys territory shall borne morphosys cost prosecution maintenance joint patent emergent territory shall borne emergent style margin margin bottom text indent font size font family time roman defense enforcement patent style margin margin bottom text indent font size font family time roman infringement third party patent subject without limiting party right procedure forth under section section each party shall promptly event later than nbsp calendar after receipt notice thereof notify other party writing event claim third party alleged patent infringement morphosys emergent their respective affiliate sublicensees with respect research development manufacture sale offer sale importation product each infringement claim subject without limiting party right procedure forth under section with respect infringement claim territory party shall attempt negotiate good faith resolution with respect thereto party settle such infringement claim with appropriate third party within thirty nbsp calendar after receipt notice pursuant this section then following shall apply style margin margin bottom text indent font size font family time roman subject section section case such claim against morphosys alone both morphosys emergent each case with respect product morphosys territory then morphosys shall deemed controlling party purpose such infringement claim case claim against emergent alone both morphosys emergent each case with respect product emergent territory then emergent shall deemed controlling party purpose such infringement claim event worldwide litigation such that related case claim being pursued both inside morphosys territory emergent territory each party shall reasonably assist other role controlling party respective territory style margin margin bottom text indent font size font family time roman subject section section controlling party shall assume control defense such infringement claim expense controlling party upon reasonable request controlling party agrees join such litigation controlling party expense event reasonably cooperate with controlling party controlling party expense controlling party will have right consult with controlling party concerning such infringement claim participate represented independent counsel litigation which such controlling party party expense controlling party shall have exclusive right settle infringement claim without consent controlling party unless such settlement shall have material adverse impact controlling party which case consent such controlling party shall required consent emergent required such settlement reasonably likely have material adverse impact emergent technology emergent platform technology emergent manufacturing technology purpose this section settlement that would involve waiver right including right receive payment payment obligation such controlling party shall deemed material adverse impact shall require consent such controlling party such consent unreasonably style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman withheld conditioned delayed controlling party shall provide controlling party with copy material correspondence from opposing party from court adjudicating dispute shall provided with draft pleading motion prior submission settlement offer documentation connection with such infringement claim style margin margin bottom text indent font size font family time roman party shall become engaged participate suit described this section other party shall cooperate shall cause affiliate employee cooperate with such party reasonable respect connection therewith including giving testimony producing document lawfully requested using reasonable effort make available other cost other other than reimbursement actually incurred reasonable pocket travel lodging expense such employee helpful with respect such suit investigation claim other proceeding style margin margin bottom text indent font size font family time roman settlement paid third party pursuant suit action proceeding brought pursuant section shall subject claim indemnification settling party pursuant section except settlement paid third party pursuant suit action proceeding that subject emergent indemnification obligation pursuant section style margin margin bottom text indent font size font family time roman potential action certain identified third party patent style margin margin bottom text indent font size font family time roman opposition proceeding event that third party patent application that nbsp nbsp claim bispecific binding domain molecule having binding domain specific psma binding domain specific nbsp claim bispecific binding domain molecule having domain derived from antibody nbsp claim binding domain molecule having psma binding domain each nbsp nbsp that claim benefit priority date earlier than april nbsp grant european patent opposition patent prior first commercial sale product emergent shall consider good faith after consultation with patent counsel mutually acceptable party with least nbsp year experience contentious patent matter with regard alternative mitigation strategy principled argument evidence that such opposition patent should considered unpatentable under applicable objective realizing potential commercialization product whether initiate opposition proceeding with respect such opposition patent within statutory time period filing such action opposition proceeding provided however that nothing this agreement shall obligate emergent file opposition proceeding party agree that they should jointly file opposition proceeding they shall cooperate good faith determining strategy filing such opposition proceeding morphosys shall percent cost such opposition proceeding emergent shall percent such cost emergent decides file opposition proceeding behalf emergent shall control such opposition proceeding shall bear cost event that morphosys decides file opposition proceeding behalf morphosys shall control such opposition proceeding shall bear cost style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom text indent font size font family time roman invalidation examination further event infringement claim occurring under section with respect third party patent major market that nbsp nbsp claim bispecific binding domain molecule having binding domain specific psma binding domain specific nbsp claim bispecific binding domain molecule having domain derived from antibody nbsp claim binding domain molecule having psma binding domain each nbsp nbsp that claim benefit priority date earlier than april nbsp invalidation examination patent emergent shall consider good faith after consultation with patent counsel mutually acceptable party with least nbsp year experience contentious patent matter with regard alternative mitigation strategy principled argument evidence that such patent should invalidated examined with objective realizing potential commercialization product whether initiate nbsp invalidation procedure major market morphosys territory with respect such invalidation examination patent invalidation proceeding applicable nbsp examination procedure united state with respect such invalidation examination patent examination proceeding event that emergent considers determines initiate invalidation proceeding major market morphosys territory nbsp party shall cooperate good faith determining strategy initiating such invalidation proceeding nbsp morphosys shall percent cost such invalidation proceeding emergent shall percent such cost nbsp emergent shall control such invalidation proceeding event that emergent considers determines initiate examination proceeding united state emergent shall bear cost such examination proceeding style margin margin bottom text indent font size font family time roman prosecution infringers style margin margin bottom text indent font size font family time roman notice either party nbsp receives notice patent nullity action declaratory judgment action alleged threatened infringement patent patent application misappropriation intellectual property territory comprising nbsp joint invention nbsp emergent patent emergent platform patent emergent sole funded invention emergent platform invention emergent know emergent platform know nbsp morphosys applied patent morphosys sole funded invention morphosys applied know nbsp learns that third party infringing allegedly infringing patent within emergent patent emergent platform patent morphosys applied patent each case territory third party claim that such patent invalid unenforceable each case with respect territory will promptly notify other party thereof provide copy document received provide evidence infringement claim invalidity unenforceability reasonably available such party style margin margin bottom text indent font size font family time roman enforcement patent style margin margin bottom text indent font size font family time roman between emergent morphosys morphosys will have first right obligation take appropriate step enforce defend patent within emergent patent joint patent against infringement third party that conducting sale offer sale import pharmaceutical product morphosys territory nullity action opposition proceeding morphosys territory provided that morphosys provides copy material correspondence from opposing party from court adjudicating dispute emergent shall provided with draft pleading motion prior submission settlement offer documentation connection with such enforcement shall have right suggest patent counsel which suggestion shall style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman considered morphosys good faith morphosys shall bear cost such enforcement defense applicable notwithstanding foregoing extent legally possible emergent will have right expense represented such action counsel choice emergent shall make declaration execute document necessary morphosys take step first sentence this clause style margin margin bottom text indent font size font family time roman pursuant section morphosys fails institute defend such litigation otherwise take step remedy infringement emergent patent joint patent within hundred eighty nbsp calendar shorter period required applicable date party provided notice other party pursuant section such infringement claim then emergent will have right obligation expense bring defend such suit action proceeding counsel choice morphosys will have right expense represented such action counsel choice style margin margin bottom text indent font size font family time roman between emergent morphosys morphosys will have first right obligation take appropriate step enforce defend patent within morphosys applied patent against infringement third party that conducting sale offer sale import pharmaceutical product emergent territory nullity action opposition proceeding emergent territory morphosys shall provide emergent with copy correspondence from opposing party from court adjudicating dispute draft pleading motion prior submission settlement offer documentation connection with such enforcement emergent shall have right suggest patent counsel which suggestion shall considered morphosys good faith morphosys take these step including initiation prosecution control suit proceeding other legal action counsel choice subject compliance with previous sentence except that party shall jointly select counsel emergent joined party such action pursuant section morphosys shall bear cost such enforcement defense applicable notwithstanding foregoing emergent will have right expense represented such action counsel choice emergent shall make declaration execute document necessary morphosys take step first sentence this clause style margin margin bottom text indent font size font family time roman morphosys fails institute litigation pursuant section otherwise step remedy infringement morphosys applied patent within hundred eighty nbsp calendar shorter period required applicable date party provided notice other party pursuant section such infringement claim then emergent will have right obligation expense bring such suit action proceeding counsel choice except that party shall jointly select counsel morphosys joined party such action pursuant section morphosys will have right expense represented such action counsel choice style margin margin bottom text indent font size font family time roman except patent application filed accordance with section morphosys shall have right bring suit action proceeding with respect infringement emergent manufacturing patent emergent platform patent morphosys territory emergent patent joint patent emergent territory style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom text indent font size font family time roman cooperation damage style margin margin bottom text indent font size font family time roman party brings suit action proceeding under section other party agrees joined party plaintiff necessary prosecute suit action proceeding give first party reasonable authority file prosecute suit action proceeding first party cost provided however that neither party will required transfer right title interest property other party other party confer standing party hereunder style margin margin bottom text indent font size font family time roman party pursuing suit action proceeding hereunder will provide reasonable assistance other party including providing access relevant document other evidence making employee available subject other party reimbursement pocket cost incurred enforcing defending party providing such assistance style margin margin bottom text indent font size font family time roman morphosys shall without prior written consent emergent which shall unreasonably withheld conditioned delayed enter into stipulation compromise settlement relating claim suit action that brought under section involving emergent patent that admits invalidity unenforceability such emergent patent requires emergent money otherwise adversely affect right emergent with respect such patent product emergent right hereunder including right receive payment style margin margin bottom text indent font size font family time roman emergent shall without prior written consent morphosys which shall unreasonably withheld conditioned delayed enter into stipulation compromise settlement relating claim suit action that brought under section involving morphosys applied patent that admits invalidity unenforceability such morphosys applied patent requires morphosys money otherwise adversely affect right morphosys with respect such patent product morphosys right hereunder including right receive payment style margin margin bottom text indent font size font family time roman settlement damage other monetary award recovery recovered pursuant suit action proceeding brought pursuant section will allocated first cost expense party taking such action second cost expense other party with remaining amount allocated follows nbsp extent that such recovery payment lost sale product field morphosys territory such recovery shall treated sale subject morphosys royalty payment emergent pursuant nbsp remaining recovery shall payable party taking such action extent such remaining recovery relate solely product field morphosys territory purpose clarity remaining recovery related product emergent territory shall payable emergent style margin margin bottom text indent font size font family time roman settlement paid third party pursuant suit action proceeding brought pursuant section shall subject claim indemnification settling party pursuant section except settlement paid third party pursuant suit action proceeding that subject emergent indemnification obligation pursuant section style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom text indent font size font family time roman infringement defense style margin margin bottom text indent font size font family time roman clarity with respect infringement defense emergent patent anywhere emergent territory emergent designee shall have sole exclusive right bring appropriate suit other action against person engaged such infringement defense such emergent patent sole discretion morphosys shall have right with respect thereto style margin margin bottom text indent font size font family time roman clarity with respect infringement defense morphosys applied patent anywhere morphosys territory morphosys designee shall have sole exclusive right bring appropriate suit other action against person engaged such infringement defense such morphosys applied patent sole discretion emergent shall have right with respect thereto style margin margin bottom text indent font size font family time roman patent term extension between morphosys emergent morphosys extent permitted applicable shall have exclusive right obligation seek emergent name required patent term extension including supplemental protection certificate like available under applicable country morphosys territory relation emergent patent joint patent emergent shall cooperate support morphosys connection with such activity morphosys agent attorney will give consideration suggestion comment emergent regarding such activity with using reasonable effort obtain available patent term extension including supplemental protection certificate like available under applicable event disagreement between party morphosys will have final decision making authority style margin margin bottom text indent font size font family time roman patent marking morphosys shall mark product marketed sold morphosys affiliate distributor hereunder with appropriate patent number indicia emergent request least extent required applicable style margin margin bottom text indent font size font family time roman patent challenge each party will permitted terminate this agreement upon written notice other party effective upon receipt other party affiliate directly indirectly nbsp initiate request interference post grant review inter partes review opposition proceeding like with respect emergent patent emergent manufacturing patent emergent platform patent morphosys applied patent case nbsp nbsp make file maintain claim demand lawsuit cause action challenge validity enforceability emergent patent emergent platform patent emergent manufacturing patent morphosys applied patent case nbsp subject without limiting morphosys right under section oppose extension grant patent term extension with respect emergent patent emergent platform patent emergent manufacturing patent morphosys applied patent case each clause nbsp patent challenge style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman align center article style margin margin bottom font size font family time roman align center representation warranty covenant style margin margin bottom text indent font size font family time roman mutual representation warranty each party hereby represents warrant applicable other party follows effective date style margin margin bottom text indent font size font family time roman corporate existence power company corporation duly organized validly existing good standing under jurisdiction which incorporated full corporate power authority legal right operate property asset carry business being conducted contemplated this agreement including right grant license granted hereunder style margin margin bottom text indent font size font family time roman authority binding agreement nbsp corporate power authority legal right enter into this agreement perform obligation hereunder nbsp taken necessary corporate action part required authorize execution delivery this agreement performance obligation hereunder nbsp this agreement been duly executed delivered behalf such party constitutes legal valid binding obligation such party that enforceable against accordance with term except enforcement affected bankruptcy insolvency other similar general principle equity style margin margin bottom text indent font size font family time roman conflict execution delivery performance this agreement nbsp conflict with agreement instrument understanding oral written which affiliate party which affiliate bound nbsp violate governmental authority having jurisdiction over style margin margin bottom text indent font size font family time roman consent approval obtained except with respect regulatory approval development manufacturing commercialization product otherwise described this agreement nbsp necessary consent approval authorization nbsp notice filing such party with governmental authority other person required obtained provided such party effective date connection with execution delivery performance this agreement have been obtained provided style margin margin bottom text indent font size font family time roman additional representation warranty emergent emergent hereby represents warrant morphosys that effective date except forth schedule purpose this agreement knowledge mean when referring knowledge emergent actual knowledge emergent personnel with following title nbsp chief scientific officer nbsp senior vice president manufacturing operation nbsp senior vice president global service group chief quality officer nbsp executive vice president bioscience division nbsp chief medical officer nbsp general counsel nbsp chief counsel nbsp chief financial officer viii nbsp person directly reporting them with substantive involvement with program nbsp member project team style margin margin bottom text indent font size font family time roman neither emergent affiliate filed marketing authorization application with governmental authority territory sale product territory style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom text indent font size font family time roman neither emergent affiliate knowledge emergent subcontractor received notice writing otherwise knowledge fact which have emergent believe that regulatory approval relating product currently good standing with their foreign equivalent style margin margin bottom text indent font size font family time roman neither emergent affiliate knowledge emergent subcontractor received written notice proceeding pending before threatened regulatory authority with respect product facility where product manufactured style margin margin bottom text indent font size font family time roman knowledge emergent nbsp issued patent encompassed within emergent patent emergent platform patent emergent manufacturing patent valid enforceable patent nbsp there fact which would render patent application encompassed within emergent patent emergent platform patent emergent manufacturing patent when issued invalid unenforceable knowledge emergent third party nbsp infringing such emergent patent emergent platform patent emergent manufacturing patent misappropriated emergent technology emergent platform technology emergent manufacturing technology nbsp challenged ownership scope duration validity enforceability priority emergent right license emergent technology emergent platform technology emergent manufacturing technology style margin margin bottom text indent font size font family time roman knowledge emergent schedule contains complete correct list emergent patent effective date schedule contains complete correct list emergent platform patent effective date schedule contains complete correct list emergent manufacturing patent effective date patent identified schedule schedule schedule patent that controlled emergent affiliate that necessary morphosys develop commercialize product morphosys territory each case currently envisioned party under initial development plan style margin margin bottom text indent font size font family time roman there claim judgment settlement against owed emergent pending reissue reexamination interference opposition similar proceeding with respect emergent technology emergent platform technology emergent manufacturing technology emergent received notice effective date threatened claim litigation reissue reexamination interference opposition similar proceeding seeking invalidate otherwise challenge emergent technology emergent platform technology emergent manufacturing technology style margin margin bottom text indent font size font family time roman knowledge emergent based current anticipated date launch sale offer sale importation emergent morphosys their respective affiliate applicable product product exists effective date excluding avoidance doubt additional technology that combined incorporated therewith future improvement enhancement product territory emergent technology emergent platform technology emergent manufacturing technology nbsp infringe issued valid enforceable patent third party nbsp misappropriate know third party style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom text indent font size font family time roman course development product knowledge emergent neither emergent affiliate used employee that debarred under generic drug enforcement analogous agency under analogous territory style margin margin bottom text indent font size font family time roman subject third party manufacturing license agreement license emergent sole legal beneficial owner emergent technology emergent manufacturing technology emergent platform technology subject credit agreement hereinafter defined free license lien encumbrance charge security interest mortgage other similar restriction including restriction governmental authority public funding third party right interest claim neither emergent affiliate party existing agreement granting right interest claim such emergent technology emergent manufacturing technology emergent technology third party including academic organization agency governmental authority that inconsistent with right license granted morphosys herein further license granted morphosys under this agreement under emergent technology emergent manufacturing technology emergent platform technology compliance with credit agreement particular condition stipulated section nbsp nbsp nbsp security right granted under credit agreement limit emergent ability grant license forth section nbsp nothing credit agreement inhibits morphosys using exploiting license provided this agreement credit agreement mean that certain credit agreement dated december nbsp amended agreement concluded under such credit agreement between emergent biosolutions bank america merrill lynch national bank amongst others style margin margin bottom text indent font size font family time roman knowledge emergent emergent affiliate have complied with applicable material respect including disclosure requirement connection with filing prosecution maintenance emergent patent emergent platform patent emergent manufacturing patent territory material renewal maintenance effective date with respect prosecution maintenance emergent platform patent emergent manufacturing patent territory have been paid style margin margin bottom text indent font size font family time roman effective date emergent disclosed morphosys reasonably relevant data information regarding emergent technology compound such data information complete accurate material aspect emergent allowed will continue allow morphosys access material information possession control nbsp containing result preclinical testing human clinical testing compound nbsp concerning side effect injury toxicity sensitivity reaction incident severity thereof with respect compound style margin margin bottom text indent font size font family time roman knowledge emergent there safety efficacy issue involving compound development commercialization product field morphosys territory forth initial development plan style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom text indent font size font family time roman research development including clinical trial regarding compound were conducted development data resulting from such research development have been generated behalf emergent affiliate knowledge emergent with respect subcontractor compliance material respect with applicable where applicable style margin margin bottom text indent font size font family time roman knowledge emergent inventor named emergent patent emergent platform patent emergent manufacturing patent listed schedule schedule schedule schedule respectively that owned emergent affiliate true inventor such patent have assigned under written obligation assign emergent their right title interest such emergent platform patent emergent manufacturing patent emergent manufacturing patent invention described therein style margin margin bottom text indent font size font family time roman knowledge emergent emergent know emergent platform know emergent manufacturing know have nbsp been licensed conflict agreement instrument understanding which emergent party including credit agreement nbsp been disclosed third party other than under obligation confidentiality style margin margin bottom text indent font size font family time roman third party manufacturing license agreement license agreement credit agreement full force effect emergent aware neither emergent affiliate default material breach obligation under such agreement style margin margin bottom text indent font size font family time roman emergent acknowledges that morphosys relying entitled rely foregoing representation warranty style margin margin bottom text indent font size font family time roman covenant emergent emergent hereby covenant morphosys that during term style margin margin bottom text indent font size font family time roman time delivery finished product development activity sole funded activity such finished product will have been manufactured accordance with standard applicable agreed product specification style margin margin bottom text indent font size font family time roman emergent affiliate have will maintain material consent license permit authorization required regulatory authority manufacture finished product accordance with applicable style margin margin bottom text indent font size font family time roman morphosys right under this agreement third party assume manufacturing compound drug substance vialed product finished product event manufacturing license occurrence morphosys request emergent shall present name such third party existing manufacturing licensor order request necessary consent such counterparties such third party manufacturer style margin margin bottom text indent font size font family time roman emergent affiliate will maintain third party manufacturing license agreement subject section license agreement full force effect material respect accordance with their respective term style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom text indent font size font family time roman covenant morphosys morphosys hereby covenant emergent that event manufacturing license occurrence time delivery finished product development activity sole funded activity such finished product will have been manufactured accordance with standard applicable product specification style margin margin bottom text indent font size font family time roman disclaimer morphosys understands that product subject ongoing clinical research development that emergent ensure usefulness product that product will receive regulatory approval style margin margin bottom text indent font size font family time roman other representation warranty except expressly stated this agreement representation warranty whatsoever whether express implied including warranty merchantability fitness particular purpose noninfringement misappropriation third party intellectual property right made given behalf party except expressly stated this agreement representation warranty whether arising operation otherwise hereby expressly excluded style margin margin bottom font size font family time roman align center article style margin margin bottom font size font family time roman align center indemnification style margin margin bottom text indent font size font family time roman indemnification emergent emergent hereby agrees save indemnify defend hold morphosys affiliate sublicensees their respective director officer agent employee harmless from against loss damage liability cost expense including reasonable attorney expense collectively loss arising connection with charge complaint action suit proceeding hearing investigation claim demand judgment order decree stipulation injunction third party each third party claim resulting otherwise arising from nbsp breach emergent representation warranty covenant obligation pursuant this agreement nbsp negligence willful misconduct emergent affiliate their respective officer director employee agent consultant subcontractor sublicensee performing obligation under this agreement nbsp matter related research development compound prior effective date territory nbsp development manufacturing packaging labeling product territory hereunder commercialization product emergent territory including clarity product liability loss resulting therefrom emergent affiliate their respective officer director employee agent consultant subcontractor sublicensees nbsp sole funded activity conducted emergent nbsp claim patent infringement brought third party basis patent that claim bispecific binding domain molecule having binding domain specific psma binding domain specific nbsp claim bispecific binding domain molecule having domain derived from antibody each nbsp nbsp nbsp claim benefit priority date earlier than april nbsp each case except extent that such loss subject indemnification morphosys pursuant section style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom text indent font size font family time roman indemnification morphosys morphosys hereby agrees save indemnify defend hold emergent affiliate sublicensees their respective director agent employee harmless from against loss arising connection with third party claim resulting otherwise arising from nbsp breach morphosys representation warranty covenant obligation pursuant this agreement nbsp negligence willful misconduct morphosys affiliate their respective officer director employee agent consultant subcontractor sublicensees performing obligation under this agreement nbsp development manufacturing event manufacturing license occurrence packaging labeling only extent actually done behalf morphosys territory hereunder commercialization product morphosys territory including clarity product liability loss resulting therefrom morphosys affiliate their respective officer director employee agent consultant subcontractor sublicensees nbsp sole funded activity conducted morphosys nbsp exercise morphosys final decision making authority pursuant section with respect matter manner inconsistent with position taken emergent chief executive officer with respect such matter provided that emergent chief executive officer within dispute procedure forth section good faith expressly objected decision because related development activity either violates applicable raise concern regarding patient safety each case except extent that such loss subject indemnification emergent pursuant section style margin margin bottom text indent font size font family time roman indemnification procedure style margin margin bottom text indent font size font family time roman notice claim indemnification claim respect indemnitee seeking indemnity under section applicable collectively indemnitees each indemnitee will made solely corresponding party indemnified party indemnified party will give indemnifying party indemnifying party prompt written notice indemnification claim notice loss legal proceeding initiated third party against indemnified party which indemnified party intends make request indemnification under section applicable event will indemnifying party liable loss that result from delay providing such notice which materially prejudice defense such proceeding each indemnification claim notice shall contain description claim nature amount such loss extent that nature amount such loss known such time together with indemnification claim notice indemnified party will furnish promptly indemnifying party copy notice document including court paper received indemnitee connection with third party claim style margin margin bottom text indent font size font family time roman control defense indemnifying party option assume defense third party claim subject indemnification provided section applicable giving written notice indemnified party within thirty nbsp calendar after indemnifying party receipt indemnification claim notice upon assuming defense third party claim indemnifying party appoint lead counsel defense third party claim legal counsel selects such indemnifying party shall thereafter continue defend such third party claim good faith should indemnifying party assume defense third party claim continue defend such third party claim good faith indemnifying party will liable indemnified party other indemnitee style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman legal expense subsequently incurred such indemnified party other indemnitee connection with analysis defense settlement third party claim unless indemnifying party failed assume defense employ counsel accordance with this section case matter subject indemnification under section style margin margin bottom text indent font size font family time roman right participate defense without limiting section indemnitee will entitled participate defense third party claim which sought indemnification hereunder employ counsel choice such purpose provided however that such employment will indemnitee expense unless nbsp employment thereof been specifically authorized indemnifying party writing nbsp indemnifying party failed assume defense continue defend such third party claim good faith employ counsel accordance with this section which case indemnified party will allowed control defense nbsp matter that subject indemnification under section which case reasonable cost such employment counsel shall indemnifying party expense style margin margin bottom text indent font size font family time roman settlement with respect loss relating solely payment money damage connection with third party claim that will result indemnitee becoming subject injunctive other relief otherwise adversely affect business indemnitee material manner which indemnifying party will have acknowledged writing obligation indemnify indemnitee hereunder indemnifying party will have sole right consent entry judgment enter into settlement otherwise dispose such loss such term indemnifying party reasonable discretion deems appropriate provided however that such term shall include complete unconditional release indemnified party from liability with respect thereto will transfer indemnified party amount which such indemnified party liable prior time entry judgment with respect other loss connection with third party claim where indemnifying party assumed defense such third party claim accordance with section indemnifying party will have authority consent entry judgment enter into settlement otherwise dispose such loss provided obtains prior written consent indemnified party which consent will indemnified party reasonable discretion indemnifying party that assumed defense continues defend such third party claim accordance with section will liable settlement other disposition loss indemnitee that reached without written consent such indemnifying party regardless whether indemnifying party chooses defend prosecute third party claim indemnitee will admit liability with respect settle compromise discharge third party claim without first offering indemnifying party opportunity assume defense such third party claim accordance with section style margin margin bottom text indent font size font family time roman cooperation indemnifying party chooses defend prosecute third party claim indemnified party will will cause each other indemnitee cooperate defense prosecution thereof will furnish such record information testimony provide such witness attend such conference discovery proceeding hearing trial appeal reasonably requested connection with such third party claim such cooperation will include access during normal business hour afforded indemnifying party reasonable retention indemnified party record information that style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman reasonably relevant such third party claim making indemnitees other employee agent available mutually convenient basis provide additional information explanation material provided hereunder indemnifying party will reimburse indemnified party reasonable pocket expense incurred connection with such cooperation style margin margin bottom text indent font size font family time roman expense indemnified party except provided above reasonable verifiable cost expense including disbursement counsel incurred indemnified party connection with third party claim will reimbursed calendar quarter basis indemnifying party without prejudice indemnifying party right contest indemnified party right indemnification subject refund event indemnifying party ultimately held obligated indemnify indemnified party style margin margin bottom text indent font size font family time roman limitation liability neither party shall liable other consequential incidental indirect damage under connection with this agreement regardless notice possibility such damage notwithstanding foregoing nothing this section intended shall limit restrict indemnification right obligation party under section damage available party breach confidentiality obligation under article party gross negligence willful misconduct fraud style margin margin bottom text indent font size font family time roman insurance each party shall have maintain such type amount liability insurance normal customary pharmaceutical industry generally party similarly situated shall upon request provide other party with copy policy such insurance along with amendment thereto understood that such insurance shall construed create limit either party liability with respect indemnification obligation under this article each party shall provide other party with written notice least thirty nbsp calendar prior cancellation nonrenewal material change such insurance self insurance which materially adversely affect right other party hereunder upon request each party will promptly provide other party with certificate insurance evidencing such coverage certificate shall specify date such coverage expires furtherance foregoing party shall share accordance with section cost nbsp emergent insurance policy phase clinical trial provided that morphosys named additional insured such insurance policy nbsp insurance policy obtained either party following discussion agreement party other development activity under development plan with respect which policy other party shall named additional insured provided that neither party able obtain insurance policy such development activity under which other party named additional insured then each party obtain insurance policy cost style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman align center article style margin margin bottom font size font family time roman align center confidentiality style margin margin bottom text indent font size font family time roman confidential information used this agreement term confidential information mean information whether written form visually orally including production schedule line product volume business process product development product design formula technical information laboratory data clinical data patent information know trade secret financial strategic information marketing promotional information data other material relating product project process party disclosing party that provided otherwise obtained other party receiving party connection with this agreement including information exchanged prior date hereof connection with transaction forth this agreement including information disclosed either party pursuant mutual disclosure agreement between party dated august nbsp amended nbsp notwithstanding foregoing sentence confidential information shall include information material that style margin margin bottom text indent font size font family time roman were already known receiving party other than under obligation confidentiality time disclosure disclosing party extent such receiving party documentary evidence that effect style margin margin bottom text indent font size font family time roman were generally available public otherwise part public domain time disclosure thereof receiving party style margin margin bottom text indent font size font family time roman became generally available public otherwise part public domain after disclosure development thereof case other than through omission party breach such party confidentiality obligation under this agreement style margin margin bottom text indent font size font family time roman were disclosed party other than under obligation confidentiality third party obligation disclosing party disclose such information others style margin margin bottom text indent font size font family time roman were independently discovered developed behalf receiving party without confidential information belonging other party extent such receiving party documentary evidence that effect style margin margin bottom text indent font size font family time roman confidentiality obligation each morphosys emergent shall keep confidential information received from behalf other party with same degree care with which maintains confidentiality confidential information case than reasonable degree care neither party shall such confidential information purpose other than performance this agreement disclose same other person other than such affiliate director officer manager employee independent contractor agent consultant potential sublicensees potential investor have need know such confidential information implement term this agreement enforce right under this agreement bound confidentiality obligation strict than those contained herein provided however that receiving party shall advise affiliate director officer manager employee independent contractor agent consultant potential sublicensees potential investor receives such confidential information confidential nature thereof obligation contained this agreement relating thereto receiving party shall ensure including case third party mean written agreement with such third party having term least protective those contained this article that such director officer manager employee independent contractor agent consultant potential sublicensees potential investor comply with such obligation understood that receipt confidential information under this agreement will limit receiving party from assigning employee particular task choose subject term condition this agreement style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom text indent font size font family time roman extended protection confidential information emergent platform know emergent platform invention emergent manufacturing know emergent manufacturing invention shall considered confidential information emergent extended protection confidential information morphosys acknowledges that extended protection confidential information treated with higher level confidentiality that addition obligation forth this article extended protection confidential information shall subject additional obligation forth this section morphosys shall commercially reasonable effort limit number person that have access extended protection confidential information morphosys shall inform recipient extended protection confidential information confidential nature extended protection confidential information confidentiality undertaking morphosys contained herein morphosys covenant that shall maintain security practice which include appropriate administrative physical technical safeguard including underlying operating system network security control designed meet generally accepted industry practice meaning those reasonably expected biotechnology company where biotechnology company possession highly sensitive information designed ensure security confidentiality integrity extended protection confidential information which include nbsp restriction copying extended protection confidential information need know basis only authorized location nbsp regular monitoring password procedure style margin margin bottom text indent font size font family time roman return confidential information upon termination this agreement receiving party shall return destroy document tape other medium containing confidential information disclosing party that remain possession receiving party director officer manager employee independent contractor agent consultant potential sublicensees potential investor except that receiving party keep nbsp copy confidential information legal department file receiving party solely archival purpose such archival copy shall deemed property disclosing party shall continue subject provision this article provision this section shall apply copy electronically exchanged confidential information made matter routine information technology backup provided that otherwise accessible receiving party other than information technology representative responsible maintaining receiving party electronic backup system confidential information copy thereof which must stored according provision mandatory applicable style margin margin bottom text indent font size font family time roman permitted disclosure notwithstanding section nbsp either party disclose confidential information belonging other party only extent such disclosure reasonably necessary nbsp comply with enforce obligation right under this agreement comply with applicable nbsp either party disclose confidential information belonging other party related product only extent such disclosure reasonably necessary obtain maintain regulatory approval product extent such disclosure made governmental authority party deems necessary disclose confidential information other party pursuant this section such party shall style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman give reasonable advance written notice such disclosure other party permit such other party sufficient opportunity object such disclosure take measure ensure confidential treatment such information including seeking protective order other appropriate remedy style margin margin bottom text indent font size font family time roman notification receiving party shall notify disclosing party promptly upon discovery unauthorized disclosure disclosing party confidential information will cooperate with disclosing party reasonably requested fashion assist disclosing party regain possession such confidential information prevent further unauthorized disclosure style margin margin bottom text indent font size font family time roman publicity filing this agreement style margin margin bottom text indent font size font family time roman publicity press release issued connection with transaction forth schedule except otherwise provided this section each party shall maintain confidentiality provision this agreement without prior written consent other party which consent shall unreasonably withheld conditioned delayed neither party respective affiliate shall make press release other public announcement otherwise disclose provision this agreement third party except nbsp disclosure those director officer employee accountant attorney underwriter lender other financing source potential strategic partner advisor agent potential sublicensees whose duty reasonably require them have access this agreement provided that such director officer employee accountant attorney underwriter lender other financing source advisor agent potential strategic partner potential sublicensees required maintain confidentiality this agreement nbsp disclosure required york stock exchange regulation frankfurt stock exchange regulation listing agreement with national security exchange which case disclosing party shall provide nondisclosing party with least forty eight nbsp hour notice unless otherwise practicable event later than time disclosure required such york stock exchange regulation frankfurt stock exchange regulation listing agreement made nbsp disclosure required which case disclosing party shall provide nondisclosing party with prompt advance notice such disclosure cooperate with nondisclosing party seek protective order other appropriate remedy including request confidential treatment case filing with security exchange commission nbsp report form which filed emergent affiliate emergent setting forth press release referred above this agreement redacted form provided section nbsp disclosure that consistent with complementary those described clause nbsp which contain confidential information other party nbsp other disclosure which consent previously been given party publicly disclose without regard preceding requirement this section information that previously publicly disclosed pursuant this section party however acknowledge that called announcement that party legally required make under german security prior notice possible style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom text indent font size font family time roman redacted agreement party acknowledge that legally required either both party obligated file copy this agreement with other governmental authority each party shall entitled make such required filing provided that initially file redacted copy this agreement approved both party redacted agreement request confidential treatment term redacted from this agreement reasonable period time event such filing each party shall nbsp permit other party review comment upon such request confidential treatment subsequent correspondence with respect thereto least seven nbsp calendar advance submission such other governmental authority nbsp reasonably consider incorporate other party comment thereon extent consistent with then current legal requirement governing redaction information from material agreement that must publicly filed nbsp promptly deliver other party written correspondence received representative from such governmental authority with respect such confidential treatment request promptly advise other party other communication between representative with such governmental authority with respect such confidential treatment request nbsp upon written request other party request appropriate extension term confidential treatment period where available nbsp such governmental authority request change redaction forth redacted agreement commercially reasonable effort support redaction redacted agreement originally filed extent consistent with then current legal requirement governing redaction information from material agreement that must publicly filed extent reasonably practicable agree change redacted agreement without first discussing such change with other party taking other party comment into consideration when deciding whether agree such change each party shall responsible legal other external cost connection with such filing registration notification style margin margin bottom text indent font size font family time roman publication party intend publish present conduct outcome clinical trial will commercially reasonable effort align such publication presentation public each party shall submit through other party approval such approval unreasonably withheld conditioned delayed copy each proposed academic scientific medical other publication presentation that contains refers emergent technology morphosys applied technology otherwise relates product research development activity under this agreement other party least thirty nbsp calendar advance submitting such proposed publication presentation publisher other third party other party shall have right review comment each such proposed publication presentation publishing party shall consider comment good faith other party shall have right remove confidential information prior submission publication presentation publishing party publishing party shall redact otherwise modify proposed publication presentation remove such confidential information other party addition event that document includes data information material generated other party scientist professional standard authorship would consistent with including other party scientist author document name such scientist will included coauthor morphosys shall publish present information that contains emergent platform technology emergent manufacturing technology without prior written consent emergent style margin margin bottom text indent font size font family time roman name except otherwise forth this agreement neither party shall name other party relation this transaction public announcement press release other public document without written consent such other party which consent shall unreasonably withheld conditioned delayed provided however that subject section either party name other party document filed with regulatory authority governmental authority including security exchange commission german federal financial supervisory authority bafin style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom text indent font size font family time roman survival obligation prohibition contained this article they apply confidential information shall survive expiration termination this agreement period nbsp year provided that confidential information nature that could reasonably expected qualify trade secret pursuant including confidential information relating development manufacture compound product quality control measure production sale distribution similar data information compilation data result obligation contained this article they apply confidential information shall survive long such confidential information qualifies trade secret pursuant style margin margin bottom font size font family time roman align center article style margin margin bottom font size font family time roman align center term termination style margin margin bottom text indent font size font family time roman term this agreement shall become effective effective date unless earlier terminated pursuant this article shall remain effect country country basis until expiration royalty term such country territory term style margin margin bottom text indent font size font family time roman morphosys termination convenience subject section time after completion stage dose escalation phase clinical trial forth initial development plan phase clinical trial dose escalation phase morphosys shall have right terminate this agreement sole discretion providing nbsp month prior written notice emergent phase clinical trial dose escalation phase deemed completed upon dosing cycle last patient stage event that morphosys grant sublicense under right granted pursuant section develop product commercialization commercialize manufacture product sale united kingdom france germany italy spain japan china emergent expressly consent such sublicensee whether such consent required pursuant section then unless such sublicense terminable emergent upon termination this agreement morphosys shall have right terminate this agreement pursuant this section first month after effective date such sublicense which effective date shall earlier than execution date thereof style margin margin bottom text indent font size font family time roman termination breach bankruptcy patent challenge without prejudice other remedy available equity under this agreement style margin margin bottom text indent font size font family time roman emergent terminate this agreement style margin margin bottom text indent font size font family time roman event that morphosys shall have materially breached defaulted performance obligation morphosys shall have hundred twenty nbsp calendar after written notice thereof provided morphosys emergent cure such breach default unless morphosys cured such breach default prior expiration such hundred twenty nbsp calendar period such termination shall become effective upon receipt written notice termination given within nbsp calendar such hundred twenty nbsp calendar period style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom text indent font size font family time roman result filing institution bankruptcy reorganization liquidation receivership proceeding upon assignment substantial portion asset benefit creditor morphosys provided that such termination shall effective only such proceeding dismissed within ninety nbsp calendar after filing thereof style margin margin bottom text indent font size font family time roman case morphosys patent challenge subject section style margin margin bottom font size font family time roman provided however that emergent shall only have such right terminate this agreement upon written notice morphosys until later nbsp completion phase clinical trial nbsp emergent receipt morphosys payment next phase clinical trial development milestone contemplated achieved then current development plan development milestone provided that such milestone payment paid morphosys prior achievement corresponding development milestone event further provided that this payment shall credited against first subsequent phase clinical trial milestone payment obligation that triggered latest emergent termination date phase clinical trial deemed completed upon dosing last patient stage accordance with relevant study protocol notwithstanding anything contrary this agreement party agree that case material breach default breaching party termination right granted this article remedy article adequate remedy breaching party style margin margin bottom text indent font size font family time roman morphosys terminate this agreement style margin margin bottom text indent font size font family time roman event that emergent shall have materially breached defaulted performance obligation emergent shall have hundred twenty nbsp calendar after written notice thereof provided emergent morphosys cure such breach default unless emergent cured such breach default prior expiration such hundred twenty nbsp calendar period such termination shall become effective upon receipt written notice termination given within nbsp calendar such hundred twenty nbsp calendar period style margin margin bottom text indent font size font family time roman result filing institution bankruptcy reorganization liquidation receivership proceeding upon assignment substantial portion asset benefit creditor emergent provided that such termination shall effective only such proceeding dismissed within ninety nbsp calendar after filing thereof style margin margin bottom text indent font size font family time roman case emergent patent challenge subject section provided however that morphosys shall only have such right terminate this agreement upon written notice emergent until completion phase clinical trial dose escalation phase style margin margin bottom text indent font size font family time roman covenant amend development plan after notice termination delivered responsibility development cost until termination morphosys shall longer have right exercise casting vote accordance with section purpose including amend development plan adding additional development activity after notice termination given morphosys pursuant section style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman emergent pursuant section decision thereafter shall taken mutual agreement party without limiting either party obligation under article each party shall responsible paying share development cost joint regulatory cost accordance with section until effective date termination neither party shall have obligation bear development cost clinical trial under development plan that commenced date written notice termination delivered accordance with this article style margin margin bottom font size font family time roman align center article style margin margin bottom font size font family time roman align center effect termination other remedy material breach default bankruptcy patent challenge termination convenience style margin margin bottom text indent font size font family time roman termination morphosys convenience termination emergent morphosys breach bankruptcy patent challenge prior latest emergent termination date without limiting other legal equitable remedy that party have this agreement terminated nbsp morphosys accordance with section nbsp emergent accordance with section then following provision shall apply style margin margin bottom text indent font size font family time roman termination license granted morphosys clarity right license granted morphosys under this agreement shall immediately terminate further force effect morphosys shall cease developing commercializing product notwithstanding foregoing sublicenses granted morphosys will remain full force effect provided that sublicensee then breach sublicense agreement sublicensee agrees bound emergent under term condition sublicense agreement that emergent shall bound perform duty obligation forth sublicenses that extend beyond duty obligation emergent forth this agreement style margin margin bottom text indent font size font family time roman continuation contribution this agreement terminated morphosys accordance with section emergent accordance with section morphosys shall continue responsible share development cost joint regulatory cost accordance with allocation forth section hundred percent nbsp morphosys sole funded activity until attainment previously specified point within such clinical trial forth development plan that multiple stage decision point progression from stage next termination such clinical trial from which point time morphosys shall longer responsible share development cost accordance with allocation forth section with respect such development activity provided however that event shall morphosys responsible cost expense exceeding cost expense occurring such clinical trial accordance with development plan later than twelve nbsp month after effective date termination this agreement accordance with allocation forth section longer until extent such clinical trial terminated accordance with applicable clarity notwithstanding obligation article emergent shall allowed from receipt termination notice seek another license partner morphosys territory forth further below within nbsp year after such termination becomes effective emergent entered into agreement with third party subject which such third party receives license develop commercialize product field under which good faith style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman length agreement such third party obligated emergent upfront near term nbsp year case until such clinical trial completed study report approved milestone payment additional license funding reimbursement with such milestone payment additional license funding reimbursement being aggregate least time amount development cost paid morphosys under this section then promptly following receipt emergent least such aggregate payment from such third party emergent will reimburse morphosys amount development cost paid morphosys under this section style margin margin bottom text indent font size font family time roman assignment this agreement terminated accordance with section with section except extent sublicense country country basis which will remain full force effect pursuant section necessary performance such sublicense emergent shall have right request writing within forty five nbsp calendar after later effective date such termination receipt applicable contract extent reasonably necessary emergent continue development manufacture commercialization product morphosys territory style margin margin bottom text indent font size font family time roman extent permitted under relevant contract assign emergent morphosys right title interest agreement portion thereof between morphosys third party that relate development commercialization product style margin margin bottom text indent font size font family time roman assign emergent morphosys right title interest promotional material copyright trademark including product mark morphosys territory including goodwill associated therewith registration design patent foregoing internet domain name registration such trademark slogan extent solely related product provided however that event emergent exercise such right have assigned such promotional material morphosys shall grant royalty free right license housemarks trademark name logo morphosys contained therein period nbsp month order such promotional material connection with commercialization product morphosys territory style margin margin bottom text indent font size font family time roman termination occurs while development activity ongoing assign emergent management continued performance clinical trial product ongoing hereunder effective date such termination style margin margin bottom text indent font size font family time roman transfer emergent morphosys right title interest regulatory filing regulatory approval other regulatory material product extent such transfer possible provided however that such application provided basis emergent release morphosys liability arising after effective date such transfer from development product style margin margin bottom text indent font size font family time roman transfer emergent morphosys right title interest development data promotional material marketing strategy market research data relating morphosys commercialization product morphosys territory information resulting from morphosys commercialization product morphosys territory style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom text indent font size font family time roman provide copy nbsp material tangible embodiment foregoing nbsp other material book record file document controlled morphosys solely extent related product which redacted exclude confidential information morphosys style margin margin bottom font size font family time roman provided however that extent agreement other asset described this section assignable morphosys then such agreement other asset will assigned upon request emergent morphosys will take such step reasonably necessary allow emergent obtain enjoy benefit such agreement other asset style margin margin bottom text indent font size font family time roman except extent sublicense country country basis which will remain full force effect pursuant section necessary performance such sublicense nbsp emergent shall have right request that morphosys take foregoing action whole part with respect portion asset forth foregoing provision nbsp extent emergent request morphosys transfer right title interest item forth this section emergent morphosys shall also cause affiliate sublicensees subject section transfer assign emergent such affiliate sublicensees right title interest foregoing item forth this section style margin margin bottom text indent font size font family time roman license grant emergent this agreement terminated accordance with section with section morphosys hereby grant emergent exclusive irrevocable perpetual worldwide license sublicense applicable with right sublicense under morphosys applied technology develop including obtaining maintaining regulatory approval make import export offer sale sell product field morphosys territory emergent territory provided that emergent shall amount including upfront payment milestone payment license royalty other payment payable morphosys third party licensors morphosys attributable exercise such license with respect product field style margin margin bottom text indent font size font family time roman royalty further consideration foregoing assignment transfer license contribution case nbsp this agreement terminated emergent accordance with section royalty term mutatis mutandis only until morphosys recouped percent nbsp development cost allocated pursuant section which were incurred accordance with development plan nbsp development cost borne morphosys pursuant section recouped morphosys under this agreement nbsp development cost which were borne morphosys pursuant section nbsp this agreement terminated morphosys accordance with section then royalty term mutatis mutandis emergent shall morphosys royalty payment sale product territory portion calendar year falling within royalty term follows nbsp termination effective before achievement earlier nbsp development milestone event nbsp development milestone event nbsp development milestone event rate twenty percent nbsp emergent royalty payment specified section nbsp termination effective after achievement earlier nbsp development milestone event nbsp development milestone event nbsp development milestone event before achievement regulatory milestone event rate percent emergent royalty payment specified section nbsp termination effective after achievement regulatory milestone event rate percent emergent royalty payment specified section style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom text indent font size font family time roman disclosure delivery morphosys will promptly transfer emergent copy physical embodiment morphosys applied know extent then used connection with development commercialization product such transfer shall effected delivery material document extent such morphosys applied know embodied such document extent that morphosys applied know fully embodied such document morphosys shall make employee agent have knowledge such morphosys applied know addition that embodied document reasonably available emergent emergent cost expense interview demonstration training effect such transfer manner sufficient enable emergent practice such morphosys applied know style margin margin bottom text indent font size font family time roman disposition inventory this agreement terminated morphosys accordance with section morphosys affiliate will entitled during period ending last calendar sixth nbsp full month following effective date such termination sell inventory product affected such termination that remains hand effective date termination long morphosys emergent royalty payment other amount payable hereunder including milestone applicable said subsequent sale with respect sale morphosys territory applicable accordance with term condition forth this agreement otherwise complies with term forth this agreement style margin margin bottom text indent font size font family time roman remedy emergent morphosys breach bankruptcy patent challenge after latest emergent termination date without limiting other legal equitable remedy that emergent have after latest emergent termination date style margin margin bottom text indent font size font family time roman morphosys shall have materially breached defaulted performance obligation under this agreement morphosys cured such breach default prior expiration such hundred twenty nbsp calendar period after receipt written notice emergent thereof style margin margin bottom text indent font size font family time roman morphosys undergoes filing institution bankruptcy reorganization liquidation receivership proceeding upon assignment substantial portion asset benefit creditor provided that such proceeding dismissed within ninety nbsp calendar after filing thereof style margin margin bottom text indent font size font family time roman case morphosys patent challenge style margin margin bottom font size font family time roman emergent right submit morphosys written notice which expressly refers this section emergent remedy notice such notice given within ninety nbsp calendar after emergent receiving knowledge above event nbsp emergent shall entitled following remedy style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom text indent font size font family time roman morphosys shall longer have casting vote including pursuant section section party will need decide upon matter accordance with section senior officer unable resolve issue within fifteen nbsp calendar after dispute first referred them decision chief executive officer subject section chief executive officer unable resolve dispute good faith negotiation within nbsp calendar after dispute referred them either party refer matter determination expert accordance with section style margin margin bottom text indent font size font family time roman emergent sole discretion assume responsibility performance specific activity forth development plan case that manufacturing license occurrence occurred morphosys manufacturing having third party contract manufacturer manufacture product manufacture product supply development activity emergent sole funded activity technology transfer forth section provided that cost expense forth section shall equally shared each party provided however that neither emergent expert allocate additional responsibility performance activity morphosys morphosys will continue bear share development cost accordance with section style margin margin bottom text indent font size font family time roman morphosys obligation emergent morphosys therapeutic royalty rate pursuant section shall increased from percent percent style margin margin bottom text indent font size font family time roman emergent obligation morphosys emergent therapeutic royalty rate pursuant section shall reduced percentage point each royalty tier style margin margin bottom text indent font size font family time roman morphosys shall continue milestone payment emergent accordance with section style margin margin bottom text indent font size font family time roman case morphosys materially breached defaulted performance commercialization obligation clarity whether such breach commercialization obligation triggering emergent remedy notice another further material breach morphosys cured such material breach default prior expiration ninety nbsp calendar after receipt written notice emergent thereof morphosys shall emergent each period three nbsp month consecutive which morphosys such breach commercialization obligation amount percent emergent development cost allocated pursuant section which were incurred accordance with development plan provided that morphosys shall only obligated make such payment until emergent recouped such development cost receipt such payment pursuant this section morphosys therapeutic royalty rate morphosys diagnostic royalty rate already paid morphosys emergent pursuant section this section clarity obligation make payment under this section shall relieve morphosys obligation morphosys therapeutic royalty rate morphosys diagnostic royalty rate payment payable under this section period three nbsp month will reduced amount morphosys therapeutic royalty rate morphosys diagnostic royalty rate paid morphosys this time period style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom text indent font size font family time roman termination morphosys emergent breach bankruptcy patent challenge prior completion phase clinical trial dose escalation phase without limiting other legal equitable remedy that party have this agreement terminated morphosys accordance with section then provision section shall apply mutatis mutandis style margin margin bottom text indent font size font family time roman remedy morphosys emergent breach bankruptcy patent challenge without limiting other legal equitable remedy that morphosys have style margin margin bottom text indent font size font family time roman emergent shall have materially breached defaulted performance obligation under this agreement emergent cured such breach default prior expiration such hundred twenty nbsp calendar period after receipt written notice morphosys thereof style margin margin bottom text indent font size font family time roman emergent undergoes filing institution bankruptcy reorganization liquidation receivership proceeding upon assignment substantial portion asset benefit creditor provided that proceeding dismissed within ninety nbsp calendar after filing thereof style margin margin bottom text indent font size font family time roman case emergent patent challenge morphosys right submit emergent written notice which expressly refers this section morphosys remedy notice such notice given within ninety nbsp calendar after emergent receiving knowledge above event nbsp morphosys shall entitled following remedy style margin margin bottom text indent font size font family time roman morphosys sole discretion assume responsibility performance specific activity forth development plan including manufacturing development activity emergent will continue bear share development cost accordance with section without limiting other remedy article manufacture product supply development activity morphosys sole funded activity sublicensing subject section section technology transfer forth section provided that cost expense forth section nbsp aforementioned technology transfer shall equally shared each party supply agreement will forth circumstance technology transfer morphosys manufacture commercial supply morphosys territory style margin margin bottom text indent font size font family time roman morphosys shall longer have obligation emergent morphosys therapeutic royalty rate pursuant section style margin margin bottom text indent font size font family time roman morphosys shall only percent milestone payment regulated section style margin margin bottom text indent font size font family time roman emergent obligation morphosys emergent therapeutic royalty rate pursuant section shall increased percentage point each royalty tier case emergent materially breached defaulted performance commercialization obligation clarity such breach commercialization obligation style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman triggering morphosys remedy notice another further breach emergent cured such breach default prior expiration ninety nbsp calendar after receipt written notice morphosys thereof emergent shall morphosys each period three nbsp month consecutive which emergent such ongoing breach commercialization obligation amount percent morphosys development cost allocated pursuant section which were incurred accordance with development plan development cost borne morphosys pursuant section provided that emergent shall only obligated make such payment long morphosys recouped such development cost receipt such payment pursuant this section emergent therapeutic royalty rate already paid morphosys emergent pursuant section clarity obligation make payment under this section relieve emergent emergent therapeutic royalty rate emergent diagnostic royalty rate payment payable under this section period three nbsp month will reduced amount emergent therapeutic royalty rate emergent diagnostic royalty rate paid emergent this time period style margin margin bottom text indent font size font family time roman expiration this agreement upon expiration this agreement pursuant section with respect given country morphosys territory morphosys will have exclusive fully paid perpetual royalty free right license under license section develop commercialize manufacture product morphosys territory upon expiration this agreement pursuant section with respect given country emergent territory emergent will have nonexclusive fully paid perpetual royalty free right license under license section develop commercialize manufacture product emergent territory provided that respective party receiving such license shall amount including upfront payment milestone payment license royalty other payment payable other party third party licensors such other party attributable exercise such license with respect product field respective territory upon request morphosys emergent will transfer morphosys copy physical embodiment emergent manufacturing know extent then used connection with manufacture product extent that emergent manufacturing know fully embodied such document emergent shall make employee agent have knowledge such emergent manufacturing know addition that embodied document reasonably available morphosys morphosys cost expense interview demonstration training effect such transfer manner sufficient enable morphosys practice such emergent manufacturing know notwithstanding foregoing morphosys shall responsible bearing third party manufacturing payment payable under third party manufacturing agreement style margin margin bottom text indent font size font family time roman accrued right termination expiration this agreement reason will without prejudice right that will have accrued benefit party prior effective date such termination such termination will relieve party from obligation that expressly indicated survive termination expiration this agreement style margin margin bottom text indent font size font family time roman survival notwithstanding anything contrary contained herein following provision shall survive expiration termination this agreement article article article article article section calendar quarter which there payment obligation calendar quarter which there payment obligation except forth this article otherwise expressly forth herein upon termination expiration this agreement other right obligation party shall cease style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom text indent font size font family time roman joint patent upon termination this agreement reason emergent shall sole cost expense have sole right prosecute maintain enforce defend joint technology style margin margin bottom text indent font size font family time roman right bankruptcy right license granted under pursuant this agreement emergent morphosys shall otherwise deemed purpose section nbsp bankruptcy code license right intellectual property defined under section nbsp bankruptcy code party agree that each party licensee certain right under this agreement shall retain fully exercise right election under bankruptcy code party further agree that event commencement bankruptcy proceeding against party such party bankrupt party under bankruptcy code nbsp other party shall entitled complete duplicate complete access appropriate intellectual property licensed such other party embodiment such intellectual property which already such other party possession shall promptly delivered nbsp upon such commencement bankruptcy proceeding upon such other party written request therefore unless bankrupt party elect continue perform obligation under this agreement nbsp delivered under clause following rejection this agreement bankrupt party upon written request therefore other party nbsp bankrupt party shall unreasonably interfere with other party right intellectual property embodiment intellectual property shall assist unreasonably interfere with other party obtaining intellectual property embodiment intellectual property from another entity embodiment intellectual property includes tangible intangible electronic other embodiment right license hereunder including compound product embodying intellectual property product filing with regulatory authority related right emergent know case that emergent bankrupt party morphosys applied know case morphosys bankrupt party style margin margin bottom font size font family time roman align center article style margin margin bottom font size font family time roman align center dispute resolution style margin margin bottom text indent font size font family time roman dispute party recognize that from time time during term dispute arise certain matter which relate either party right obligation hereunder objective party establish procedure facilitate resolution dispute arising under this agreement expedient manner mutual cooperation without resort litigation accomplish this objective party agree follow procedure forth this article resolve controversy claim arising relating connection with provision this agreement other than dispute resolved expert which shall addressed forth therein section style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom text indent font size font family time roman arising between party with respect dispute arising between party their representative arising from under section including alleged failure perform breach this agreement issue relating interpretation application this agreement party unable resolve such dispute within thirty nbsp calendar after such dispute first identified either party writing other party shall refer such dispute chief executive officer each party attempted resolution good faith negotiation within thirty nbsp calendar after such notice received style margin margin bottom text indent font size font family time roman dispute resolution chief executive officer able resolve such dispute referred them under section within such thirty nbsp calendar period then either party shall have right obligation submit such controversy claim binding mediation party unable resolve such dispute within thirty nbsp calendar after such dispute referred binding mediation accordance with this section within thirty nbsp calendar after dispute referred chief executive officer under section case then either party refer matter expedited arbitration accordance with section unless such dispute controversy claim relating scope validity enforceability infringement patent right covering manufacture sale product trademark right relating product which case shall resolved accordance with section style margin margin bottom text indent font size font family time roman patent trademark dispute resolution dispute controversy claim relating scope validity enforceability infringement patent right covering manufacture sale product trademark right relating product shall submitted court patent authority competent jurisdiction territory which such patent trademark right were granted arose style margin margin bottom text indent font size font family time roman arbitration dispute relating validity performance construction interpretation this agreement which resolved amicably between party shall determined arbitration accordance with arbitration rule american arbitration association decision arbitrator shall final binding upon party enforceable court competent jurisdiction place arbitration vienna austria number arbitrator three language arbitration proceeding english judgment upon award made arbitrator entered court having jurisdiction thereof style margin margin bottom text indent font size font family time roman injunctive relief nothing herein prevent either party from seeking preliminary injunction temporary restraining order court competent jurisdiction prevent confidential information from being disclosed violation this agreement style margin margin bottom font size font family time roman align center article style margin margin bottom font size font family time roman align center miscellaneous style margin margin bottom text indent font size font family time roman entire agreement amendment this agreement including schedule hereto forth complete final exclusive agreement covenant promise agreement warranty representation condition understanding between party hereto with respect subject matter hereof supersedes effective date prior agreement understanding between party with respect subject matter hereof including confidential disclosure agreement between party dated august nbsp amended nbsp which shall remain effective prior effective date there style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman covenant promise agreement warranty representation condition understanding either oral written between party other than forth herein therein subsequent alteration amendment change addition this agreement shall binding upon party unless reduced writing signed authorized representative each party style margin margin bottom text indent font size font family time roman force majeure party shall excused from performance obligation under this agreement extent that such performance prevented force majeure nonperforming party promptly provides notice prevention other party such excuse shall continued long condition constituting force majeure continues nonperforming party make reasonable effort remove condition purpose this agreement force majeure shall include condition beyond reasonable control party including civil commotion terrorist epidemic failure default public utility common carrier destruction production facility material fire earthquake storm like catastrophe notwithstanding foregoing party shall excused from making payment owed hereunder because force majeure affecting such party when such circumstance arise party shall discus what modification term this agreement required order arrive equitable solution notwithstanding anything contrary foregoing condition covered this section result delay emergent supplying finished product morphosys accordance with term this agreement such delay last nbsp month more then procedure forth section shall apply accordingly style margin margin bottom text indent font size font family time roman notice notice required permitted given under this agreement shall writing shall specifically refer this agreement shall addressed appropriate party address specified below such other address specified such party writing accordance with this section shall deemed have been given purpose nbsp when delivered hand delivered sent facsimile business nbsp next business sent reputable international overnight courier service nbsp five nbsp business after mailing mailed first class certified registered airmail postage prepaid return receipt requested unless otherwise specified writing mailing address party shall described below style font size margin margin bottom nbsp table cellspacing cellpadding width border style border collapse collapse font family time roman font size align center width valign bottom width width valign bottom width width style font family time roman font size valign valign bottom nbsp valign emergent valign bottom nbsp nbsp valign style margin margin bottom font size font family time roman emergent product development seattle style margin margin bottom font size font family time roman suite style margin margin bottom font size font family time roman seattle washington style margin margin bottom font size font family time roman attention site head style font size margin margin bottom nbsp style margin margin bottom font size font family time roman nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp style font size margin margin bottom nbsp style margin margin bottom font size font family time roman emergent biosolutions style margin margin bottom font size font family time roman research blvd suite style margin margin bottom font size font family time roman rockville style margin margin bottom font size font family time roman attention general counsel style margin margin bottom font size font family time roman table style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center table cellspacing cellpadding width border style border collapse collapse font family time roman font size align center width valign bottom width width valign bottom width width style font size height height colspan height colspan style font family time roman font size valign valign bottom nbsp valign with copy valign bottom nbsp nbsp valign style margin margin bottom font size font family time roman morgan lewis bockius style margin margin bottom font size font family time roman carnegie center style margin margin bottom font size font family time roman princeton jersey style margin margin bottom font size font family time roman attn style margin margin bottom font size font family time roman style font size height height colspan height colspan style font family time roman font size valign valign bottom nbsp valign morphosys valign bottom nbsp nbsp valign style margin margin bottom font size font family time roman morphosys style margin margin bottom font size font family time roman lena christ strasse style margin margin bottom font size font family time roman martinsried planegg style margin margin bottom font size font family time roman germany style margin margin bottom font size font family time roman attention style margin margin bottom font size font family time roman style font size height height colspan height colspan style font family time roman font size valign valign bottom nbsp valign with copy valign bottom nbsp nbsp valign style margin margin bottom font size font family time roman morphosys style margin margin bottom font size font family time roman lena christ strasse style margin margin bottom font size font family time roman martinsried planegg style margin margin bottom font size font family time roman germany style margin margin bottom font size font family time roman attention general counsel style margin margin bottom font size font family time roman table style margin margin bottom text indent font size font family time roman strict construction interpretation this agreement been prepared jointly shall strictly construed against either party ambiguity this agreement shall construed against party irrespective which party deemed have authored ambiguous provision heading each article section this agreement have been inserted convenience reference only intended limit expand meaning language contained particular article section style margin margin bottom text indent font size font family time roman assignment neither party assign transfer this agreement right obligation hereunder without prior written consent other party except that nbsp emergent make such assignment without morphosys consent nbsp affiliate provided however that nbsp emergent provides prior written information planned assignment affiliate nbsp will remain jointly severally liable with will guarantee written form agrave morphosys performance relevant affiliate under this agreement nbsp relevant affiliate assignee will assume writing agrave morphosys emergent obligation under this agreement nbsp successor substantially business emergent which this agreement relates whether merger sale stock sale asset other transaction nbsp morphosys make such assignment without emergent consent nbsp affiliate provided however that nbsp morphosys provides prior written information planned assignment affiliate nbsp will remain jointly severally liable with will guarantee written form agrave emergent performance relevant affiliate under this agreement relevant affiliate assignee will assume writing agrave emergent morphosys obligation under this agreement nbsp successor substantially business morphosys whether merger sale stock sale asset other transaction provided however that patent know such transferee successor entity other than party this agreement patent know affiliate party that became affiliate result change control party shall included patent know licensed hereunder otherwise subject this agreement other than morphosys applied technology incorporated into product permitted assignment shall binding successor assigning party assignment attempted assignment either party violation term this section shall null void legal effect style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom text indent font size font family time roman further action each party agrees execute acknowledge deliver such further instrument perform such other necessary appropriate order carry purpose intent this agreement style margin margin bottom text indent font size font family time roman severability more provision this agreement held invalid unenforceable court competent jurisdiction from which appeal taken such provision provision shall considered severed from this agreement shall serve invalidate remaining provision hereof party shall make good faith effort replace invalid unenforceable provision with valid enforceable such that objective contemplated party when entering this agreement realized style margin margin bottom text indent font size font family time roman waiver delay enforcing party right under this agreement waiver particular default other matter shall constitute waiver such party right future enforcement right under this agreement except with respect express written signed waiver relating particular matter particular period time style margin margin bottom text indent font size font family time roman independent contractor each party shall solely independent contractor nothing this agreement shall construed give either party power authority bind commit other party nothing herein shall construed create relationship partner principal agent joint venture partner between party style margin margin bottom text indent font size font family time roman english language governing this agreement prepared english language which language shall govern interpretation dispute regarding term this agreement this agreement dispute arising related this agreement breach hereof shall governed construed under substantive state york without giving effect choice principle that would require application different state style margin margin bottom text indent font size font family time roman counterpart this agreement executed nbsp counterpart each which shall deemed original which together shall constitute same instrument style margin margin bottom font size font family time roman align center further text this page style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom text indent font size font family time roman witness whereof party have executed this agreement their duly authorized representative effective date style font size margin margin bottom nbsp table cellspacing cellpadding width border style border collapse collapse font family time roman font size width valign bottom width width valign bottom width width valign bottom width width valign bottom width width style font family time roman font size valign bottom colspan morphosys valign bottom nbsp valign bottom valign bottom nbsp valign colspan emergent product development seattle style font size height height colspan height colspan height colspan height colspan style font family time roman font size valign valign bottom style border bottom solid nbsp valign style border bottom solid moroney valign bottom nbsp valign style margin margin bottom font size nbsp valign bottom nbsp valign valign bottom style border bottom solid nbsp valign style border bottom solid barry labinger style font family time roman font size valign name valign bottom nbsp valign moroney valign bottom nbsp valign valign bottom nbsp valign name valign bottom nbsp valign bottom barry labinger style font family time roman font size valign title valign bottom nbsp valign valign bottom nbsp valign valign bottom nbsp valign title valign bottom nbsp valign bottom executive president bioscience division style font size height height colspan height colspan height colspan height colspan style font family time roman font size valign valign bottom nbsp valign style margin margin bottom border bottom solid font size font family time roman sproll valign bottom nbsp valign valign bottom nbsp valign valign bottom nbsp valign bottom style font family time roman font size valign name valign bottom nbsp valign sproll valign bottom nbsp valign valign bottom nbsp valign valign bottom nbsp valign bottom style font family time roman font size valign title valign bottom nbsp valign valign bottom nbsp valign valign bottom nbsp valign valign bottom nbsp valign bottom table style margin margin bottom font size font family time roman align center signature page license development agreement style page break before always size style color width align center style margin margin bottom font size font family time roman align center schedule style margin margin bottom font size font family time roman align center emergent manufacturing patent style font size margin margin bottom nbsp table cellspacing cellpadding width border style border collapse collapse font family time roman font size align center width valign bottom width width valign bottom width width valign bottom width width style font family time roman font size valign bottom nowrap style margin margin bottom border bottom solid width font size font family time roman country valign bottom nbsp nbsp valign bottom align center style border bottom solid style margin margin bottom font size font family time roman align center serial number valign bottom nbsp nbsp valign bottom align center style border bottom solid style margin margin bottom font size font family time roman align center publication number valign bottom nbsp nbsp valign bottom align center style border bottom solid style margin margin bottom font size font family time roman align center emergent style margin margin bottom font size font family time roman align center reference number bgcolor cceeff style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp nbsp valign bottom align right valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom align right table style page break before always size style color width align center style margin margin bottom font size font family time roman align center schedule style margin margin bottom font size font family time roman align center emergent patent style font size margin margin bottom nbsp table cellspacing cellpadding width border style border collapse collapse font family time roman font size align center width valign bottom width width valign bottom width width valign bottom width width style font family time roman font size valign bottom nowrap style margin margin bottom border bottom solid width font size font family time roman country valign bottom nbsp nbsp valign bottom align center style border bottom solid style margin margin bottom font size font family time roman align center serial number valign bottom nbsp nbsp valign bottom align center style border bottom solid style margin margin bottom font size font family time roman align center publication nbsp number valign bottom nbsp nbsp valign bottom align center style border bottom solid style margin margin bottom font size font family time roman align center emergent style margin margin bottom font size font family time roman align center reference nbsp number bgcolor cceeff style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp nbsp valign bottom align right valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom align right bgcolor cceeff style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp nbsp valign bottom align right valign bottom nbsp nbsp valign bottom align right valign bottom nbsp nbsp valign bottom align right style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp nbsp valign bottom align right valign bottom nbsp nbsp valign bottom align right valign bottom nbsp nbsp valign bottom align right bgcolor cceeff style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp nbsp valign bottom align right valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom align right style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp nbsp valign bottom align right valign bottom nbsp nbsp valign bottom align right valign bottom nbsp nbsp valign bottom align right bgcolor cceeff style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp nbsp valign bottom align right valign bottom nbsp nbsp valign bottom align right valign bottom nbsp nbsp valign bottom align right style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp nbsp valign bottom align right valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom align right bgcolor cceeff style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp nbsp valign bottom align right valign bottom nbsp nbsp valign bottom align right valign bottom nbsp nbsp valign bottom align right style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp nbsp valign bottom align right valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom align right bgcolor cceeff style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp nbsp valign bottom align right valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom align right style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp nbsp valign bottom align right valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom align right bgcolor cceeff style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp nbsp valign bottom align right valign bottom nbsp nbsp valign bottom align right valign bottom nbsp nbsp valign bottom align right style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp nbsp valign bottom align right valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom align right bgcolor cceeff style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp nbsp valign bottom align right valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom align right style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp nbsp valign bottom align right valign bottom nbsp nbsp valign bottom align right valign bottom nbsp nbsp valign bottom align right bgcolor cceeff style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp nbsp valign bottom align right valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom align right style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp nbsp valign bottom align right valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom align right bgcolor cceeff style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp nbsp valign bottom align right valign bottom nbsp nbsp valign bottom align right valign bottom nbsp nbsp valign bottom align right style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp nbsp valign bottom align right valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom align right bgcolor cceeff style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp nbsp valign bottom align right valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom align right style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp nbsp valign bottom align right valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom align right bgcolor cceeff style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp nbsp valign bottom align right valign bottom nbsp nbsp valign bottom align right valign bottom nbsp nbsp valign bottom align right style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp nbsp valign bottom align right valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom align right table style page break before always size style color width align center style margin margin bottom font size font family time roman align center schedule style margin margin bottom font size font family time roman align center emergent platform patent style font size margin margin bottom nbsp table cellspacing cellpadding width border style border collapse collapse font family time roman font size align center width valign bottom width width valign bottom width width valign bottom width width style font family time roman font size valign bottom nowrap style margin margin bottom border bottom solid width font size font family time roman country valign bottom nbsp nbsp valign bottom align center style border bottom solid style margin margin bottom font size font family time roman align center serial number valign bottom nbsp nbsp valign bottom align center style border bottom solid style margin margin bottom font size font family time roman align center publication number valign bottom nbsp nbsp valign bottom align center style border bottom solid style margin margin bottom font size font family time roman align center emergent style margin margin bottom font size font family time roman align center reference number table style margin margin bottom font size font family time roman confidential material omitted filed separately with security exchange commission total page were omitted style page break before always size style color width align center style margin margin bottom font size font family time roman align center schedule style margin margin bottom font size font family time roman align center phase clinical trial style margin margin bottom font size font family time roman align center synopsis phase clinical trial style font size margin margin bottom nbsp table cellspacing cellpadding width border style border collapse collapse font family time roman font size align center width style font family time roman font size valign style margin margin bottom font size font family time roman name sponsor company style font size margin margin bottom nbsp style margin margin bottom font size font family time roman emergent product development seattle style font size height style font family time roman font size valign style margin margin bottom font size font family time roman name investigational product style font size margin margin bottom nbsp style margin margin bottom font size font family time roman style font size height style font family time roman font size valign style margin margin bottom font size font family time roman name active ingredient style font size margin margin bottom nbsp style margin margin bottom font size font family time roman style font size height style font family time roman font size valign style margin margin bottom font size font family time roman title study style font size margin margin bottom nbsp style margin margin bottom font size font family time roman phase study patient with metastatic castration resistant prostate cancer mcrpc style font size height style font family time roman font size valign style margin margin bottom font size font family time roman objective stage style font size margin margin bottom nbsp style margin margin bottom font size font family time roman nbsp nbsp nbsp nbsp primary style font size margin margin bottom nbsp style margin margin bottom font size font family time roman style font size margin margin bottom nbsp style margin margin bottom font size font family time roman nbsp nbsp nbsp nbsp secondary style font size margin margin bottom nbsp style margin margin bottom font size font family time roman style font size margin margin bottom nbsp style margin margin bottom font size font family time roman objective stage style font size margin margin bottom nbsp style margin margin bottom font size font family time roman nbsp nbsp nbsp nbsp primary style font size margin margin bottom nbsp style margin margin bottom font size font family time roman style font size margin margin bottom nbsp style margin margin bottom font size font family time roman nbsp nbsp nbsp nbsp secondary style font size margin margin bottom nbsp style margin margin bottom font size font family time roman style font size height style font family time roman font size valign style margin margin bottom font size font family time roman study design style font size margin margin bottom nbsp style margin margin bottom font size font family time roman study will conducted stage stage dose escalation study determine stage stage style font size height style font family time roman font size valign table style page break before always size style color width align center table cellspacing cellpadding width border style border collapse collapse font family time roman font size align center width style font family time roman font size valign style margin margin bottom font size font family time roman stage dose escalation dosing will start style font size margin margin bottom nbsp style margin margin bottom font size font family time roman stage style font size height style font family time roman font size valign style margin margin bottom font size font family time roman number patient planned style font size margin margin bottom nbsp style margin margin bottom font size font family time roman approximately patient will enrolled stage patient will enrolled stage style font size height style font family time roman font size valign style margin margin bottom font size font family time roman selected entry criterion style font size margin margin bottom nbsp style margin margin bottom font size font family time roman inclusion criterion style font size margin margin bottom nbsp style margin margin bottom font size font family time roman style font size margin margin bottom nbsp style margin margin bottom font size font family time roman exclusion criterion style font size margin margin bottom nbsp style margin margin bottom font size font family time roman style font size height style font family time roman font size valign style margin margin bottom font size font family time roman investigational product dosage mode administration style font size margin margin bottom nbsp style margin margin bottom font size font family time roman will style font size height style font family time roman font size valign style margin margin bottom font size font family time roman duration treatment style font size margin margin bottom nbsp style margin margin bottom font size font family time roman patient will dosed until style font size height style font family time roman font size valign style margin margin bottom font size font family time roman reference therapy dosage mode administration style font size margin margin bottom nbsp style margin margin bottom font size font family time roman style font family time roman font size valign style font size margin margin bottom nbsp style margin margin bottom font size font family time roman assessment style font size margin margin bottom nbsp style margin margin bottom font size font family time roman safety style font size margin margin bottom nbsp style margin margin bottom font size font family time roman safety will assessed style font size margin margin bottom nbsp style margin margin bottom font size font family time roman pharmacokinetics style font size margin margin bottom nbsp style margin margin bottom font size font family time roman will examined table style font size margin margin bottom nbsp table cellspacing cellpadding width border style border collapse collapse font family time roman font size align center width style font family time roman font size valign style margin margin bottom font size font family time roman clinical activity style font size margin margin bottom nbsp style margin margin bottom font size font family time roman clinical activity endpoint include style font size height style font family time roman font size valign style margin margin bottom font size font family time roman statistical method style font size margin margin bottom nbsp style margin margin bottom font size font family time roman descriptive statistic will table style page break before always size style color width align center style margin margin bottom font size font family time roman align center schedule style margin margin bottom font size font family time roman align center initial development plan style margin margin bottom font size font family time roman style margin margin bottom font size font family time roman note initial development plan effective date describes activity timeline clinical study using prostate cancer style margin margin bottom font size font family time roman estimated development cost initial development plan style font size margin margin bottom nbsp table cellspacing cellpadding width border style border collapse collapse font family time roman font size align center width valign bottom width valign bottom width valign bottom width valign bottom width valign bottom width valign bottom width style font family time roman font size valign bottom nowrap style margin margin bottom border bottom solid width font size font family time roman million rounded valign bottom nbsp nbsp valign bottom align center style border bottom solid valign bottom nbsp valign bottom align center style border bottom solid valign bottom nbsp valign bottom align center style border bottom solid valign bottom nbsp valign bottom align center style border bottom solid valign bottom nbsp valign bottom align center style border bottom solid valign bottom nbsp valign bottom align center style border bottom solid total bgcolor cceeff style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman annual estimated development cost valign bottom nbsp nbsp valign bottom align center valign bottom nbsp valign bottom align center valign bottom nbsp valign bottom align center valign bottom nbsp valign bottom align center valign bottom nbsp valign bottom align center valign bottom nbsp valign bottom align center style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman morphosys share development cost valign bottom nbsp nbsp valign bottom align center valign bottom nbsp valign bottom align center valign bottom nbsp valign bottom align center valign bottom nbsp valign bottom align center valign bottom nbsp valign bottom align center valign bottom nbsp valign bottom align center bgcolor cceeff style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman emergent share development cost valign bottom nbsp nbsp valign bottom align center valign bottom nbsp valign bottom align center valign bottom nbsp valign bottom align center valign bottom nbsp valign bottom align center valign bottom nbsp valign bottom align center valign bottom nbsp valign bottom align center table style margin margin bottom font size font family time roman note cost summary above calculated development clarity development cost listed above include style margin margin bottom font size font family time roman phase clinical trial style margin margin bottom font size font family time roman scope emergent shall conduct phase clinical trial according clinical study protocol protocol which synopsis schedule such future agreed amendment style margin margin bottom font size font family time roman clinical trial site phase clinical trial style margin margin bottom font size font family time roman stage phase clinical trial clinical trial site style margin margin bottom font size font family time roman stage phase clinical trial style margin margin bottom font size font family time roman style page break before always size style color width align center style margin margin bottom font size font family time roman align center schedule style margin margin bottom font size font family time roman align center development supply price clinical supply cost summary style font size margin margin bottom nbsp table cellspacing cellpadding width border style border collapse collapse font family time roman font size align center width valign bottom width width style font family time roman font size valign logo valign bottom nbsp nbsp valign bottom align right confidential proprietary table table cellspacing cellpadding width border style border collapse collapse font family time roman font size align center width valign bottom width width valign bottom width width valign bottom width width valign bottom width width bgcolor cceeff style font family time roman font size valign valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom bgcolor cceeff style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom bgcolor cceeff style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom bgcolor cceeff style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom bgcolor cceeff style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom bgcolor cceeff style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom bgcolor cceeff style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom table style margin margin bottom font size font family time roman style margin margin bottom font size font family time roman align right confidential proprietary style page break before always size style color width align center table cellspacing cellpadding width border style border collapse collapse font family time roman font size align center width valign bottom width width valign bottom width valign bottom width valign bottom width valign bottom width bgcolor cceeff style font family time roman font size valign valign bottom nbsp nbsp valign bottom colspan valign bottom nbsp nbsp colspan valign bottom style font family time roman font size valign valign bottom nbsp nbsp valign bottom colspan valign bottom nbsp nbsp valign bottom colspan bgcolor cceeff style font family time roman font size valign valign bottom nbsp nbsp valign bottom colspan valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom bgcolor cceeff style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp nbsp colspan valign bottom style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom bgcolor cceeff style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom bgcolor cceeff style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp nbsp valign bottom colspan valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom bgcolor cceeff style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom bgcolor cceeff style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom bgcolor cceeff style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp nbsp colspan valign bottom style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom bgcolor cceeff style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom bgcolor cceeff style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom bgcolor cceeff style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom table style page break before always size style color width align center table cellspacing cellpadding width border style border collapse collapse font family time roman font size align center width valign bottom width width valign bottom width valign bottom width valign bottom width valign bottom width bgcolor cceeff style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom bgcolor cceeff style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom bgcolor cceeff style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom bgcolor cceeff style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom bgcolor cceeff style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom bgcolor cceeff style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom bgcolor cceeff style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom bgcolor cceeff style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp nbsp valign valign bottom nbsp nbsp valign valign bottom nbsp nbsp valign valign bottom nbsp nbsp valign valign bottom nbsp nbsp valign table style page break before always size style color width align center style margin margin bottom align center logo style margin margin bottom font size font family time roman align center schedule style margin margin bottom font size font family time roman align center disclosure style margin margin bottom font size font family time roman information forth this disclosure schedule which relates representation warranty covenant agreement agreement subject following qualification style margin margin bottom font size font family time roman this disclosure schedule qualified entirety reference specific provision agreement intended constitute shall construed constituting representation warranty covenant agreement emergent except extent provided agreement inclusion information this disclosure schedule shall construed admission liability fault with respect matter covered such information style margin margin bottom font size font family time roman exception disclosure forth part subpart this disclosure schedule qualify particular section subsection agreement which such representation warranty appears style margin margin bottom font size font family time roman heading contained this disclosure schedule convenience reference only shall deemed part agreement shall referred connection with construction interpretation agreement style page break before always size style color width align center style margin margin bottom font size font family time roman section nbsp style margin margin bottom font size font family time roman confidential material omitted filed separately with security exchange commission total page omitted style page break before always size style color width align center style margin margin bottom font size font family time roman section nbsp study performed with which were performed listed below style font size margin margin bottom nbsp table cellspacing cellpadding width border style border collapse collapse font family time roman font size align center width valign bottom width valign bottom width valign bottom width valign bottom width style font family time roman font size valign bottom nowrap style margin margin bottom border bottom solid width font size font family time roman location data room valign bottom nbsp nbsp valign bottom align center style border bottom solid valign bottom nbsp valign bottom align center style border bottom solid fileroom valign bottom nbsp valign bottom align center style border bottom solid file nbsp type valign bottom nbsp valign bottom align center style border bottom solid nbsp status bgcolor cceeff style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp nbsp valign bottom align center valign bottom nbsp valign bottom align center valign bottom nbsp valign bottom align center valign bottom nbsp valign bottom align center style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp nbsp valign bottom align center valign bottom nbsp valign bottom align center valign bottom nbsp valign bottom align center valign bottom nbsp valign bottom align center bgcolor cceeff style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp nbsp valign bottom align center valign bottom nbsp valign bottom align center valign bottom nbsp valign bottom align center valign bottom nbsp valign bottom align center style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp nbsp valign bottom align center valign bottom nbsp valign bottom align center valign bottom nbsp valign bottom align center valign bottom nbsp valign bottom align center bgcolor cceeff style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp nbsp valign bottom align center valign bottom nbsp valign bottom align center valign bottom nbsp valign bottom align center valign bottom nbsp valign bottom align center style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp nbsp valign bottom align center valign bottom nbsp valign bottom align center valign bottom nbsp valign bottom align center valign bottom nbsp valign bottom align center bgcolor cceeff style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp nbsp valign bottom align center valign bottom nbsp valign bottom align center valign bottom nbsp valign bottom align center valign bottom nbsp valign bottom align center style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp nbsp valign bottom align center valign bottom nbsp valign bottom align center valign bottom nbsp valign bottom align center valign bottom nbsp valign bottom align center bgcolor cceeff style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp nbsp valign bottom align center valign bottom nbsp valign bottom align center valign bottom nbsp valign bottom align center valign bottom nbsp valign bottom align center style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp nbsp valign bottom align center valign bottom nbsp valign bottom align center valign bottom nbsp valign bottom align center valign bottom nbsp valign bottom align center bgcolor cceeff style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp nbsp valign bottom align center valign bottom nbsp valign bottom align center valign bottom nbsp valign bottom align center valign bottom nbsp valign bottom align center style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp nbsp valign bottom align center valign bottom nbsp valign bottom align center valign bottom nbsp valign bottom align center valign bottom nbsp valign bottom align center bgcolor cceeff style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp nbsp valign bottom align center valign bottom nbsp valign bottom align center valign bottom nbsp valign bottom align center valign bottom nbsp valign bottom align center style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp nbsp valign bottom align center valign bottom nbsp valign bottom align center valign bottom nbsp valign bottom align center valign bottom nbsp valign bottom align center bgcolor cceeff style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp nbsp valign bottom align center valign bottom nbsp valign bottom align center valign bottom nbsp valign bottom align center valign bottom nbsp valign bottom align center style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp nbsp valign bottom align center valign bottom nbsp valign bottom align center valign bottom nbsp valign bottom align center valign bottom nbsp valign bottom align center bgcolor cceeff style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp nbsp valign bottom align center valign bottom nbsp valign bottom align center valign bottom nbsp valign bottom align center valign bottom nbsp valign bottom align center style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp nbsp valign bottom align center valign bottom nbsp valign bottom align center valign bottom nbsp valign bottom align center valign bottom nbsp valign bottom align center bgcolor cceeff style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp nbsp valign bottom align center valign bottom nbsp valign bottom align center valign bottom nbsp valign bottom align center valign bottom nbsp valign bottom align center style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp nbsp valign bottom align center valign bottom nbsp valign bottom align center valign bottom nbsp valign bottom align center valign bottom nbsp valign bottom align center bgcolor cceeff style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp nbsp valign bottom align center valign bottom nbsp valign bottom align center valign bottom nbsp valign bottom align center valign bottom nbsp valign bottom align center table style page break before always size style color width align center table cellspacing cellpadding width border style border collapse collapse font family time roman font size align center width valign bottom width valign bottom width valign bottom width valign bottom width style font family time roman font size valign bottom nowrap style margin margin bottom border bottom solid width font size font family time roman location data room valign bottom nbsp nbsp valign bottom align center style border bottom solid valign bottom nbsp valign bottom align center style border bottom solid fileroom valign bottom nbsp valign bottom align center style border bottom solid file nbsp type valign bottom nbsp valign bottom align center style border bottom solid nbsp status bgcolor cceeff style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp nbsp valign bottom align center valign bottom nbsp valign bottom align center valign bottom nbsp valign bottom align center valign bottom nbsp valign bottom align center style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp nbsp valign bottom align center valign bottom nbsp valign bottom align center valign bottom nbsp valign bottom align center valign bottom nbsp valign bottom align center bgcolor cceeff style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp nbsp valign bottom align center valign bottom nbsp valign bottom align center valign bottom nbsp valign bottom align center valign bottom nbsp valign bottom align center style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp nbsp valign bottom align center valign bottom nbsp valign bottom align center valign bottom nbsp valign bottom align center valign bottom nbsp valign bottom align center bgcolor cceeff style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp nbsp valign bottom align center valign bottom nbsp valign bottom align center valign bottom nbsp valign bottom align center valign bottom nbsp valign bottom align center style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp nbsp valign bottom align center valign bottom nbsp valign bottom align center valign bottom nbsp valign bottom align center valign bottom nbsp valign bottom align center bgcolor cceeff style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp nbsp valign bottom align center valign bottom nbsp valign bottom align center valign bottom nbsp valign bottom align center valign bottom nbsp valign bottom align center style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp nbsp valign bottom align center valign bottom nbsp valign bottom align center valign bottom nbsp valign bottom align center valign bottom nbsp valign bottom align center bgcolor cceeff style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp nbsp valign bottom align center valign bottom nbsp valign bottom align center valign bottom nbsp valign bottom align center valign bottom nbsp valign bottom align center style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp nbsp valign bottom align center valign bottom nbsp valign bottom align center valign bottom nbsp valign bottom align center valign bottom nbsp valign bottom align center bgcolor cceeff style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp nbsp valign bottom align center valign bottom nbsp valign bottom align center valign bottom nbsp valign bottom align center valign bottom nbsp valign bottom align center style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp nbsp valign bottom align center valign bottom nbsp valign bottom align center valign bottom nbsp valign bottom align center valign bottom nbsp valign bottom align center bgcolor cceeff style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp nbsp valign bottom align center valign bottom nbsp valign bottom align center valign bottom nbsp valign bottom align center valign bottom nbsp valign bottom align center style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp nbsp valign bottom align center valign bottom nbsp valign bottom align center valign bottom nbsp valign bottom align center valign bottom nbsp valign bottom align center bgcolor cceeff style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp nbsp valign bottom align center valign bottom nbsp valign bottom align center valign bottom nbsp valign bottom align center valign bottom nbsp valign bottom align center style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp nbsp valign bottom align center valign bottom nbsp valign bottom align center valign bottom nbsp valign bottom align center valign bottom nbsp valign bottom align center bgcolor cceeff style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp nbsp valign bottom align center valign bottom nbsp valign bottom align center valign bottom nbsp valign bottom align center valign bottom nbsp valign bottom align center style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp nbsp valign bottom align center valign bottom nbsp valign bottom align center valign bottom nbsp valign bottom align center valign bottom nbsp valign bottom align center bgcolor cceeff style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp nbsp valign bottom align center valign bottom nbsp valign bottom align center valign bottom nbsp valign bottom align center valign bottom nbsp valign bottom align center style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp nbsp valign bottom align center valign bottom nbsp valign bottom align center valign bottom nbsp valign bottom align center valign bottom nbsp valign bottom align center bgcolor cceeff style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp nbsp valign bottom align center valign bottom nbsp valign bottom align center valign bottom nbsp valign bottom align center valign bottom nbsp valign bottom align center style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp nbsp valign bottom align center valign bottom nbsp valign bottom align center valign bottom nbsp valign bottom align center valign bottom nbsp valign bottom align center bgcolor cceeff style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp nbsp valign bottom align center valign bottom nbsp valign bottom align center valign bottom nbsp valign bottom align center valign bottom nbsp valign bottom align center style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp nbsp valign bottom align center valign bottom nbsp valign bottom align center valign bottom nbsp valign bottom align center valign bottom nbsp valign bottom align center table style page break before always size style color width align center table cellspacing cellpadding width border style border collapse collapse font family time roman font size align center width valign bottom width valign bottom width valign bottom width valign bottom width style font family time roman font size valign bottom nowrap style margin margin bottom border bottom solid width font size font family time roman location data room valign bottom nbsp nbsp valign bottom align center style border bottom solid valign bottom nbsp valign bottom align center style border bottom solid fileroom valign bottom nbsp valign bottom align center style border bottom solid file nbsp type valign bottom nbsp valign bottom align center style border bottom solid nbsp status bgcolor cceeff style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp nbsp valign bottom align center valign bottom nbsp valign bottom align center valign bottom nbsp valign bottom align center valign bottom nbsp valign bottom align center style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp nbsp valign bottom align center valign bottom nbsp valign bottom align center valign bottom nbsp valign bottom align center valign bottom nbsp valign bottom align center bgcolor cceeff style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp nbsp valign bottom align center valign bottom nbsp valign bottom align center valign bottom nbsp valign bottom align center valign bottom nbsp valign bottom align center style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp nbsp valign bottom align center valign bottom nbsp valign bottom align center valign bottom nbsp valign bottom align center valign bottom nbsp valign bottom bgcolor cceeff style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp nbsp valign bottom align center valign bottom nbsp valign bottom align center valign bottom nbsp valign bottom align center valign bottom nbsp valign bottom style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp nbsp valign bottom align center valign bottom nbsp valign bottom align center valign bottom nbsp valign bottom align center valign bottom nbsp valign bottom bgcolor cceeff style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp nbsp valign bottom align center valign bottom nbsp valign bottom align center valign bottom nbsp valign bottom align center valign bottom nbsp valign bottom align center style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp nbsp valign bottom align center valign bottom nbsp valign bottom align center valign bottom nbsp valign bottom align center valign bottom nbsp valign bottom align center bgcolor cceeff style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp nbsp valign bottom align center valign bottom nbsp valign bottom align center valign bottom nbsp valign bottom align center valign bottom nbsp valign bottom align center style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp nbsp valign bottom align center valign bottom nbsp valign bottom align center valign bottom nbsp valign bottom align center valign bottom nbsp valign bottom align center bgcolor cceeff style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp nbsp valign bottom align center valign bottom nbsp valign bottom align center valign bottom nbsp valign bottom align center valign bottom nbsp valign bottom align center style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp nbsp valign bottom align center valign bottom nbsp valign bottom align center valign bottom nbsp valign bottom align center valign bottom nbsp valign bottom align center bgcolor cceeff style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp nbsp valign bottom align center valign bottom nbsp valign bottom align center valign bottom nbsp valign bottom align center valign bottom nbsp valign bottom align center style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp nbsp valign bottom align center valign bottom nbsp valign bottom align center valign bottom nbsp valign bottom align center valign bottom nbsp valign bottom align center bgcolor cceeff style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp nbsp valign bottom align center valign bottom nbsp valign bottom align center valign bottom nbsp valign bottom align center valign bottom nbsp valign bottom align center style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp nbsp valign bottom align center valign bottom nbsp valign bottom align center valign bottom nbsp valign bottom align center valign bottom nbsp valign bottom align center bgcolor cceeff style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp nbsp valign bottom align center valign bottom nbsp valign bottom align center valign bottom nbsp valign bottom align center valign bottom nbsp valign bottom align center style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp nbsp valign bottom align center valign bottom nbsp valign bottom align center valign bottom nbsp valign bottom align center valign bottom nbsp valign bottom align center bgcolor cceeff style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp nbsp valign bottom align center valign bottom nbsp valign bottom align center valign bottom nbsp valign bottom align center valign bottom nbsp valign bottom align center style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp nbsp valign bottom align center valign bottom nbsp valign bottom align center valign bottom nbsp valign bottom align center valign bottom nbsp valign bottom align center bgcolor cceeff style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp nbsp valign bottom align center valign bottom nbsp valign bottom align center valign bottom nbsp valign bottom align center valign bottom nbsp valign bottom align center style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp nbsp valign bottom align center valign bottom nbsp valign bottom align center valign bottom nbsp valign bottom align center valign bottom nbsp valign bottom align center bgcolor cceeff style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp nbsp valign bottom align center valign bottom nbsp valign bottom align center valign bottom nbsp valign bottom align center valign bottom nbsp valign bottom align center table style page break before always size style color width align center table cellspacing cellpadding width border style border collapse collapse font family time roman font size align center width valign bottom width valign bottom width valign bottom width valign bottom width style font family time roman font size valign bottom nowrap style margin margin bottom border bottom solid width font size font family time roman location data room valign bottom nbsp nbsp valign bottom align center style border bottom solid valign bottom nbsp valign bottom align center style border bottom solid fileroom valign bottom nbsp valign bottom align center style border bottom solid file nbsp type valign bottom nbsp valign bottom align center style border bottom solid nbsp status bgcolor cceeff style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp nbsp valign bottom align center valign bottom nbsp valign bottom align center valign bottom nbsp valign bottom align center valign bottom nbsp valign bottom align center style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp nbsp valign bottom align center valign bottom nbsp valign bottom align center valign bottom nbsp valign bottom align center valign bottom nbsp valign bottom align center bgcolor cceeff style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp nbsp valign bottom align center valign bottom nbsp valign bottom align center valign bottom nbsp valign bottom align center valign bottom nbsp valign bottom align center style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp nbsp valign bottom align center valign bottom nbsp valign bottom align center valign bottom nbsp valign bottom align center valign bottom nbsp valign bottom align center bgcolor cceeff style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp nbsp valign bottom align center valign bottom nbsp valign bottom align center valign bottom nbsp valign bottom align center valign bottom nbsp valign bottom align center style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp nbsp valign bottom align center valign bottom nbsp valign bottom align center valign bottom nbsp valign bottom align center valign bottom nbsp valign bottom align center bgcolor cceeff style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp nbsp valign bottom align center valign bottom nbsp valign bottom align center valign bottom nbsp valign bottom align center valign bottom nbsp valign bottom align center style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp nbsp valign bottom align center valign bottom nbsp valign bottom align center valign bottom nbsp valign bottom align center valign bottom nbsp valign bottom align center bgcolor cceeff style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp nbsp valign bottom align center valign bottom nbsp valign bottom align center valign bottom nbsp valign bottom align center valign bottom nbsp valign bottom align center style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp nbsp valign bottom align center valign bottom nbsp valign bottom align center valign bottom nbsp valign bottom align center valign bottom nbsp valign bottom align center bgcolor cceeff style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp nbsp valign bottom align center valign bottom nbsp valign bottom align center valign bottom nbsp valign bottom align center valign bottom nbsp valign bottom align center style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp nbsp valign bottom align center valign bottom nbsp valign bottom align center valign bottom nbsp valign bottom align center valign bottom nbsp valign bottom align center bgcolor cceeff style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp nbsp valign bottom align center valign bottom nbsp valign bottom align center valign bottom nbsp valign bottom align center valign bottom nbsp valign bottom align center style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp nbsp valign bottom align center valign bottom nbsp valign bottom align center valign bottom nbsp valign bottom align center valign bottom nbsp valign bottom align center bgcolor cceeff style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp nbsp valign bottom align center valign bottom nbsp valign bottom align center valign bottom nbsp valign bottom align center valign bottom nbsp valign bottom align center style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp nbsp valign bottom align center valign bottom nbsp valign bottom align center valign bottom nbsp valign bottom align center valign bottom nbsp valign bottom align center table style page break before always size style color width align center style margin margin bottom font size font family time roman align center schedule style margin margin bottom font size font family time roman align center press release style margin margin bottom font size font family time roman align center morphosys press release following page style page break before always size style color width align center style margin margin bottom align center logo style margin margin bottom font size font family time roman medium release style margin margin bottom font size font family time roman martinsried munich germany rockville nbsp august style margin margin bottom font size font family time roman morphosys emergent biosolutions sign license agreement develop commercialize prostate cancer drug candidate style margin margin bottom font size font family time roman align center morphosys hold public conference call english wednesday nbsp august style margin margin bottom font size font family time roman align center cest style margin margin bottom font size font family time roman morphosys prime standard segment tecdax mpsyy emergent biosolutions nyse today announced agreement joint development commercialization compound renamed anti psma anti specific antibody targeting prostate cancer which developed emergent using proprietary adaptir style font size vertical align modular protein technology platform preclinical vitro vivo study have shown that redirects cell cytotoxicity towards prostate cancer cell expressing prostate specific membrane antigen psma antigen commonly found such cell style margin margin bottom font size font family time roman under term agreement morphosys gain worldwide commercialization right excluding canada where emergent will retain right emergent will receive upfront payment million will eligible receive potential milestone payment million milestone payment linked specific event including successful development several indication securing approval certain territory morphosys emergent will jointly develop with morphosys bearing emergent total cost emergent will manufacture supply clinical material from manufacturing facility baltimore maryland emergent will receive single digit royalty product sale morphosys territory morphosys will receive tiered royalty from single digit product sale emergent territory additional financial detail were disclosed style margin margin bottom font size font family time roman nbsp arndt schottelius chief development officer morphosys added pleased working with emergent biosolutions believe potential important therapy prostate cancer where there pressing need better treatment preclinical data suggest that molecule number potential advantage over other drug candidate this indication goal combine capability with those emergent enable fastest possible development commercialization style margin margin bottom font size font family time roman barry labinger executive vice president president bioscience division emergent biosolutions stated emergent look forward collaborating with morphosys potentially address important unmet need amongst patient suffering from prostate cancer company bring complementary capability compatible culture value shared commitment highest quality development commercialization expect begin clinical development within next month encouraged partnership with morphosys continued interest multiple party adaptir platform style page break before always size style color width align center style margin margin bottom font size font family time roman morphosys emergent plan initiate phase clinical trial evaluating patient with metastatic castration resistant prostate cancer mcrpc within next month initial phase trial will conducted australia with emergent sponsor style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign morphosys will hold public conference call tomorrow nbsp august cest present information agreement with emergent biosolutions table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign dial number conference call listen only table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign germany nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign resident nbsp nbsp nbsp nbsp nbsp nbsp table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign resident nbsp nbsp nbsp nbsp nbsp nbsp table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign please dial minute before beginning conference table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left viii align left valign addition morphosys offer participant opportunity follow presentation through simultaneous slide presentation online http morphosys table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign live webcast slide webcast replay transcript will made available http morphosys table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign approximately hour after press conference slide synchronized audio replay conference will available http morphosys table style margin margin bottom font size font family time roman about style margin margin bottom font size font family time roman targeted immunotherapeutic protein which activates host cell immunity specifically against prostate cancer cell expressing prostate specific membrane antigen psma antigen commonly overexpressed prostate cancer cell molecule constructed using emergent adaptir technology platform selectively bind cell receptor cytotoxic cell psma tumor cell contains pair binding domain each targeting unique antigen linked opposite immunoglobulin domain extend half life enable purification process typical based molecule preclinical study been shown redirect cell cytotoxicity towards prostate cancer cell expressing psma style page break before always size style color width align center style margin margin bottom font size font family time roman about adaptir platform style margin margin bottom font size font family time roman adaptir bispecific protein modular single chain polypeptide that comprise separate binding domain hinge segment effector domain hufc they have differentiated structure from monoclonal antibody generate unique signaling response some adaptir molecule like mediate cell cytotoxicity redirecting cell against tumor cell addition monospecific adaptir protein mediate complement dependent cytotoxicity dependent cytotoxicity similar monoclonal antibody style margin margin bottom font size font family time roman adaptir emergent biosolutions brand product service feature name logo slogan trademark registered trademark emergent biosolutions subsidiary united state other country right reserved style margin margin bottom font size font family time roman about prostate cancer style margin margin bottom font size font family time roman prostate cancer most common cancer with approximately case annually united state case annually worldwide screening radiation surgery hormone ablation therapy have greatly improved detection treatment early stage prostate cancer however therapy only improve life expectancy month patient with metastatic castration resistant prostate cancer style margin margin bottom font size font family time roman about morphosys style margin margin bottom font size font family time roman morphosys developed hucal most successful antibody library technology pharmaceutical industry successfully applying this other patented technology morphosys become leader field therapeutic antibody fastest growing drug class human healthcare style margin margin bottom font size font family time roman together with pharmaceutical partner morphosys built therapeutic pipeline more than human antibody drug candidate treatment cancer rheumatoid arthritis alzheimer disease name just with ongoing commitment antibody technology drug development morphosys focused making healthcare product tomorrow morphosys listed frankfurt stock exchange under symbol regular update about morphosys visit http morphosys style margin margin bottom font size font family time roman hucal style font size vertical align hucal gold style font size vertical align hucal platinum style font size vertical align cysdisplay style font size vertical align rapmat style font size vertical align aryla style font size vertical align ylanthia style font size vertical align billion high potential style font size vertical align registered trademark morphosys style margin margin bottom font size font family time roman slonomics style font size vertical align registered trademark sloning biotechnology gmbh subsidiary morphosys style margin margin bottom font size font family time roman about emergent biosolutions style margin margin bottom font size font family time roman emergent biosolutions global specialty biopharmaceutical company seeking protect enhance life offering specialized product healthcare provider government address medical need emerging health threat additional information about found emergentbiosolutions follow twitter emergentbiosolu style margin margin bottom font size font family time roman adaptir trademark emergent biosolutions style margin margin bottom font size font family time roman morphosys safe harbor statement style margin margin bottom font size font family time roman this communication contains certain forward looking statement concerning morphosys group company forward looking statement contained herein represent judgment morphosys date this release involve risk uncertainty should actual condition differ from company assumption actual result action differ from those anticipated morphosys intend update these forward looking statement wording relevant press release concerned style page break before always size style color width align center style margin margin bottom font size font family time roman emergent biosolutions safe harbor statement style margin margin bottom font size font family time roman this press release includes forward looking statement within meaning private security litigation reform statement other than statement historical fact forward looking statement forward looking statement this press release include statement about potential therapeutic opportunity molecule potential milestone royalty payment development regulatory approval sale product candidate these forward looking statement based current intention belief expectation regarding future event guarantee that forward looking statement will accurate investor should realize that underlying assumption prove inaccurate unknown risk uncertainty materialize actual result could differ materially from expectation investor therefore cautioned place undue reliance forward looking statement forward looking statement speaks only date this press release except required undertake update forward looking statement reflect information event circumstance style margin margin bottom font size font family time roman there number important factor that could cause company actual result differ materially from those indicated such forward looking statement including success clinical trial timing ability obtain maintain regulatory approval rate degree market acceptance clinical utility product commercialization marketing manufacturing capability strategy with respect foregoing forth many factor that could cause actual result differ from expectation forward looking statement investor should consider this cautionary statement well risk factor identified periodic report filed with when evaluating forward looking statement style font size margin margin bottom nbsp table cellspacing cellpadding width border style border collapse collapse font family time roman font size align center width valign bottom width width valign bottom width width style font family time roman font size valign style margin margin bottom font size font family time roman more information please contact morphosys style margin margin bottom font size font family time roman claudia gutjahr ouml style margin margin bottom font size font family time roman head corporate communication style font size margin margin bottom nbsp style margin margin bottom font size font family time roman mario brkulj style margin margin bottom font size font family time roman associate director corporate style margin margin bottom font size font family time roman communication style font size margin margin bottom nbsp style margin margin bottom font size font family time roman alexandra goller style margin margin bottom font size font family time roman specialist corporate communication style font size margin margin bottom nbsp style margin margin bottom font size font family time roman jessica rush style margin margin bottom font size font family time roman specialist corporate communication style margin margin bottom font size font family time roman style margin margin bottom font size font family time roman investor morphosys valign bottom nbsp nbsp valign style font size margin margin bottom nbsp style margin margin bottom font size font family time roman emergent biosolutions style margin margin bottom font size font family time roman investor contact style margin margin bottom font size font family time roman robert burrow style margin margin bottom font size font family time roman vice president investor relation style margin margin bottom font size font family time roman style margin margin bottom font size font family time roman burrowsr ebsi style font size margin margin bottom nbsp style margin margin bottom font size font family time roman medium contact style margin margin bottom font size font family time roman tracey schmitt style margin margin bottom font size font family time roman vice president global public affair style margin margin bottom font size font family time roman corporate responsibility style margin margin bottom font size font family time roman style margin margin bottom font size font family time roman schmittt ebsi valign bottom nbsp nbsp valign table style page break before always size style color width align center style margin margin bottom font size font family time roman align center emergent press release following page style page break before always size style color width align center style margin margin bottom align center logo style margin margin bottom font size font family time roman medium release style margin margin bottom font size font family time roman rockville martinsried munich germany nbsp august style margin margin bottom font size font family time roman emergent biosolutions morphosys sign license agreement develop commercialize prostate cancer drug candidate style margin margin bottom font size font family time roman emergent biosolutions nyse morphosys prime standard segment tecdax mpsyy today announced agreement joint development commercialization emergent preclinical specific antibody targeting prostate cancer under term agreement emergent will receive upfront payment million milestone payment million these milestone payment linked specific event including successful development several indication securing approval certain territory emergent morphosys will jointly develop with morphosys bearing emergent total cost emergent will retain commercialization right canada with tiered royalty obligation morphosys from single digit morphosys will gain worldwide commercialization right excluding canada with single digit royalty obligation emergent emergent will manufacture supply clinical material from manufacturing facility baltimore maryland additional financial detail were disclosed style margin margin bottom font size font family time roman which will renamed developed emergent using proprietary adaptir modular protein technology platform preclinical vitro vivo study have shown that redirects cell cytotoxicity towards prostate cancer cell expressing prostate specific membrane antigen psma antigen commonly found such cell style margin margin bottom font size font family time roman barry labinger executive vice president president bioscience division emergent biosolutions stated emergent look forward collaborating with morphosys potentially address important unmet need amongst patient suffering from prostate cancer company bring complementary capability compatible culture value shared commitment highest quality development commercialization expect begin clinical development within next month progress with will help validate adaptir platform which believe broad potential generate additional novel treatment cancer other important disease encouraged partnership with morphosys continued interest multiple party adaptir platform style margin margin bottom font size font family time roman arndt schottelius chief development officer morphosys added pleased working with emergent biosolutions believe potential important therapy prostate cancer where there pressing need better treatment preclinical data suggest that molecule number potential advantage over other drug candidate this indication goal combine capability with those emergent enable fastest possible development commercialization style page break before always size style color width align center style margin margin bottom font size font family time roman emergent morphosys plan initiate phase clinical trial evaluating patient with metastatic castration resistant prostate cancer mcrpc within next month initial phase trial will conducted australia with emergent sponsor style margin margin bottom font size font family time roman about style margin margin bottom font size font family time roman targeted immunotherapeutic protein which activates host cell immunity specifically against prostate cancer cell expressing prostate specific membrane antigen psma antigen commonly overexpressed prostate cancer cell molecule constructed using emergent adaptir technology platform selectively bind cell receptor cytotoxic cell psma tumor cell contains pair binding domain each targeting unique antigen linked opposite immunoglobulin domain extend half life enable purification process typical based molecule preclinical study been shown redirect cell cytotoxicity towards prostate cancer cell expressing psma style margin margin bottom font size font family time roman about adaptir platform style margin margin bottom font size font family time roman adaptir bispecific protein modular single chain polypeptide that comprise separate binding domain hinge segment effector domain hufc they have differentiated structure from monoclonal antibody generate unique signaling response some adaptir molecule like mediate cell cytotoxicity redirecting cell against tumor cell addition monospecific adaptir protein mediate complement dependent cytotoxicity dependent cytotoxicity similar monoclonal antibody style margin margin bottom font size font family time roman adaptir emergent biosolutions brand product service feature name logo slogan trademark registered trademark emergent biosolutions subsidiary united state other country right reserved style margin margin bottom font size font family time roman about prostate cancer style margin margin bottom font size font family time roman prostate cancer most common cancer with approximately case annually united state case annually worldwide screening radiation surgery hormone ablation therapy have greatly improved detection treatment early stage prostate cancer however therapy only improve life expectancy month patient with metastatic castration resistant prostate cancer style margin margin bottom font size font family time roman about emergent biosolutions style margin margin bottom font size font family time roman emergent biosolutions global specialty biopharmaceutical company seeking protect enhance life offering specialized product healthcare provider government address medical need emerging health threat additional information about found emergentbiosolutions follow twitter emergentbiosolu style margin margin bottom font size font family time roman about morphosys style margin margin bottom font size font family time roman morphosys developed hucal most successful antibody library technology pharmaceutical industry successfully applying this other patented technology morphosys become leader field therapeutic antibody fastest growing drug class human healthcare style page break before always size style color width align center style margin margin bottom font size font family time roman together with pharmaceutical partner morphosys built therapeutic pipeline more than human antibody drug candidate treatment cancer rheumatoid arthritis alzheimer disease name just with ongoing commitment antibody technology drug development morphosys focused making healthcare product tomorrow morphosys listed frankfurt stock exchange under symbol regular update about morphosys visit http morphosys style margin margin bottom font size font family time roman hucal style font size vertical align hucal gold style font size vertical align hucal platinum style font size vertical align cysdisplay style font size vertical align rapmat style font size vertical align aryla style font size vertical align ylanthia style font size vertical align billion high potential style font size vertical align registered trademark morphosys style margin margin bottom font size font family time roman slonomics style font size vertical align registered trademark sloning biotechnology gmbh subsidiary morphosys style margin margin bottom font size font family time roman emergent biosolutions safe harbor statement style margin margin bottom font size font family time roman this press release includes forward looking statement within meaning private security litigation reform statement other than statement historical fact forward looking statement forward looking statement this press release include statement about potential therapeutic opportunity molecule potential milestone royalty payment development regulatory approval sale product candidate these forward looking statement based current intention belief expectation regarding future event guarantee that forward looking statement will accurate investor should realize that underlying assumption prove inaccurate unknown risk uncertainty materialize actual result could differ materially from expectation investor therefore cautioned place undue reliance forward looking statement forward looking statement speaks only date this press release except required undertake update forward looking statement reflect information event circumstance style margin margin bottom font size font family time roman there number important factor that could cause company actual result differ materially from those indicated such forward looking statement including success clinical trial timing ability obtain maintain regulatory approval rate degree market acceptance clinical utility product commercialization marketing manufacturing capability strategy with respect foregoing forth many factor that could cause actual result differ from expectation forward looking statement investor should consider this cautionary statement well risk factor identified periodic report filed with when evaluating forward looking statement style margin margin bottom font size font family time roman morphosys safe harbor statement style margin margin bottom font size font family time roman this communication contains certain forward looking statement concerning morphosys group company forward looking statement contained herein represent judgment morphosys date this release involve risk uncertainty should actual condition differ from company assumption actual result action differ from those anticipated morphosys intend update these forward looking statement wording relevant press release concerned style page break before always size style color width align center style margin margin bottom font size font family time roman more information please contact style font size margin margin bottom nbsp table cellspacing cellpadding width border style border collapse collapse font family time roman font size align center width valign bottom width width style font family time roman font size valign style margin margin bottom font size font family time roman emergent biosolutions style font size margin margin bottom nbsp style margin margin bottom font size font family time roman investor contact style margin margin bottom font size font family time roman robert burrow style margin margin bottom font size font family time roman vice president investor relation style margin margin bottom font size font family time roman style margin margin bottom font size font family time roman burrowsr ebsi style font size margin margin bottom nbsp style margin margin bottom font size font family time roman medium contact style margin margin bottom font size font family time roman tracey schmitt style margin margin bottom font size font family time roman vice president global public affair style margin margin bottom font size font family time roman corporate responsibility style margin margin bottom font size font family time roman style margin margin bottom font size font family time roman schmittt ebsi valign bottom nbsp nbsp valign style margin margin bottom font size font family time roman morphosys style margin margin bottom font size font family time roman claudia gutjahr ouml style margin margin bottom font size font family time roman head corporate communication style font size margin margin bottom nbsp style margin margin bottom font size font family time roman mario brkulj style margin margin bottom font size font family time roman associate director corporate style margin margin bottom font size font family time roman communication style font size margin margin bottom nbsp style margin margin bottom font size font family time roman alexandra goller style margin margin bottom font size font family time roman specialist corporate communication style font size margin margin bottom nbsp style margin margin bottom font size font family time roman jessica rush style margin margin bottom font size font family time roman specialist corporate communication style margin margin bottom font size font family time roman style margin margin bottom font size font family time roman investor morphosys table body html text document